
<html lang="en"     class="pb-page"  data-request-id="9ef6dd21-9070-432d-9dde-46d405fe9a65"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.9b01626;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2020.63.issue-2;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Scaffold Hopping of Natural Product Evodiamine: Discovery of a Novel Antitumor Scaffold with Excellent Potency against Colon Cancer" /></meta><meta name="dc.Creator" content="Lei  Wang" /></meta><meta name="dc.Creator" content="Kun  Fang" /></meta><meta name="dc.Creator" content="Junfei  Cheng" /></meta><meta name="dc.Creator" content="Yu  Li" /></meta><meta name="dc.Creator" content="Yahui  Huang" /></meta><meta name="dc.Creator" content="Shuqiang  Chen" /></meta><meta name="dc.Creator" content="Guoqiang  Dong" /></meta><meta name="dc.Creator" content="Shanchao  Wu" /></meta><meta name="dc.Creator" content="Chunquan  Sheng" /></meta><meta name="dc.Description" content="Inspired by the natural product evodiamine, a novel antitumor indolopyrazinoquinazolinone scaffold was designed by scaffold hopping. Structure–activity relationship studies led to the discovery of ..." /></meta><meta name="Description" content="Inspired by the natural product evodiamine, a novel antitumor indolopyrazinoquinazolinone scaffold was designed by scaffold hopping. Structure–activity relationship studies led to the discovery of ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 27, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01626" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01626" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01626" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01626" /></link>
        
    
    

<title>Scaffold Hopping of Natural Product Evodiamine: Discovery of a Novel Antitumor Scaffold with Excellent Potency against Colon Cancer | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01626" /></meta><meta property="og:title" content="Scaffold Hopping of Natural Product Evodiamine: Discovery of a Novel Antitumor Scaffold with Excellent Potency against Colon Cancer" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0019.jpeg" /></meta><meta property="og:description" content="Inspired by the natural product evodiamine, a novel antitumor indolopyrazinoquinazolinone scaffold was designed by scaffold hopping. Structure–activity relationship studies led to the discovery of compound 15j, which shows low nanomolar inhibitory activity against the HCT116 cell line. Further antitumor mechanism studies indicated that compound 15j acted by the dual inhibition of topoisomerase 1 and tubulin and induced apoptosis with G2 cell-cycle arrest. The quaternary ammonium salt of compound 15j (compound 15js) exhibited excellent in vivo antitumor activity (TGI = 66.6%) in the HCT116 xenograft model with low toxicity. Indolopyrazinoquinazolinone derivatives represent promising multitargeting antitumor leads for the development of novel antitumor agents." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01626"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01626">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01626&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01626&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01626&amp;href=/doi/10.1021/acs.jmedchem.9b01626" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 2</span><span class="cit-fg-pageRange">, 696-713</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/2" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01618" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01670" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Scaffold Hopping of Natural Product Evodiamine: Discovery of a Novel Antitumor Scaffold with Excellent Potency against Colon Cancer</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Lei Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lei Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</div><div class="loa-info-affiliations-info">School of Pharmacy, Fujian University of Traditional Chinese Medicine, 1 Qiuyang Road, Fuzhou, Fujian 350122, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lei++Wang">Lei Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kun Fang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kun Fang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kun++Fang">Kun Fang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Junfei Cheng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Junfei Cheng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Junfei++Cheng">Junfei Cheng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yu Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yu Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yu++Li">Yu Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yahui Huang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yahui Huang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yahui++Huang">Yahui Huang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shuqiang Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shuqiang Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shuqiang++Chen">Shuqiang Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Guoqiang Dong</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Guoqiang Dong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#1a7e7d6b37222b5a2b2c2934797577"><span class="__cf_email__" data-cfemail="94f0f3e5b9aca5d4a5a2a7baf7fbf9">[email protected]</span></a>. Phone/Fax: +86 21 81871242 (G.D.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Guoqiang++Dong">Guoqiang Dong</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shanchao Wu</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shanchao Wu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#addad8dec5ccc3cec5ccc29d9af29fed9c9f9b83cec2c0"><span class="__cf_email__" data-cfemail="a8dfdddbc0c9c6cbc0c9c7989ff79ae8999a9e86cbc7c5">[email protected]</span></a>. Phone/Fax: +86 21 81871242 (S.W.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shanchao++Wu">Shanchao Wu</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Chunquan Sheng</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chunquan Sheng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</div><div class="loa-info-affiliations-info">School of Pharmacy, Fujian University of Traditional Chinese Medicine, 1 Qiuyang Road, Fuzhou, Fujian 350122, China</div><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#6d1e0508030a0e1c2d1e00001843080918430e03"><span class="__cf_email__" data-cfemail="483b202d262f2b39083b25253d662d2c3d662b26">[email protected]</span></a>. Phone/Fax: +86 21 81871239 (C.S.).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chunquan++Sheng">Chunquan Sheng</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9489-804X" title="Orcid link">http://orcid.org/0000-0001-9489-804X</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01626&amp;href=/doi/10.1021%2Facs.jmedchem.9b01626" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 2</span><span class="cit-pageRange">, 696–713</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 27, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 October 2019</li><li><span class="item_label"><b>Published</b> online</span>27 December 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 January 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01626" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01626</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D696%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLei%2BWang%252C%2BKun%2BFang%252C%2BJunfei%2BCheng%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D2%26contentID%3Dacs.jmedchem.9b01626%26title%3DScaffold%2BHopping%2Bof%2BNatural%2BProduct%2BEvodiamine%253A%2BDiscovery%2Bof%2Ba%2BNovel%2BAntitumor%2BScaffold%2Bwith%2BExcellent%2BPotency%2Bagainst%2BColon%2BCancer%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D713%26publicationDate%3DJanuary%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01626"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2035</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01626" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Scaffold Hopping of Natural Product Evodiamine: Discovery of a Novel Antitumor Scaffold with Excellent Potency against Colon Cancer&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Lei&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Kun&quot;,&quot;last_name&quot;:&quot;Fang&quot;},{&quot;first_name&quot;:&quot;Junfei&quot;,&quot;last_name&quot;:&quot;Cheng&quot;},{&quot;first_name&quot;:&quot;Yu&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Yahui&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Shuqiang&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Guoqiang&quot;,&quot;last_name&quot;:&quot;Dong&quot;},{&quot;first_name&quot;:&quot;Shanchao&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Chunquan&quot;,&quot;last_name&quot;:&quot;Sheng&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;27&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;696-713&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01626&quot;},&quot;abstract&quot;:&quot;Inspired by the natural product evodiamine, a novel antitumor indolopyrazinoquinazolinone scaffold was designed by scaffold hopping. Structure–activity relationship studies led to the discovery of compound 15j, which shows low nanomolar inhibitory activity against the HCT116 cell line. Further antitumor mechanism studies indicated that compound 15j acted by the dual inhibition of topoisomerase 1 and tubulin and induced apoptosis with G2 cell-cycle arrest. The quaternary ammonium salt of compound 15j (compound 15js) exhibited excellent in vivo antitumor activity (TGI = 66.6%) in the HCT116 xenograft model with low toxicity. Indolopyrazinoquinazolinone derivatives represent promising multitargeting antitumor leads for the development of novel antitumor agents.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01626&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01626" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01626&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01626" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01626&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01626" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01626&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01626&amp;href=/doi/10.1021/acs.jmedchem.9b01626" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01626" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01626" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01626%26sid%3Dliteratum%253Aachs%26pmid%3D31880942%26genre%3Darticle%26aulast%3DWang%26date%3D2020%26atitle%3DScaffold%2BHopping%2Bof%2BNatural%2BProduct%2BEvodiamine%253A%2BDiscovery%2Bof%2Ba%2BNovel%2BAntitumor%2BScaffold%2Bwith%2BExcellent%2BPotency%2Bagainst%2BColon%2BCancer%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D2%26spage%3D696%26epage%3D713%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (4)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=292201" title="Scaffolds">Scaffolds</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291098" title="Antitumor activity">Antitumor activity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/2" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/jmcmar.2020.63.issue-2/20200123/jmcmar.2020.63.issue-2.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01626&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Inspired by the natural product evodiamine, a novel antitumor indolopyrazinoquinazolinone scaffold was designed by scaffold hopping. Structure–activity relationship studies led to the discovery of compound <b>15j</b>, which shows low nanomolar inhibitory activity against the HCT116 cell line. Further antitumor mechanism studies indicated that compound <b>15j</b> acted by the dual inhibition of topoisomerase 1 and tubulin and induced apoptosis with G2 cell-cycle arrest. The quaternary ammonium salt of compound <b>15j</b> (compound <b>15js</b>) exhibited excellent in vivo antitumor activity (TGI = 66.6%) in the HCT116 xenograft model with low toxicity. Indolopyrazinoquinazolinone derivatives represent promising multitargeting antitumor leads for the development of novel antitumor agents.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74542" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74542" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Natural products (NPs) are critical in antitumor drug discovery and development.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> To date, approximately 83% (113 out of 136) of anticancer small molecules approved by the FDA are NPs or NP derivatives.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> For instance, camptothecin (CPT), a typical topoisomerase 1 (Top1) inhibitor isolated in 1966 from the Chinese tree <i>Camptotheca acuminnata</i> shows potent antitumor activity. The modification of natural CPT resulted in several clinical antitumor drugs, such as topotecan (TPT)<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and irinotecan (IRT).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">Historical analysis of NP-based drug discovery indicates that successful examples of the direct development of unmodified NPs are still rare,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> mainly due to insufficient levels of activity, high structural complexity, unfavorable physicochemical and pharmacokinetic properties, significant toxicity, and so on.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Therefore, the structural optimization of NPs to improve their pharmacological activities and druggabilities is always required before they can be developed into clinical drugs.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> Strategies for the structural modification of NPs mainly include designing NP derivatives through step-by-step structure–activity relationship (SAR) analyses,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> structural simplification of structurally complex NPs,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and the generation of NP-based compound libraries with scaffold diversity.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In particular, the design of NP-based novel molecular scaffolds by scaffold hopping is an effective strategy to better navigate the drug-like chemical space around NPs and identify drug candidates.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">Evodiamine (<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) is the main alkaloid component of the traditional Chinese herb Wu-Chu-Yu, and it has diverse biological activities.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> In recent years, evodiamine has attracted broad research interest as an antitumor lead compound.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Evodiamine has a multitargeting antitumor effect and acts by the induction of apoptosis and the inhibition of invasion and metastasis.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11−13)</a> Previously, we performed systematic structural optimizations of evodiamine and identified highly active evodiamine derivatives.<a onclick="showRef(event, 'ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16">(14−16)</a> Moreover, diverse evodiamine-inspired scaffolds were designed, leading to the discovery of several novel evodiamine derivatives (<b>2–4</b>) with potent in vitro and in vivo antitumor activities (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16">(14−16)</a> Thus, designing novel scaffolds based on evodiamine offers an effective and promising strategy for developing novel antitumor agents. Thus, the chemical space around the evodiamine skeleton must be extensively explored. Furthermore, the in vivo antitumor activities of our previously identified oxo- and thio-evodiamine derivatives (<b>2–4</b>) remain to be improved.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of evodiamine, oxo-, and thio-evodiamine derivatives and indolopyrazinoquinazolinone <b>15a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01626&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To this end, an evodiamine-based scaffold hopping strategy was applied to design a novel indolopyrazinoquinazolinone scaffold (<b>15a</b>) by reversing the connectivity of the B/C rings of evodiamine (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Systematic SAR studies led to compound <b>15j</b>, which was shown to possess excellent antitumor potency. Interestingly, the quaternary ammonium salt of <b>15j</b> (compound <b>15js</b>) showed potent in vivo antitumor efficacy in HCT116 colon cancer xenograft models with low toxicity.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78565" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78565" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The chemical synthesis of various substituted indolopyrazinoquinazolinone derivatives is depicted in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<named-content content-type="anchor" rid="sch2" type="simple"></named-content><named-content content-type="anchor" rid="sch3" type="simple"></named-content><named-content content-type="anchor" rid="sch4" type="simple"></named-content><a class="ref internalNav" href="#sch5" aria-label="5">5</a>. First, substituted 1<i>H</i>-indole-2-carboxylic acids <b>5</b> and ethanol were refluxed in the presence of concentrated sulfuric acid to afford various ethyl 1<i>H</i>-indole-2-carboxylates <b>6</b>. Then, intermediates <b>6</b> were reacted with 2-bromoacetonitrile in the presence of sodium hydride (NaH) and <i>N</i>,<i>N</i>-dimethylformamide (DMF) at room temperature, and subsequent intramolecular ring closure provided intermediates <b>8</b>. Starting from substituted 2-aminobenzoic acids <b>9</b>, methyl 2-(methylamino)benzoate intermediates <b>13</b> were synthesized through esterification, <i>N</i>-Boc protection, <i>N</i>-methylation, and hydrolysis. The coupling of intermediates <b>8</b> and <b>13</b> in the presence of POCl<sub>3</sub> under microwave conditions produced corresponding dehydro-intermediates <b>14</b>.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Finally, target compounds <b>15a–z</b> and <b>15aa–ab</b> were obtained by reduction with NaBH<sub>4</sub> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01626&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) EtOH, H<sub>2</sub>SO<sub>4</sub>, reflux, 10 h; (b) BrCH<sub>2</sub>CN, NaH, DMF, rt, overnight, yield 45–62% over two steps; (c) NaBH<sub>4</sub>, CoCl<sub>2</sub>, MeOH, THF, reflux, 6 h, yield 39–55%; (d) MeOH, SOCl<sub>2</sub>, reflux, overnight; (e) (Boc)<sub>2</sub>O, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, overnight, yield 31–56%; (f) MeI, NaH, DMF, rt, 6 h, yield 61–85%; (g) CF<sub>3</sub>COOH, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h, yield 82–96%; (h) POCl<sub>3</sub>, toluene, microwave, 130 °C, 45 min; and (i) NaBH<sub>4</sub>, EtOH, rt, 1 h, yield 23–62% over two steps.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01626&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Na, MeOH, 0 °C, 6 h, yield 53–72%; (b) 1,2-dichlorobenzene, 180 °C, 2 h, yield 65–78%. (c) BrCH<sub>2</sub>CN, NaH, DMF, rt, overnight; NaBH<sub>4</sub>, CoCl<sub>2</sub>, MeOH, THF, reflux, 6 h, yield 45–62% over two steps; (d) POCl<sub>3</sub>, toluene, microwave, 130 °C, 45 min; and (e) NaBH<sub>4</sub>, EtOH, rt, 1 h, yield 36–37% over two steps.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01626&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C, 2.5 h, yield 43%; (b) benzoyl peroxide, NBS, CCl<sub>4</sub>, reflux, 3.5 h, yield 24–26%; (c) Lawesson’s reagent, toluene, reflux, 4 h, yield 37%; (d) POCl<sub>3</sub>, DMF, rt, 2 h, yield 82–86%; (e) NaBH<sub>4</sub>, MeOH, rt, 1 h, yield 92–93%; and (f) methylpiperazine, NaBH<sub>3</sub>CN, CH<sub>3</sub>COOH, DCM, rt, overnight, yield 63%.</p></p></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01626&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (Me<sub>3</sub>Si)<sub>2</sub>NHNa, MeI, THF, rt, overnight, yield 44%; (b) NaBH<sub>4</sub>, CoCl<sub>2</sub>, MeOH, THF, reflux, 6 h, yield 36%; (c) POCl<sub>3</sub>, toluene, microwave, 130 °C, 45 min; and (d) NaBH<sub>4</sub>, EtOH, rt, 1 h, yield 32–35% over two steps.</p></p></figure><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01626&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) benzyltrimethylammonium hydroxide, 1,4-dioxane, reflux, 1 h, yield 72%; (b) NaBH<sub>4</sub>, CoCl<sub>2</sub>, MeOH, THF, reflux, 6 h, yield 36%; (c) POCl<sub>3</sub>, toluene, microwave, 130 °C, 45 min; (d) NaBH<sub>4</sub>, EtOH, rt, 1 h, yield 32% over two steps; and (e) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C, 2.5 h, yield 48%.</p></p></figure><div class="NLM_p">Intermediates <b>18</b> were prepared by reacting various benzaldehydes <b>16</b> with ethyl 2-azidoacetate <b>17</b>, followed by intramolecular cyclization in the presence of 1,2-dichlorobenzene at high temperatures to afford substituted ethyl 1<i>H</i>-indole-2-carboxylates <b>19</b>. Then, target compounds <b>23a–c</b> were prepared following synthetic methods similar to those described for derivatives <b>15a–z</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><div class="NLM_p">Target compounds <b>24</b>, <b>25a–b</b>, <b>26–27</b>, <b>28a–b</b>, <b>29a–b,</b> and <b>30</b> were synthesized as shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. 1-Hydroxy-substituted derivative <b>24</b> was obtained by demethylation of <b>15b</b> in the presence of BBr<sub>3</sub> and DCM at −78 °C. The reactions of compounds <b>15b</b> and <b>15f</b> with benzoyl peroxide and <i>N</i>-bromosuccinimide (NBS) produced 9-bromine derivatives <b>25a</b> and <b>b</b>. Treatment of compound <b>15e</b> with Lawesson’s reagent gave thiocarbonyl derivative <b>27</b>. The Vilsmeier reactions<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> of compounds <b>15j</b> and <b>15o</b> afforded corresponding formylated derivatives <b>28a</b> and <b>28b</b>. Compound <b>26</b> was obtained from the reductive amination of compound <b>28a</b>. Additionally, reduction reactions were used to prepare compounds <b>29a</b> and <b>29b</b>.</div><div class="NLM_p last">The structural modification of the C-ring was focused on alkylation of the side chain and ring expansion to a seven-membered ring (<a class="ref internalNav" href="#sch4" aria-label="Schemes 4">Schemes 4</a> and <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). The methylation of intermediate <b>31</b><a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> in the presence of (Me<sub>3</sub>Si)<sub>2</sub>NHNa and MeI gave intermediate <b>32</b>.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The Michael addition of intermediate <b>37</b> and acrylonitrile <b>38</b> smoothly provided intermediate <b>39</b>.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The following methods for the synthesis of derivatives <b>36a–b</b> and <b>43</b> were similar to those used to obtain compounds <b>15a–z</b>.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17463" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17463" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Design, in Vitro Antitumor Activity, and SARs of Indolopyrazinoquinazolinone Derivatives</h3><div class="NLM_p">The indolopyrazinoquinazolinone scaffold (<b>15a</b>) was designed by changing the connectivity between the B-ring and the C-ring of evodiamine. Based on the scaffold of <b>15a</b>, a number of derivatives were designed and synthesized according to their synthetic accessibility and chemical diversity (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). In total, 45 new compounds were designed and synthesized by introducing various substituents on the A, B, and E rings and variations of the C/D ring structures. The growth inhibitory activities of indolopyrazinoquinazolinone derivatives were assayed against human cancer cell lines HCT116 (colon cancer), MDA-MB-435 (breast cancer), and A549 (lung cancer) using CCK8 assay.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Evodiamine and CPT were used as reference drugs. Compared with natural evodiamine, indolopyrazinoquinazolinone <b>15a</b> showed improved activity against the HCT116 and A549 cell lines (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Further modification of compound <b>15a</b> led to the discovery of several derivatives with excellent activities against the HCT116 cell line.</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of indolopyrazinoquinazolinone derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01626&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Antitumor Activities of A- or E-Ring-Modified Derivatives (IC<sub>50</sub>, μM)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0013.gif" alt="" id="GRAPHIC-d7e857-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">HCT116</th><th class="colsep0 rowsep0" align="center">MDA-MB-435</th><th class="colsep0 rowsep0" align="center">A549</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">48.5</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">21.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15b</b></td><td class="colsep0 rowsep0" align="left">1-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">12.0</td><td class="colsep0 rowsep0" align="left">20.2</td><td class="colsep0 rowsep0" align="left">2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15c</b></td><td class="colsep0 rowsep0" align="left">1-Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4.4</td><td class="colsep0 rowsep0" align="left">13.5</td><td class="colsep0 rowsep0" align="left">27.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15d</b></td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15e</b></td><td class="colsep0 rowsep0" align="left">1-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15f</b></td><td class="colsep0 rowsep0" align="left">1-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">13.3</td><td class="colsep0 rowsep0" align="left">>200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15g</b></td><td class="colsep0 rowsep0" align="left">1-Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">7.3</td><td class="colsep0 rowsep0" align="left">15.9</td><td class="colsep0 rowsep0" align="left">15.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15h</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">22-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">124.2</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">24.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15i</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">21-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">49.2</td><td class="colsep0 rowsep0" align="left">168.2</td><td class="colsep0 rowsep0" align="left">15.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23a</b></td><td class="colsep0 rowsep0" align="left">1,2,3-trimethoxy</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">1-OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">44.3</td><td class="colsep0 rowsep0" align="left">16.8</td><td class="colsep0 rowsep0" align="left">14.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">22.1</td><td class="colsep0 rowsep0" align="left">>200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>CPT</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.02</td><td class="colsep0 rowsep0" align="left">2.7</td><td class="colsep0 rowsep0" align="left">2.8</td></tr></tbody></table></div></div><div class="NLM_p">First, various substituents were introduced on the A-ring (<b>15a–g</b>, <b>23a,</b> and <b>24</b>) or E-ring (<b>15h–i</b>). Among them, 1-methyl derivative <b>15f</b> showed the best antitumor activity, and it was particularly active against the HCT116 cell line (IC<sub>50</sub> = 0.03 μM, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). When the 1-methyl group of compound <b>15f</b> was replaced with 1-chloro (<b>15c</b>) and 1-bromo (<b>15g</b>), the antitumor activities against the HCT116 cell line were significantly decreased (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). In contrast, the 1-fluoro analogue (<b>15e</b>) was completely inactive. Unfortunately, the movement of the chloro substituent from C1 (<b>15c</b>) to C2 (<b>15d</b>) or 1,2,3-trimethyl substitution (<b>23a</b>) resulted in total loss of the antitumor activity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Additionally, a 22-methoxy substituent (<b>15h</b>) was unfavorable for activity.</div><div class="NLM_p">Second, A, E-ring di-substituted derivatives were designed and synthesized. In general, 21-fluoro-substituted derivatives (<b>15j</b>, <b>15r</b>, <b>15s</b>, <b>15t</b>, and <b>23b</b>) had better antitumor activities than other 21-substituted derivatives (<b>15k</b>, <b>15l</b>, <b>15m,</b> and <b>15o</b>). In particular, 1-methoxy-21-fluoro analogue <b>15j</b> was highly active against the HCT116 cell line (IC<sub>50</sub> = 0.002 μM, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), and its activity was superior to that of CPT. The results suggested that the 21-fluoro group was important for antitumor activity. Based on compound <b>15j</b>, the replacement of the 1-methoxy group with bromo (<b>15p</b>), chloro (<b>15r</b>), cycloalkoxy (<b>15u–w</b>), and methylthio (<b>23b</b>) groups led to substantial decreases in the antitumor activity, while the 1-methyl (<b>15s</b>) and 1-trifluoromethoxy (<b>15t</b>) derivatives retained excellent activity against the HCT116 cell line (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Therefore, 1-methoxy and 21-fluoro groups were the best combination for antitumor activity.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Antitumor Activities of A- and E-Ring-Modified Derivatives (IC<sub>50</sub>, μM)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0014.gif" alt="" id="GRAPHIC-d7e1217-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">HCT116</th><th class="colsep0 rowsep0" align="center">MDA-MB-435</th><th class="colsep0 rowsep0" align="center">A549</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15j</b></td><td class="colsep0 rowsep0" align="left">1-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">21-F</td><td class="colsep0 rowsep0" align="left">0.002</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">158.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15k</b></td><td class="colsep0 rowsep0" align="left">1-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">21-Cl</td><td class="colsep0 rowsep0" align="left">61.3</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15l</b></td><td class="colsep0 rowsep0" align="left">1-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">21-Br</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15m</b></td><td class="colsep0 rowsep0" align="left">1-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">21-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15n</b></td><td class="colsep0 rowsep0" align="left">1-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">22-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">180.5</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">30.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15o</b></td><td class="colsep0 rowsep0" align="left">1-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">21-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">19.4</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15p</b></td><td class="colsep0 rowsep0" align="left">1-Br</td><td class="colsep0 rowsep0" align="left">21-F</td><td class="colsep0 rowsep0" align="left">28.5</td><td class="colsep0 rowsep0" align="left">97.6</td><td class="colsep0 rowsep0" align="left">>200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15q</b></td><td class="colsep0 rowsep0" align="left">1-Br</td><td class="colsep0 rowsep0" align="left">22-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15r</b></td><td class="colsep0 rowsep0" align="left">1-Cl</td><td class="colsep0 rowsep0" align="left">21-F</td><td class="colsep0 rowsep0" align="left">6.7</td><td class="colsep0 rowsep0" align="left">142.9</td><td class="colsep0 rowsep0" align="left">53.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15s</b></td><td class="colsep0 rowsep0" align="left">1-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">21-F</td><td class="colsep0 rowsep0" align="left">0.06</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">22.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15t</b></td><td class="colsep0 rowsep0" align="left">1-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">21-F</td><td class="colsep0 rowsep0" align="left">0.83</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">95.52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15u</b></td><td class="colsep0 rowsep0" align="left">1-cyclobutoxy</td><td class="colsep0 rowsep0" align="left">21-F</td><td class="colsep0 rowsep0" align="left">34.15</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">98.54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15v</b></td><td class="colsep0 rowsep0" align="left">1-cyclopentyloxy</td><td class="colsep0 rowsep0" align="left">21-F</td><td class="colsep0 rowsep0" align="left">57.85</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">>200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15w</b></td><td class="colsep0 rowsep0" align="left">1-cyclohexyloxy</td><td class="colsep0 rowsep0" align="left">21-F</td><td class="colsep0 rowsep0" align="left">66.82</td><td class="colsep0 rowsep0" align="left">50.14</td><td class="colsep0 rowsep0" align="left">173.50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15x</b></td><td class="colsep0 rowsep0" align="left">1-OCD<sub>3</sub></td><td class="colsep0 rowsep0" align="left">21-F</td><td class="colsep0 rowsep0" align="left">0.01</td><td class="colsep0 rowsep0" align="left">11.43</td><td class="colsep0 rowsep0" align="left">31.33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23b</b></td><td class="colsep0 rowsep0" align="left">2-SCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">21-F</td><td class="colsep0 rowsep0" align="left">9.4</td><td class="colsep0 rowsep0" align="left">85.8</td><td class="colsep0 rowsep0" align="left">8.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23c</b></td><td class="colsep0 rowsep0" align="left">1-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">21,22-diOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>120.60</td><td class="colsep0 rowsep0" align="left">23.82</td><td class="colsep0 rowsep0" align="left">>200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">48.5</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">21.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left">22.1</td><td class="colsep0 rowsep0" align="left">>200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>CPT</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.02</td><td class="colsep0 rowsep0" align="left">2.7</td><td class="colsep0 rowsep0" align="left">2.8</td></tr></tbody></table></div></div><div class="NLM_p">Third, various substituents were introduced on the B- or C-rings (<b>25a–b</b>, <b>26</b>, <b>28a–b</b>, <b>29a–b</b>, <b>30,</b> and <b>36a–b</b>). Based on highly potent compounds <b>15j</b> and <b>15f</b>, the addition of a bromo group at the C9 position (<b>25a</b> and <b>25b</b>) resulted in improved antitumor activity against the A549 cell line, whereas the potencies against the other two cell lines were lower (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Introducing methyl (compound <b>30</b>), formyl methylene (<b>28a</b>), ethanol (<b>29a</b>), or <i>N</i>-methyl piperidyl methylene (<b>26</b>) moieties at the C9 position of compound <b>15j</b> also led to obviously lower activities against the HCT116 cell line (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Moreover, the addition of a dimethyl group (<b>36a–b</b>) to the C10 position of compounds <b>15b</b> and <b>15j</b> led to the loss of the antiproliferative activity (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Antitumor Activities of B-Ring-Modified Derivatives (IC<sub>50</sub>, μM)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0015.gif" alt="" id="GRAPHIC-d7e1671-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0016.gif" alt="" id="gr13" /></img><div></div></div><div class="NLM_p">Finally, the modification of the scaffold was also investigated. However, when the scaffold carbonyl group was converted to a thiocarbonyl, the resulting compound (<b>27</b>) was completely inactive (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). In addition, the replacement of the E-ring phenyl group with a pyrrole (<b>15y–z</b>) or thiophene (<b>15aa</b> and <b>15ab</b>) was unfavorable for the antitumor activity (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Pyrazole derivatives <b>15y–z</b> were almost inactive, and thiophene derivatives <b>15aa</b> and <b>15ab</b> showed moderate antitumor activity with IC<sub>50</sub> values in the range of 9.5–105.9 μM (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). These results indicated that the introduction of a heterocycle at the E-ring might lead to decreased antitumor activity, and detailed SARs remained to be further investigated. Similarly, when the C-ring was enlarged to a seven-membered ring (compounds <b>42</b> and <b>43</b>), no improvement in the antitumor activity was observed (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro Antitumor Activities of Scaffold-Modified Derivatives (IC<sub>50</sub>, μM)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0017.gif" alt="" id="GRAPHIC-d7e1732-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0018.gif" alt="" id="gr14" /></img><div></div></div><div class="NLM_p">The abovementioned analyses suggested preliminary SARs for the indolopyrazinoquinazolinone antitumor scaffold that can be summarized as follows (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). (1) The installation of methoxy or methyl substituents at the C1 position is preferred, whereas the introduction of halogen atoms (F, Cl, and Br) at this position is unfavorable. (2) C21 fluoro substitution is of great importance for antitumor activity. The combination of C21-fluoro and C1-methoxy substitution resulted in the most potent compound (<b>15j</b>). (3) Ring expansion of the C-ring to a seven-membered ring is not beneficial. (4) The conversion of the D-ring carbonyl group into the thiocarbonyl group has a negative effect on the antitumor activity. (5) Substitution at the C9 position is unfavorable.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Summary of the SARs of indolopyrazinoquinazolinone derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01626&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Antitumor Spectrum of Compound <b>15j</b></h3><div class="NLM_p">The abovementioned results showed that a number of derivatives offered highly potent activity against the HCT116 cell line. In an attempt to investigate the antitumor spectrum of this scaffold, compound <b>15j</b> was selected for assays against a variety of human cancer cell lines, including K562 (leukemia cells), PC-3 (pancreatic cancer), MV3 (melanoma cells), BEL7404 (liver cancer), SK-Hep-1 (liver cancer), SW579 (thyroid cancer), and NCI-H446 (small-cell lung cancer). As shown in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, compound <b>15j</b> exhibited good to excellent antitumor activities against the tested cancer cell lines, with the exception of the NCI–H446 cell line. Notably, compound <b>15j</b> was particularly effective against the K562 cell line, with an IC<sub>50</sub> value lower than 3 nM. Moreover, it also showed good antiproliferative activity against the PC-3 (IC<sub>50</sub> = 0.3 μM) and BEL7404 cell lines (IC<sub>50</sub> = 0.1 μM), and its activity was superior to that of CPT (IC<sub>50</sub> = 2.4 and 0.4 μM, respectively). These results revealed that compound <b>15j</b> has a broad antitumor spectrum.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vitro Antitumor Spectrum of Compound <b>15j</b> (IC<sub>50</sub>, μM)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Compd</th><th class="colsep0 rowsep0" align="center">K562</th><th class="colsep0 rowsep0" align="center" char=".">PC-3</th><th class="colsep0 rowsep0" align="center" char=".">MV3</th><th class="colsep0 rowsep0" align="center" char=".">BEL7404</th><th class="colsep0 rowsep0" align="center" char=".">SK-Hep-1</th><th class="colsep0 rowsep0" align="center" char=".">SW579</th><th class="colsep0 rowsep0" align="center">NCI-H446</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15j</b></td><td class="colsep0 rowsep0" align="left"><0.003</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="left">>200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>CPT</b></td><td class="colsep0 rowsep0" align="left"><0.003</td><td class="colsep0 rowsep0" align="char" char=".">2.4</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="left">>200</td></tr></tbody></table></div></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Inhibitory Activities of Compound <b>15j</b> against Top1, Top2, and Tubulin</h3><div class="NLM_p">Previously, evodiamine and its derivatives were identified as dual Top1/Top2 inhibitors.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> They induced cell death by enhancing Top1- or Top2-mediated DNA cleavage through the stabilization of the transient Top1- or Top2-DNA cleavable complexes. To further evaluate the inhibitory effects of indolopyrazinoquinazolinone derivatives on Top1 and Top2, representative compounds (i.e., <b>15a</b>, <b>15j</b>, <b>15c,</b> and <b>15f</b>) were assayed. CPT and etoposide (Eto) were employed as positive controls. As shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A, all of the tested compounds were active against Top1-mediated relaxation of supercoiled DNA at a concentration of 100 μM. However, they were inactive against Top2-mediated DNA relaxation at the same concentration. The abovementioned results confirmed that these derivatives were Top1 inhibitors. Further Top1-mediated DNA cleavage assays of compound <b>15j</b> were conducted to identify whether the derivatives were poisons or catalytic inhibitors. Similar to CPT (a Top1 poison), compound <b>15j</b> could also increase the intensity of the nicked band (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B), suggesting that it was a Top1 poison.</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Top1 and Top2 inhibitory activities of the selected indolopyrazinoquinazolinone derivatives. Inhibition of Top1 relaxation activity at 100 μM: Lane 1, supercoiled plasmid DNA; lane 2, DNA + Top1; lane 3, DNA + Top1 + CPT; lanes 4–7, DNA + Top1 + test compound (<b>15a</b>, <b>15j</b>, <b>15e</b>, and <b>15f</b>, respectively). Inhibition of Top2 relaxation activity at 100 μM: lane 1, supercoiled plasmid DNA; lane 2, DNA + Top2; lane 3, DNA + Top2 + Eto; lanes 4–7, DNA + Top2 + test compound (<b>15a</b>, <b>15j</b>, <b>15e</b>, and <b>15f</b>, respectively). (B) Top1-mediated DNA cleavage assay gel of compound <b>15j</b> using supercoiled pUC19. Lane 1, supercoiled plasmid DNA (pUC19); lane 2, DNA + Top1; lane 3, DNA + Top1 + CPT (100 μM); lanes 4–7, DNA + Top1 + <b>15j</b> (100, 50, 25, and 12.5 μM). (C) Tubulin inhibitory activities of compound <b>15j</b> and colchicine. Following treatment with different concentrations of <b>15j</b> and colchicine, the in vitro polymerization of tubulin at 37 °C was continuously monitored by recording the absorbance at 340 nm over 20 min. The data are the average of two independent experiments. Compound <b>15j</b> showed concentration-dependent inhibition of tubulin polymerization. (D) Tubulin polymerization inhibitory effects of <b>15j</b> by immunostaining assay. HCT116 cells were treated with paclitaxel and <b>15j</b> at different concentrations for 12 h. The nuclei were stained with DAPI (blue), and the microtubules were stained with mouse anti-α-tubulin (green). The images were taken using a TSC SP8 laser confocal microscope (Leica, Germany).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01626&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Our previous work also revealed that 3-chloro-10-hydroxy thio-evodiamine was the first triple Top1/Top2/tubulin inhibitor.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Notably, indolopyrazinoquinazolinone derivatives only exhibited moderate Top1 inhibitory activities, but their antiproliferative activities were comparable or superior to those of CPT, suggesting they might act on additional targets. Given the structural similarity between 3-chloro-10-hydroxy thio-evodiamine and the indolopyrazinoquinazolinone derivatives, the tubulin inhibitory activity of compound <b>15j</b> was determined using a concentration-activity assay<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> with colchicine as the positive control. Similar to colchicine, compound <b>15j</b> was found to inhibit tubulin polymerization in a concentration-dependent manner with an IC<sub>50</sub> value of 26.3 μM (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C), implying that compound <b>15j</b> was a microtubule depolymerization agent. Moreover, visual evidence for the disruption of microtubules can be concurrently obtained using fluorescein mouse anti-α-tubulin analysis. Herein, the tubulin polymerization inhibitory effects of compound <b>15j</b> were further explored by immunofluorescent staining of HCT116 cells using paclitaxel as the control. As shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D, the microtubule networks in untreated HCT116 cells had a normal arrangement with microtubules extending from the central regions of the cell to the cell periphery. In contrast, after treatment with different concentrations of compound <b>15j</b> for 12 h, the microtubules in the cytosol were clustered around the cell nucleus. These findings indicated that compound <b>15j</b> disrupted the microtubule organization of HCT116 cells.</div><div class="NLM_p">Compound <b>15j</b> was also analyzed for its off-target effects in 30 antitumor targets (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A), which did not show any affinity for the examined proteins (<20% inhibition at 5 μM). The abovementioned results suggest that compound <b>15j</b> might selectively act on both Top1 and tubulin. The combination use of Top1 and tubulin inhibitors has a synergistic antitumor effect in cancer patients.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> However, only a few dual Top1/tubulin inhibitors have been reported.<a onclick="showRef(event, 'ref16 ref22'); return false;" href="javascript:void(0);" class="ref ref16 ref22">(16,22)</a> This work provides a new type of dual Top1/tubulin inhibitor and further validated its efficacy in antitumor chemotherapy. Additionally, it should be noted that additional targets might account for the antitumor activity of the indolopyrazinoquinazolinone derivatives, and their multitargeting antitumor mechanisms require further exploration.</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Inhibition rates of compound <b>15j</b> against a panel of 30 antitumor targets. G9a, lysine methyltransferase G9a; Sirtuin1, NAD-dependent deacetylase sirtuin-1; TNKS1, tankyrase 1; TNKS2, tankyrase 2; PARP, poly-ADP-ribose polymerase; JMJD3, jumonji domain-containing 3; SHP2, phosphatase shatterproof 2; DNMT3a/3L, DNA methyltransferase 3a/3L; PRMT1, protein arginine N-methyltransferase 1; EZH2, enhancer of zeste homologue 2; SET8, lysine methyltransferase enzyme SET8; CDK, cell cycle-dependent kinase; MMP, matrix metalloproteinase; PKAC-α, protein kinase A catalytic subunit α; HDAC3, histone deacetylase 3; Abl, Abelson tyrosine kinase; PLK1, polo-like kinase 1; EGFR, epidermal growth factor receptor; JMJD2A, jumonji domain-containing protein 2A; PI3K (p110α/p85α), phosphoinositide-3-kinase (p110α/p85α); FAK, focal adhesion kinase; PDE4A1A, phosphodiesterase 4A1A; PDE4D7, phosphodiesterase 4D7; PDE4A4, phosphodiesterase 4A4. (B) Proposed binding modes for compound <b>15j</b> with the Top1–DNA complex (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T8I">1T8I</a>). (C) Proposed binding modes for compound <b>15j</b> with the colchicine-binding domain of tubulin (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SA0">1SA0</a>). The figures were generated using Pymol (<a href="http://www.pymol.org/" class="extLink">http://www.pymol.org/</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01626&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Binding Modes of Compound <b>15j</b> with Top1/Tubulin</h3><div class="NLM_p last">To better understand the interactions of compound <b>15j</b> with Top1 and tubulin, molecular docking studies were performed using our well-established docking protocols.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> As depicted in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B, compound <b>15j</b> displayed a “planar” configuration and formed base-stacking interactions with the TGP11 base pair in the active site of Top1. As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C, compound <b>15j</b> fit well within the colchicine-binding domain of tubulin. The oxygen atom of the D-ring carbonyl formed a hydrogen bond with Ala 250, and the E-ring formed a salt bridge with the surrounding residue Lys 254.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Compound <b>15j</b>-Induced Apoptosis and G2 Cell-Cycle Arrest in HCT116 Cells</h3><div class="NLM_p">The effect of compound <b>15j</b> on the induction of apoptosis in HCT116 cells was evaluated by flow cytometry. As shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A, compound <b>15j</b> induced apoptosis of HCT116 cells in a concentration-dependent manner. After exposure to various concentrations (0.04, 0.2, and 1 μM) of compound <b>15j</b> for 24 h, the percentages of apoptotic cells were 32.52, 45.97, and 52.00%, respectively. In contrast, the percentage of apoptotic cells in the untreated control was 0.86%. These results demonstrated that compound <b>15j</b> could effectively inhibit cancer cell growth through apoptosis induction. The cell-cycle arrest caused by compound <b>15j</b> in HCT116 cells was determined by flow cytometry, using an equivalent volume of dimethyl sulfoxide (DMSO) as the control (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). After treatment with 4, 12, and 36 nM compound <b>15j</b> for 24 h, the percentage of cells in the G2 fraction increased from 17.73, 35.49 to 84.13%, with a concomitant decrease in the proportion of cells in other phases of the cell cycle, suggesting G2 cell-cycle arrest in HCT116 cells.</div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Induction of apoptosis and cell-cycle arrest by compound <b>15j</b> in HCT116 cells. (A) Effects of compound <b>15j</b> on the induction of apoptosis. The cells were exposed to increasing concentrations of the test compound for 24 h and analyzed by annexin V/propidium iodide double staining. The data are representative of two independent experiments. (B) The effect of compound <b>15j</b> on the cell cycle as determined by flow cytometry. HCT116 cells were treated with compound <b>15j</b> at 4, 12, or 36 nM for 24 h. The data are representative of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01626&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> In Vivo Antitumor Efficacy</h3><div class="NLM_p">Inspired by the excellent in vitro antitumor activity of compound <b>15j</b>, its in vivo antitumor efficacy was further evaluated in an HCT116 xenograft mouse model. However, after intraperitoneal (IP) administration of the test compound for 21 consecutive days at a dose of 4 mg/kg, compound <b>15j</b> only exhibited moderate antitumor activity with a tumor growth inhibition (TGI) rate of 37.0% (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A, <i>P</i> < 0.01). The test compound was well tolerated by the treated mice, and no significant losses of body weight were observed (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B). In contrast, TPT caused a significant loss of body weight at a dose of 0.5 mg/kg.</div><figure id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Antitumor efficacies of compounds <b>15j</b> and <b>15js</b> in the xenograft model. (A) Efficacy of compound <b>15j</b> in the HCT116 xenograft model at a dose of 4 mg/kg. (B) Change in the body weight of nude mice treated with compound <b>15j</b>. (C) Efficacy of compound <b>15js</b> in the HCT116 xenograft model at a dose of 16 mg/kg. (D) Change in the body weight of nude mice treated with compound <b>15js</b>. Data are presented as the mean ± SEM; <i>n</i> = 6 nude mice per group: (*) <i>P</i> < 0.05, (**) <i>P</i> < 0.01, (***) <i>P</i> < 0.001 vs the control group, determined with Student’s <i>t</i>-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01626&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Although compound <b>15j</b> had excellent growth inhibitory activity against the HCT116 cell line (IC<sub>50</sub> = 2 nM), its marginal in vivo antitumor efficacy may be due to its poor aqueous solubility (1.5 μg/mL at pH 7.4) under physiological conditions. To address this limitation, we synthesized the quaternary ammonium salt of compound <b>15j</b> (compound <b>15js</b>), which showed a 500-fold higher aqueous solubility (850.4 μg/mL at pH 7.4). Then, the in vivo antitumor efficacy of compound <b>15js</b> was evaluated in the HCT116 xenograft mouse model. After IP administration for 21 consecutive days at a dose of 16 mg/kg, compound <b>15js</b> exhibited remarkable antitumor potency with a TGI rate of 66.6% (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C), which was comparable to the clinical antitumor agent TPT (TGI = 68.5%). In addition, the body weights of the mice in the three groups were recorded to evaluate the toxicity of the test compounds. As shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>D, compound <b>15js</b> had little effect on the body weight of the treated mice, suggesting that its toxicity was significantly lower than that of TPT.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32414" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32414" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, a novel indolopyrazinoquinazolinone antitumor scaffold was identified by scaffold hopping from evodiamine. Systematic structural optimization and SAR studies led to the discovery of a highly active indolopyrazinoquinazolinone derivative (<b>15j</b>) with low nanomolar inhibitory activity against the HCT116 cell line. Further mechanistic studies revealed that it acted by the dual inhibition of Top1 and tubulin. Compound <b>15js</b> (the quaternary ammonium salt of <b>15j</b>) exhibited excellent in vivo antitumor activity, representing a promising lead compound for the development of new antitumor agents. Additionally, scaffold hopping was shown to be an effective approach to improve the druggability of evodiamine. Further structural optimization and antitumor mechanism studies are currently underway in our laboratories.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20640" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20640" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemistry</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> General Methods</h4><div class="NLM_p last"><sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded on Bruker AVANCE300 or AVANCE600 spectrometers (Bruker Company, Germany) using TMS as an internal standard and DMSO-<i>d</i><sub>6</sub> or CDCl<sub>3</sub> as the solvent. Chemical shifts are given in ppm (δ). The mass spectra were recorded on an Esquire 3000 LC–MS mass spectrometer. Silica gel thin-layer chromatography separations were performed on precoated plates GF-254 (Qingdao Haiyang Chemical, China). All solvents and reagents were analytically pure, and no further purification was needed. All starting materials were commercially available. The purity of each compound was analyzed by HPLC (Agilent Technologies 1260 Infinity) using MeOH/H<sub>2</sub>O as the mobile phase at a flow rate of 0.6 mL/min on a C18 column (Agilent 20RBA × SB-C18, 5 μm, 4.6 mm × 150 mm). All final compounds exhibited purities greater than 95%.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Ethyl 1-(Cyanomethyl)-5-methoxy-1<i>H</i>-indole-2-carboxylate (<b>7a</b>)</h4><div class="NLM_p last">To a solution of intermediate <b>5a</b> (5.00 g, 25.90 mmol) in EtOH (80 mL) was slowly added concentrated sulfuric acid (4 mL), and the mixture was refluxed for 12 h. After the reaction, the solution was cooled to room temperature, and the resulting brown solid was separated by filtration and washed with water to afford crude intermediate <b>6a</b>, which can be directly used in the next step without further purification. Then, <b>6a</b> was dissolved in DMF (40 mL), and NaH (60% dispersion in mineral oil, 1.10 g, 27.40 mmol) was slowly added at 0 °C. After the reaction was stirred at 0 °C for 30 min, 2-bromoacetonitrile (4.38 g, 36.50 mmol) was added in one portion. The mixture was stirred at room temperature for 12 h and then poured into ice water (250 mL). The aqueous layer was extracted with ethyl acetate (3 × 150 mL), and the combined organic layers were washed with brine, dried over sodium sulfate, and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel (PE/EtOAc = 10:1) to afford intermediate <b>7a</b> (4.2 g, yield 62% over two steps) as a white solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.09 (s, 1H), 7.44 (d, <i>J</i> = 9.0 Hz, 1H), 7.13 (s, 1H), 6.94 (m, 2H), 6.15 (t, <i>J</i> = 5.8 Hz, 2H), 3.76 (s, 3H), 3.62 (m, 1H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 161.82, 155.57, 134.10, 126.97, 126.86, 117.62, 114.96, 112.12, 110.51, 103.43, 61.13, 55.75, 32.44, 14.29; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>14</sub>H<sub>15</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 259.1077; found, 259.1076.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 8-Methoxy-3,4-dihydropyrazino[1,2-<i>a</i>]indol-1(2<i>H</i>)-one (<b>8a</b>)</h4><div class="NLM_p">Intermediate <b>7a</b> (2.00 g, 7.70 mmol) and CoCl<sub>2</sub> (2.00 g, 15.40 mmol) were dissolved in dry MeOH (30 mL) and THF (15 mL), and NaBH<sub>4</sub> (1.85 g, 77.00 mmol) was slowly added in an ice bath. After the mixture was heated to 60 °C for 4 h, the mixture was filtered through a plug of Celite and washed with DCM. Then, the filtrate was concentrated and purified by column chromatography on SiO<sub>2</sub> (DCM/MeOH = 100:1) to afford <b>8a</b> (0.90 g, 51%) as a white solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.09 (s, 1H), 7.46 (d, <i>J</i> = 9.0 Hz, 1H), 7.14 (d, <i>J</i> = 2.3 Hz, 1H), 6.92–6.96 (m, 2H), 4.22 (t, <i>J</i> = 5.6 Hz, 2H), 3.76 (s, 3H), 3.59–3.64 (m, 2H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 160.65, 154.58, 132.11, 130.52, 127.27, 115.54, 112.04, 104.09, 102.85, 55.75; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>12</sub>H<sub>12</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 217.0972; found, 217.0970.</div><div class="NLM_p last">Intermediates <b>8b–f</b> were synthesized via a procedure similar to that used for intermediate <b>8a</b>.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Methyl 3-((<i>tert</i>-Butoxycarbonyl)amino)thiophene-2-carboxylate (<b>11i</b>)</h4><div class="NLM_p last">To a stirred solution of 3-aminothiophene-2-carboxylic acid (2.30 g, 16.00 mmol) in MeOH (150 mL) was added SOCl<sub>2</sub> (20 mL) dropwise at 0 °C, and the mixture was then refluxed for 12 h. Then, the solvent was removed under reduced pressure, and H<sub>2</sub>O (50 mL) was added to the residue. The pH of the solution was adjusted to 7 with saturated Na<sub>2</sub>CO<sub>3</sub> solution, and the mixture was extracted with DCM (3 × 100 mL). The combined organic phase was dried over sodium sulfate and concentrated to 100 mL. Then, (Boc)<sub>2</sub>O (4.20 g, 19.10 mmol) and DMAP (0.15 g, 1.27 mmol) were added, and the mixture was stirred for 12 h at room temperature. After the reaction, the solvent was evaporated, and the residue was purified by column chromatography on silica gel (PE/EtOAc = 100:1) to afford <b>9i</b> (1.3 g, yield 31% over two steps) as a white solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.28 (s, 1H), 7.88–7.90 (m, 1H), 7.73 (d, <i>J</i> = 5.4 Hz, 1H), 3.81 (s, 3H), 1.48 (s, 9H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.36, 151.66, 145.18, 133.86, 121.16, 108.41, 81.48, 52.52, 28.26; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>11</sub>H<sub>15</sub>NNaO<sub>4</sub>S [M + Na]<sup>+</sup>, 280.0614; found, 280.0621.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Methyl 3-((<i>tert</i>-Butoxycarbonyl) (methyl)amino)thiophene-2-carboxylate (<b>12i</b>)</h4><div class="NLM_p last">To a solution of intermediate <b>11i</b> (1.00 g, 3.90 mmol) in DMF (20 mL) was slowly added NaH (60% dispersion in mineral oil, 0.24 g, 5.80 mmol) at 0 °C, and after stirring for 0.5 h, MeI (0.80 g, 12.70 mmol) was added. The mixture was further stirred at room temperature overnight and then poured into ice water (150 mL). Then, the aqueous layer was extracted with ethyl acetate (3 × 50 mL), and the combined organic layers were washed with brine, dried over sodium sulfate, and concentrated under reduced pressure. The crude product was purified by column chromatography on silica gel (PE/EtOAc = 10:1) to afford intermediate <b>12i</b> (0.70 g, yield 67%) as a white solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.82 (d, <i>J</i> = 5.2 Hz, 1H), 7.13 (d, <i>J</i> = 5.2 Hz, 1H), 3.77 (s, 3H), 3.08 (s, 3H), 1.27 (s, 9H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.36, 151.66, 145.18, 133.86, 121.16, 108.41, 81.48, 52.52, 28.26; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>12</sub>H<sub>17</sub>NNaO<sub>4</sub>S [M + Na]<sup>+</sup>, 294.0770; found, 294.0852.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Methyl 3-(Methylamino)thiophene-2-carboxylate (<b>13i</b>)</h4><div class="NLM_p last">Intermediate <b>12i</b> (0.5 g, 1.8 mmol) and trifluoroacetic acid (4.10 g, 36.00 mmol) were suspended in CH<sub>2</sub>Cl<sub>2</sub> (25 mL). The mixture was stirred at room temperature for 2 h and then concentrated in vacuo. The residue was neutralized with saturated Na<sub>2</sub>CO<sub>3</sub> solution and extracted with EtOAc (3 × 100 mL). The combined organic layers were washed with brine, dried over sodium sulfate, and concentrated under reduced pressure to yield intermediate <b>13i</b> (0.25 g, yield 86%) as a yellow solid, which was used directly in the next step without purification. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.67–7.69 (m, 1H), 6.78–6.80 (m, 1H), 6.70 (s, 1H), 3.71 (s, 3H), 2.91 (d, <i>J</i> = 5.0 Hz, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.59, 157.23, 133.64, 117.22, 96.94, 51.24, 31.85; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>7</sub>H<sub>10</sub>NO<sub>2</sub>S [M + H]<sup>+</sup>, 172.0437; found, 172.0431. The synthetic methods for preparing intermediates <b>13a–h</b> and <b>13j</b> were similar to those used to prepare intermediate <b>13i</b>.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 14-Methyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>15a</b>)</h4><div class="NLM_p last">To a small microwave tube were added intermediate <b>5a</b> (0.20 g, 0.93 mmol), methyl 2-(methylamino)benzoate (0.15 g, 0.93 mmol), POCl<sub>3</sub> (0.5 mL), and toluene (15 mL). The resulting mixture was submitted to the following microwave sequence: prestirring for 30 s and stirring at 130 °C for 45 min. After reaction, the solvent was evaporated and the residue was dissolved in EtOH (20 mL). Then, it was cooled to 0 °C and NaBH<sub>4</sub> (0.11 g, 2.79 mmol) was added slowly. After 2 h stirring at room temperature, the solvent was evaporated and the residue was purified by column chromatography on silica gel (PE/EtOAc = 2:1) to afford compound <b>15a</b> (0.14 g, yield 36%) as a white solid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 6.92–7.98 (m, 8H), 6.49 (s, 1H), 6.06 (s, 1H), 4.96–5.02 (m, 1H), 4.20–4.24 (m, 2H), 3.39–3.49 (m, 1H), 3.06 (s, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 164.41, 148.38, 136.69, 134.00, 132.74, 128.95, 127.58, 122.31, 120.96, 120.52, 120.05, 117.93, 115.21, 109.17, 100.06, 71.39, 40.77, 36.87, 29.72; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>19</sub>H<sub>18</sub>N<sub>3</sub>O [M + H]<sup>+</sup>, 304.1444; found, 304.1445.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 2-Methoxy-14-methyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>15b</b>)</h4><div class="NLM_p last">It was obtained as a light yellow solid: 0.12 g (yield 39%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.66 (d, <i>J</i> = 7.6 Hz, 1H), 7.43 (t, <i>J</i> = 7.8 Hz, 1H), 7.28 (d, <i>J</i> = 8.9 Hz, 1H), 6.98 (s, 1H), 6.88 (d, <i>J</i> = 8.3 Hz, 1H), 6.75–6.79 (m, 2H), 6.30 (s, 1H), 6.25 (s, 1H), 4.72 (dd, <i>J</i> = 5.4, 13.7 Hz, 1H), 3.13–4.16 (m, 1H), 3.95–3.99 (m, 1H), 3.71 (s, 3H), 3.56–3.61 (m, 1H), 3.23 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.78, 154.06, 147.27, 135.63, 134.23, 131.66, 127.79, 127.42, 117.78, 115.22, 113.13, 111.41, 110.18, 102.29, 97.46, 71.17, 55.30, 40.86, 39.56, 36.71; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>20</sub>H<sub>20</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 334.1550; found, 334.1551. The synthetic methods for compounds <b>15a</b>, <b>15c–z</b> and <b>15aa–ab</b> were similar to that of compound <b>15b</b>.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 2-Chloro-14-methyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>15c</b>)</h4><div class="NLM_p last">It was obtained as a white solid: 0.13 g (yield 35%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.65 (dd, <i>J</i> = 7.7, 1.4 Hz, 1H), 7.53 (s, 1H), 7.41–7.45 (m, 2H), 7.14 (dd, <i>J</i> = 8.7, 1.6 Hz, 1H), 6.89 (d, <i>J</i> = 8.4 Hz, 1H), 6.76 (t, <i>J</i> = 7.6 Hz, 1H), 6.36 (s, 1H), 6.35 (s, 1H), 4.73 (dd, <i>J</i> = 10.7, 5.4 Hz, 1H), 4.19–4.23 (m, 1H), 4.00–4.05 (m, 1H), 3.59–3.64 (m, 1H), 3.26 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.77, 147.09, 137.02, 134.86, 134.39, 128.04, 127.81, 124.51, 121.48, 119.47, 117.85, 114.95, 113.13, 111.16, 97.34, 71.08, 40.76, 39.42, 36.80; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>19</sub>H<sub>17</sub>ClN<sub>3</sub>O [M + H]<sup>+</sup>, 338.1055; found, 338.1056.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 3-Chloro-14-methyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>15d</b>)</h4><div class="NLM_p last">It was obtained as a white solid: 0.07 g (yield 27%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.65–7.67 (m, 1H), 7.53–7.54 (m, 1H), 7.49 (d, <i>J</i> = 8.4 Hz, 1H), 7.43–7.46 (m, 1H), 7.06 (dd, <i>J</i> = 8.3, 1.9 Hz, 1H), 6.89 (d, <i>J</i> = 7.9 Hz, 1H), 6.75–6.78 (m, 1H), 6.39 (t, <i>J</i> = 1.1 Hz, 1H), 6.37 (s, 1H), 4.73 (dd, <i>J</i> = 13.4, 5.4 Hz, 1H), 4.21–4.24 (m, 1H), 3.99–4.05 (m, 1H), 3.59–3.65 (m, 1H), 3.27 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.05, 151.88, 140.86, 137.84, 137.54, 132.70, 132.06, 129.82, 125.52, 124.99, 123.80, 121.42, 118.83, 113.02, 103.69, 75.19, 44.50, 40.81, 33.43; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>19</sub>H<sub>17</sub>ClN<sub>3</sub>O [M + H]<sup>+</sup>, 338.8102; found, 338.8101.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 2-Fluoro-14-methyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>15e</b>)</h4><div class="NLM_p last">It was obtained as a white solid: 0.17 g (yield 44%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.67 (dd, <i>J</i> = 7.7, 1.6 Hz, 1H), 7.43–7.46 (m, 1H), 7.41 (dd, <i>J</i> = 8.9, 4.4 Hz, 1H), 7.26 (dd, <i>J</i> = 9.8, 2.6 Hz, 1H), 7.00 (td, <i>J</i> = 9.4, 2.5 Hz, 1H), 6.90 (d, <i>J</i> = 8.3 Hz, 1H), 6.75–6.78 (m, 1H), 6.36 (s, 1H), 6.35 (s, 1H), 4.75 (dd, <i>J</i> = 13.6, 5.4 Hz, 1H), 4.20–4.22 (m, 1H), 4.00–4.06 (m, 1H), 3.59–3.65 (m, 1H), 3.26 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.26, 157.89, 147.64, 137.71, 134.83, 133.63, 128.32, 127.71, 118.31, 115.54, 113.61, 111.13, 110.23, 105.54, 98.23, 71.63, 41.32, 37.30; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>19</sub>H<sub>17</sub>FN<sub>3</sub>O [M + H]<sup>+</sup>, 322.1350; found, 322.1351.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 2,14-Dimethyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>15f</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid: 0.08 g (yield 38%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.66 (d, <i>J</i> = 7.5 Hz, 1H), 7.42–7.45 (m, 1H), 7.28 (s, 1H), 7.26 (s, 1H), 6.97 (d, <i>J</i> = 8.2 Hz, 1H), 6.89 (d, <i>J</i> = 8.3 Hz, 1H), 6.76 (t, <i>J</i> = 3.5 Hz, 1H), 6.33 (s, 1H), 6.25 (s, 1H), 4.73 (dd, <i>J</i> = 15.6, 5.3 Hz, 1H), 4.15–4.18 (m, 1H), 3.96–4.01 (m, 1H), 3.57–3.63 (m, 1H), 3.25 (s, 3H), 2.34 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.78, 147.24, 135.19, 134.87, 134.26, 128.59, 127.77, 127.18, 123.08, 119.88, 117.73, 115.12, 113.09, 109.22, 97.14, 71.22, 40.89, 39.55, 36.73, 21.08; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>20</sub>H<sub>20</sub>N<sub>3</sub>O [M + H]<sup>+</sup>, 318.1601; found, 318.1602.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-Bromo-14-methyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>15g</b>)</h4><div class="NLM_p last">It was obtained as a white solid: 0.15 g (yield 38%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.65 (d, <i>J</i> = 1.8 Hz, 1H), 7.63 (d, <i>J</i> = 7.7, 1.3 Hz, 1H), 7.40–7.43 (m, 1H), 7.36 (d, <i>J</i> = 8.6 Hz, 1H), 7.23 (dd, <i>J</i> = 8.6, 1.8 Hz, 1H), 6.87 (d, <i>J</i> = 8.1 Hz, 1H), 6.74 (t, <i>J</i> = 7.3 Hz, 1H), 6.34 (s, 1H), 6.33 (s, 1H), 4.71 (dd, <i>J</i> = 13.7, 5.3 Hz, 1H), 4.19 (dd, <i>J</i> = 12.0, 5.4 Hz, 1H), 3.97–4.03 (m, 1H), 3.56–3.62 (m, 1H), 3.23 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.24, 147.63, 137.36, 135.61, 134.86, 129.25, 128.33, 124.52, 123.01, 118.37, 115.54, 113.68, 112.96, 112.14, 97.75, 71.56, 41.25, 37.34; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>19</sub>H<sub>17</sub>BrN<sub>3</sub>O [M + H]<sup>+</sup>, 382.0550; found, 382.0551.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 12-Methoxy-14-methyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>15h</b>)</h4><div class="NLM_p last">It was obtained as a white solid: 0.11 g (yield 39%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.89 (d, <i>J</i> = 8.6 Hz, 1H), 7.59 (dt, <i>J</i> = 7.9, 0.96 Hz, 1H), 7.33 (dq, <i>J</i> = 8.2, 0.9 Hz, 1H), 7.24–7.27 (m, 1H), 7.73–7.16 (m, 1H), 6.47 (d, <i>J</i> = 2.3 Hz, 1H), 6.45–6.46 (m, 1H), 6.33 (d, <i>J</i> = 2.3 Hz, 1H), 6.05 (s, 1H), 4.99–5.03 (m, 1H), 4.17–4.26 (m, 2H), 3.88 (s, 3H), 3.41–3.46 (m, 1H), 3.14 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.85, 164.33, 149.38, 136.93, 136.05 130.33, 127.44, 122.00, 120.77, 120.50, 110.03, 108.83, 104.80, 97.90, 97.82, 72.01, 55.81, 41.33, 37.38; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>20</sub>H<sub>20</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 334.1550; found, 334.1551.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 11-Methoxy-14-methyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>15i</b>)</h4><div class="NLM_p last">It was obtained as a white solid: 0.09 g (yield 33%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.51 (d, <i>J</i> = 7.7 Hz, 1H), 7.42 (dd, <i>J</i> = 8.3, 0.8 Hz, 1H), 7.24 (d, <i>J</i> = 3.1 Hz, 1H), 7.14–7.17 (m, 1H), 7.11 (dd, <i>J</i> = 8.9, 3.1 Hz, 1H), 7.04–7.07 (m, 1H), 6.97 (d, <i>J</i> = 8.9 Hz, 1H), 6.39 (s, 1H), 6.27 (s, 1H), 4.69–4.72 (m, 1H), 4.26–4.29 (m, 1H), 4.01–4.06 (m, 1H), 3.70 (s, 3H), 3.58–3.63 (m, 1H), 3.05 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.07, 153.14, 142.86, 136.66, 134.79, 127.53, 121.98, 120.80, 120.43, 118.19, 117.66, 111.30, 110.02, 98.72, 71.30, 55.83, 40.99, 37.57; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>20</sub>H<sub>20</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 334.1550; found, 334.1551.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 11-Fluoro-2-methoxy-14-methyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>15j</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid: 0.05 g (yield 32%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.39 (dd, <i>J</i> = 8.9, 3.2 Hz, 1H), 7.32–7.36 (m, 1H), 7.29 (d, <i>J</i> = 8.8 Hz, 1H), 7.00 (d, <i>J</i> = 2.4 Hz, 1H), 6.97 (dd, <i>J</i> = 9.1, 4.3 Hz, 1H), 6.79 (dd, <i>J</i> = 9.1, 8.8 Hz, 1H), 6.30 (s, 1H), 6.29 (s, 1H), 4.69 (dd, <i>J</i> = 13.6, 4.8 Hz, 1H), 4.18–4.21 (m, 1H), 3.95–4.00 (m, 1H), 3.72 (s, 3H), 3.57–3.62 (m, 1H), 3.14 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.81, 156.12, 154.56, 154.07, 144.41, 134.82, 131.58, 127.43, 121.25, 116.12, 113.27, 111.53, 110.26, 102.24, 97.85, 70.95, 55.29, 40.75, 39.73, 36.94; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>20</sub>H<sub>19</sub>FN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 352.1456; found, 352.1457; HPLC purity 99.0%. Retention time: 9.26 min, eluted with 60:40 MeOH/H<sub>2</sub>O.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 11-Fluoro-2-methoxy-14-methyl-9-oxo-6,7-dihydro-9<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-14-ium (<b>15js</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid: 0.15 g (yield 39%). <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD): δ 8.18 (dd, <i>J</i> = 9.3, 3.8 Hz, 1H), 8.12 (dd, <i>J</i> = 7.4, 2.9 Hz, 1H) 7.91–7.93 (m, 1H), 7.89 (s, 1H), 7.58 (d, <i>J</i> = 9.0 Hz, 1H), 7.21–7.27 (m, 2H), 4.69 (s, 4H), 4.47 (s, 3H), 3.87 (s, 3H); <sup>13</sup>C NMR (150 MHz, CD<sub>3</sub>OD): δ 162.50, 160.83, 156.91, 150.26, 136.86, 134.41, 127.93, 124.55, 122.15, 121.88, 120.58, 118.99, 116.82, 113.36, 111.49, 101.30, 54.72, 42.45, 41.83, 38.93; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>20</sub>H<sub>17</sub>FN<sub>3</sub>O<sub>2</sub> M<sup>+</sup>, 350.1299; found, 350.1311; HPLC purity 99.9%. Retention time: 4.26 min, eluted with 80:20 MeOH/H<sub>2</sub>O.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 11-Chloro-2-methoxy-14-methyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>15k</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid: 0.11 g (yield 28%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.57 (d, <i>J</i> = 2.6 Hz, 1H), 7.47 (dd, <i>J</i> = 8.8, 2.6 Hz, 1H), 7.28 (d, <i>J</i> = 8.9 Hz, 1H), 6.99 (d, <i>J</i> = 2.5 Hz, 1H), 6.93 (d, <i>J</i> = 8.9 Hz, 1H), 6.79 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 6.35 (s, 1H), 6.27 (s, 1H), 4.71 (dd, <i>J</i> = 13.6, 5.5 Hz, 1H), 4.15–4.18 (m, 1H), 3.94–4.00 (m, 1H), 3.71 (s, 3H), 3.58–3.63 (m, 1H), 3.24 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.11, 154.58, 146.50, 135.71, 134.30, 132.19, 127.87, 127.30, 122.21, 116.74, 115.70, 112.03, 110.75, 102.78, 97.89, 71.60, 55.79, 41.45, 37.28; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>20</sub>H<sub>19</sub>ClN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 368.1160; found, 368.1161.</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 11-Bromo-2-methoxy-14-methyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>15l</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid: 0.06 g (yield 32%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.69 (d, <i>J</i> = 2.5 Hz, 1H), 7.58 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 7.28 (d, <i>J</i> = 8.9 Hz, 1H), 6.98 (d, <i>J</i> = 2.4 Hz, 1H), 6.88 (d, <i>J</i> = 8.9 Hz, 1H), 6.79 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 6.35 (s, 1H), 6.26 (s, 1H), 4.71 (dd, <i>J</i> = 13.6, 5.5 Hz, 1H), 4.15–4.18 (m, 1H), 3.94–3.99 (m, 1H), 3.71 (s, 3H), 3.58–3.63 (m, 1H), 3.24 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.03, 154.58, 146.79, 137.05, 135.73, 132.20, 130.21, 127.87, 117.10, 116.00, 112.03, 110.75, 109.43, 102.78, 97.96, 71.60, 55.78, 41.48, 37.25; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>20</sub>H<sub>19</sub>BrN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 412.0655; found, 412.0655.</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 12-Amino-2-methoxy-14-methyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>15m</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid: 0.05 g (yield 23%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.29 (d, <i>J</i> = 8.4 Hz, 1H), 7.25 (d, <i>J</i> = 8.8 Hz, 1H), 6.97 (d, <i>J</i> = 2.3 Hz, 1H), 6.76 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 6.20 (s, 1H), 6.14 (s, 1H), 5.93 (dd, <i>J</i> = 8.4, 2.0, Hz 1H), 5.89 (d, <i>J</i> = 1.8 Hz, 1H), 5.81 (s, 2H), 4.64 (dd, <i>J</i> = 13.7, 5.5 Hz, 1H), 4.03–4.07 (m, 1H), 3.88–3.93 (m, 1H), 3.70 (s, 3H), 3.47–3.52 (m, 1H), 3.18 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 151.03, 154.88, 154.49, 149.28, 137.11, 132.12, 130.09, 127.95, 111.61, 110.57, 105.15, 104.37, 102.73, 97.64, 95.67, 71.97, 55.79, 41.32, 37.22; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>20</sub>H<sub>21</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 349.1659; found, 349.1658.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 2,12-Dimethoxy-14-methyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>15n</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid: 0.05 g (yield 24%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.90 (d, <i>J</i> = 8.6 Hz, 1H), 7.21 (d, <i>J</i> = 8.8 Hz, 1H), 7.05 (d, <i>J</i> = 2.4 Hz, 1H), 6.91 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 6.46 (dd, <i>J</i> = 8.6, 2.3 Hz, 1H), 6.37 (s, 1H), 6.33 (d, <i>J</i> = 2.3 Hz, 1H), 6.02 (s, 1H), 4.97–5.00 (m, 1H), 4.12–4.22 (m, 2H), 3.87 (s, 3H), 3.85 (s, 3H), 3.39–3.44 (m, 1H), 3.12 (s, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 168.20, 158.46, 153.50, 137.59, 135.85, 134.69, 131.69, 116.24, 114.60, 113.61, 109.33, 106.38, 103.27, 103.02, 75.56, 59.63, 59.13, 44.63, 44.41, 40.71, 37.22; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>21</sub>H<sub>22</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 364.1656; found, 364.1655.</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 2-Methoxy-11,14-dimethyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>15o</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid: 0.09 g (yield 38%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.46–7.47 (m, 1H), 7.27 (d, <i>J</i> = 9.0 Hz, 1H), 7.24–7.26 (m, 1H), 6.97 (d, <i>J</i> = 2.4 Hz, 1H), 6.82 (d, <i>J</i> = 8.4 Hz, 1H), 6.77 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 6.24 (s, 1H), 6.23 (s, 1H), 4.69 (dd, <i>J</i> = 13.4, 4.7 Hz, 1H), 4.15 (dd, <i>J</i> = 11.9, 4.4 Hz, 1H), 3.95 (dd, <i>J</i> = 11.9, 5.5 Hz, 1H), 3.70 (s, 3H), 3.53–3.59 (m, 1H), 3.15 (s, 3H), 2.17 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 169.21, 159.29, 150.74, 140.72, 140.11, 136.84, 133.05, 132.69, 132.28, 120.91, 119.09, 116.64, 115.43, 107.48, 102.88, 76.35, 60.54, 46.05, 42.00, 25.11; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>21</sub>H<sub>22</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 348.1707; found, 348.1706.</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 2-Bromo-11-fluoro-14-methyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>15p</b>)</h4><div class="NLM_p last">It was obtained as a white solid: 0.14 g (yield 40%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.67 (d, <i>J</i> = 1.7 Hz, 1H), 7.35–7.39 (m, 2H), 7.30–7.34 (m, 1H), 7.25 (dd, <i>J</i> = 8.7, 2.0 Hz, 1H), 6.94–6.97 (m, 1H), 6.36 (s, 1H), 6.33 (s, 1H), 4.66–4.72 (m, 1H), 4.21–4.25 (m, 1H), 3.98–4.03 (m, 1H), 3.57–3.63 (m, 1H), 3.15 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.23, 156.51, 155.05, 144.73, 136.56, 135.52, 129.23, 124.54, 123.03, 121.90, 121.75, 117.19, 116.65, 113.85, 113.69, 112.95, 112.17, 98.11, 71.31, 41.10, 37.56; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>19</sub>H<sub>16</sub>BrFN<sub>3</sub>O [M + H]<sup>+</sup>, 400.0455; found, 400.0454.</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 2-Bromo-12-methoxy-14-methyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>15q</b>)</h4><div class="NLM_p last">It was obtained as a white solid: 0.21 g (yield 45%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.64 (d, <i>J</i> = 2.0 Hz, 1H), 7.54–7.55 (m, 1H), 7.34 (d, <i>J</i> = 8.6 Hz, 1H), 7.23 (dd, <i>J</i> = 8.7, 1.9 Hz, 1H), 6.29–6.31 (m, 4H), 4.68 (dd, <i>J</i> = 13.7, 5.8 Hz, 1H), 4.13–4.16 (m, 1H), 3.95–4.00 (m, 1H), 3.79 (s, 3H), 3.54–3.59 (m, 1H), 3.26 (s, 3H); <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.89, 164.28, 149.28, 137.66, 135.63, 130.37, 129.22, 124.46, 122.96, 112.93, 112.11, 108.73, 104.91, 97.89, 97.54, 71.81, 55.83, 41.17, 37.42; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>20</sub>H<sub>19</sub>BrN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 412.0655; found, 412.0654.</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 2-Chloro-11-fluoro-14-methyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>15r</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid: 0.15 g (yield 43%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.52 (d, <i>J</i> = 1.9 Hz, 1H), 7.41 (d, <i>J</i> = 8.7 Hz, 1H), 7.37 (dd, <i>J</i> = 8.8, 3.1 Hz, 1H), 7.33 (td, <i>J</i> = 8.7, 3.1 Hz, 1H), 7.13 (dd, <i>J</i> = 8.7, 2.0 Hz, 1H), 6.96 (dd, <i>J</i> = 9.1, 4.3 Hz, 1H), 6.36 (s, 1H), 6.33 (s, 1H), 6.69 (dd, <i>J</i> = 13.5, 5.1 Hz, 1H), 4.23 (dd, <i>J</i> = 12.1, 4.6 Hz, 1H), 3.99–4.04 (m, 1H), 3.57–3.63 (m, 1H), 3.15 (s, 3H); <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.26, 155.70, 144.74, 136.77, 135.31, 128.57, 125.05, 122.03, 121.69, 120.02, 117.17, 116.60, 113.79, 111.73, 98.22, 71.38, 41.15, 37.57; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>19</sub>H<sub>16</sub>ClFN<sub>3</sub>O [M + H]<sup>+</sup>, 356.0960; found, 356.0961.</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 11-Fluoro-2,14-dimethyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>15s</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid: 0.06 g (yield 31%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.37 (dd, <i>J</i> = 8.9, 3.1 Hz, 1H), 7.32 (td, <i>J</i> = 8.8, 3.1 Hz, 1H), 7.26 (s, 1H), 7.25 (s, 1H), 6.93–6.96 (m, 2H), 6.29 (s, 1H), 6.25 (s, 1H), 4.68 (dd, <i>J</i> = 13.7, 5.1 Hz, 1H), 4.16–4.20 (m, 1H), 3.93–3.99 (m, 1H), 3.55–3.61 (m, 1H), 3.13 (s, 3H), 2.32 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.28, 155.86, 144.86, 135.30, 134.86, 129.12, 127.72, 123.63, 121.80, 120.43, 116.51, 113.86, 113.70, 109.74, 98.04, 71.51, 41.26, 37.42, 21.57; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>20</sub>H<sub>19</sub>FN<sub>3</sub>O [M + H]<sup>+</sup>, 336.1507; found, 336.1508.</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 11-Fluoro-14-methyl-2-(trifluoromethoxy)-6,7,14,14a-tetrahydro-9<i>H</i>-indolo[2′,1′:3,4]pyrazi-no[2,1-<i>b</i>]quinazolin-9-one (<b>15t</b>)</h4><div class="NLM_p last">It was obtained as a white solid: 0.09 g (yield 42%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.89 (s, 1H), 7.60 (d, <i>J</i> = 8.7 Hz, 1H), 7.44 (dd, <i>J</i> = 8.6, 1.4 Hz, 1H), 7.40 (dd, <i>J</i> = 8.6, 3.0 Hz, 1H), 7.33–7.37 (m, 1H), 7.00 (dd, <i>J</i> = 9.3, 4.4 Hz, 1H), 6.56 (s, 1H), 6.4 (s, 1H), 4.73 (dd, <i>J</i> = 13.2, 4.6 Hz, 1H), 4.33 (dd, <i>J</i> = 12.9, 4.4 Hz, 1H), 4.06–4.15 (m, 1H), 3.60–3.71 (m, 1H), 3.18 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.24, 156.68, 155.12, 144.76, 138.20, 137.35, 126.87, 124.91, 121.94, 121.79, 118.48, 117.25, 116.78, 113.88, 113.72, 111.05, 99.51, 71.34, 41.10, 37.63; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>20</sub>H<sub>15</sub>F<sub>4</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 406.1173; found, 406.1182.</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-Cyclobutoxy-11-fluoro-14-methyl-6,7,14,14<i>a</i>-tetrahydro-9<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9-one (<b>15u</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid: 0.06 g (yield 28%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.37 (dd, <i>J</i> = 8.8, 3.1 Hz, 1H), 7.30–7.35 (m, 1H), 7.26 (d, <i>J</i> = 8.9 Hz, 1H), 6.95 (dd, <i>J</i> = 8.9, 4.4 Hz, 1H), 6.86 (d, <i>J</i> = 2.2 Hz, 1H), 6.71 (dd, <i>J</i> = 8.8, 2.3 Hz, 1H), 6.29 (s, 1H), 6.25 (s, 1H), 4.68 (dd, <i>J</i> = 13.6, 5.0 Hz, 1H), 4.59 (t, <i>J</i> = 7.0 Hz, 1H), 4.17 (dd, <i>J</i> = 12.1, 4.7 Hz, 1H), 3.92–3.99 (m, 1H), 3.52–3.61 (m, 1H), 3.13 (s, 3H), 2.35–2.40 (m, 2H), 1.96–2.03 (m, 2H), 1.92–1.77 (m, 1H), 1.57–1.63 (m, 1H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz): δ 163.32, 156.58, 155.02, 152.16, 144.87, 135.40, 132.16, 127.96, 121.81, 117.31, 116.53, 113.85, 112.67, 110.81, 104.37, 98.28, 71.57, 41.27, 40.93, 37.45, 31.61, 30.76, 30.69, 30.30; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>23</sub>H<sub>23</sub>FN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 392.1769; found, 392.1776.</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 2-(Cyclopentyloxy)-11-fluoro-14-methyl-6,7,14,14a-tetrahydro-9<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9-one (<b>15v</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid: 0.03 g (yield 36%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.67 (dd, <i>J</i> = 8.6, 3.1 Hz, 1H), 7.21 (d, <i>J</i> = 8.9 Hz, 1H), 7.17 (td, <i>J</i> = 8.6, 3.1 Hz, 1H), 7.04 (d, <i>J</i> = 2.2 Hz, 1H), 6.94 (dd, <i>J</i> = 8.9, 4.3 Hz, 1H), 6.89 (dd, <i>J</i> = 8.9, 2.3 Hz 1H), 6.44 (s, 1H), 6.01 (s, 1H), 4.87–4.92 (m, 1H), 4.75–4.79 (m, 1H), 4.19–4.24 (m, 1H), 4.10–4.16 (m, 1H), 3.40–3.46 (m, 1H), 2.85 (s, 3H), 1.86–1.91 (m, 4H), 1.78–1.84 (m, 2H), 1.58–1.63 (m, 4H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz): δ 162.29, 157.24, 155.65, 151.79, 144.40, 130.62, 126.87, 119.86, 119.59, 117.98, 113.56, 113.12, 108.60, 104.16, 99.00, 78.86, 69.55, 39.73, 39.07, 35.87, 31.63, 22.81; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>25</sub>FN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 406.1925; found, 406.1934.</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 2-(Cyclohexyloxy)-10-fluoro-13-methyl-7,7a,13,13a-tetrahydrobenzo[<i>b</i>]indolo[1,2-<i>h</i>][1,7]naphthyridin-8(6<i>H</i>)-one (<b>15w</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid: 0.11 g (yield 34%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.68 (dd, <i>J</i> = 8.7, 3 Hz, 1H), 7.21 (d, <i>J</i> = 8.9 Hz, 1H), 7.15–7.19 (m, 1H), 7.10 (d, <i>J</i> = 2.5 Hz, 1H), 6.91–6.96 (m, 2H), 6.43 (s, 1H), 6.01 (s, 1H), 4.87–4.93 (m, 1H), 4.21–4.25 (m, 1H), 4.16–4.20 (m, 1H), 4.11–4.16 (m, 1H), 3.40–3.47 (m, 1H), 2.86 (s, 3H), 2.00 (d, <i>J</i> = 11.6 Hz, 2H), 1.80 (d, <i>J</i> = 6.6 Hz, 2H), 1.48–1.61 (m, 6H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz): δ 163.32, 156.58, 155.02, 144.87, 135.42, 132.32, 128.00, 121.82, 121.67, 117.30, 117.26, 116.53, 114.09, 113.86, 110.68, 106.59, 98.22, 75.92, 71.50, 41.29, 37.46, 32.00, 31.86, 25.71, 23.68; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>27</sub>FN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 420.2082; found, 420.2089.</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 11-Fluoro-2-(methoxy-<i>d</i><sub>3</sub>)-14-methyl-6,7,14,14a-tetrahydro-9<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9-one (<b>15x</b>)</h4><div class="NLM_p last">It was obtained as a white solid: 0.15 g (yield 35%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.40 (dd, <i>J</i> = 8.8, 3.3 Hz, 1H), 7.32–7.36 (m, 1H), 7.30 (d, <i>J</i> = 8.76 Hz, 1H), 7.00 (d, <i>J</i> = 2.5 Hz, 1H), 6.98 (dd, <i>J</i> = 8.9, 4.2 Hz, 1H), 6.80 (dd, <i>J</i> = 8.6, 2.5 Hz, 1H), 6.30 (d, <i>J</i> = 9.9 Hz, 2H), 4.70 (dd, <i>J</i> = 14.4, 5.2 Hz, 1H), 4.21 (dd, <i>J</i> = 12.6, 5.7 Hz, 1H), 3.9–4.0 (m, 1H), 3.72 (s, 3H), 3.5–3.6 (m, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz): δ 163.34, 154.57, 144.92, 135.33, 132.08, 127.94, 121.83, 121.68, 117.38, 117.34, 116.66, 116.61, 113.85, 113.69, 112.03, 110.77, 102.73, 98.34, 71.46, 41.26; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>20</sub>H<sub>15</sub>D<sub>3</sub>FN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 355.1644; found, 355.1651.</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 11-Methoxy-3,14-dimethyl-6,7,13<i>b</i>,14-tetrahydropyrrolo[3″,2″:4′,5′]pyrimido[2′,1′:3,4]pyrazino[1,2-<i>a</i>]indol-4(3<i>H</i>)-one (<b>15y</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid: 0.11 g (yield 41%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.35 (d, <i>J</i> = 8.9 Hz, 1H), 7.06 (d, <i>J</i> = 2.4 Hz, 1H), 6.91 (dd, <i>J</i> = 2.8, 0.4 Hz, 1H), 6.81 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 6.44 (s, 1H), 5.92 (s, 1H), 5.81 (d, <i>J</i> = 2.7 Hz, 1H), 4.45–4.49 (m, 1H), 4.27–4.30 (m, 1H), 3.93–3.98 (m, 1H), 3.77 (s, 3H), 3.75 (s, 3H), 3.30–3.35 (m, 1H), 2.62 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 159.27, 153.96, 144.06, 132.73, 131.22, 129.13, 127.55, 112.19, 111.53, 110.26, 102.03, 99.61, 96.55, 71.38, 55.31, 40.72, 38.53, 36.45, 35.29; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>19</sub>H<sub>21</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 337.1659; found, 337.1658.</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 11-Hydroxy-3,14-dimethyl-6,7,13<i>b</i>,14-tetrahydropyrrolo[3″,2″:4′,5′]pyrimido[2′,1′:3,4]pyrazino[1,2-<i>a</i>]indol-4(3<i>H</i>)-one (<b>15z</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid: 0.18 g (yield 56%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.75 (s, 1H), 7.23 (d, <i>J</i> = 8.8 Hz, 1H), 6.90 (dd, <i>J</i> = 2.7, 0.5 Hz, 1H), 6.86 (d, <i>J</i> = 2.3 Hz, 1H), 6.68 (dd, <i>J</i> = 8.7, 2.3 Hz, 1H), 6.33 (s, 1H), 5.89 (d, <i>J</i> = 1.0 Hz, 1H), 5.79 (d, <i>J</i> = 2.7 Hz, 1H), 4.45–4.48 (m, 1H), 4.21–4.24 (m, 1H), 3.89–3.94 (m, 1H), 3.77 (s, 3H), 3.29–3.34 (m, 1H), 2.62 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 159.80, 151.85, 144.56, 133.04, 131.22, 129.63, 128.40, 112.57, 112.20, 110.38, 104.66, 99.50, 96.94, 71.97, 41.12, 39.09, 36.95, 35.81; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>18</sub>H<sub>19</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 323.1503; found, 323.1504.</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 11-Methoxy-14-methyl-6,7,13b,14-tetrahydro-4<i>H</i>-thieno[3″,2″:4′,5′]pyrimido[2′,1′:3,4]pyrazino[1,2-<i>a</i>]indol-4-one (<b>15aa</b>)</h4><div class="NLM_p last">It was obtained as a brown solid: 0.13 g (yield 44%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.81 (d, <i>J</i> = 5.3 Hz, 1H), 7.32 (d, <i>J</i> = 8.9 Hz, 1H), 7.04 (d, <i>J</i> = 2.3 Hz, 1H), 6.96 (d, <i>J</i> = 5.3 Hz, 1H), 6.81 (dd, <i>J</i> = 8.9, 2.5, Hz, 1H), 6.39 (s, 1H), 6.24 (s, 1H), 4.54–4.57 (m, 1H), 4.20–4.23 (m, 1H), 3.94–3.99 (m, 1H), 3.74 (s, 3H), 3.45–3.50 (m, 1H), 3.07 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 161.24, 154.12, 154.04, 134.05, 133.42, 131.69, 127.42, 118.24, 111.58, 110.25, 110.25, 108.97, 102.19, 98.71, 71.67, 55.31, 40.03, 36.89; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>18</sub>H<sub>18</sub>N<sub>3</sub>O<sub>2</sub>S [M + H]<sup>+</sup>, 340.1114; found, 340.1113.</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 11-Hydroxy-14-methyl-6,7,13b,14-tetrahydro-4<i>H</i>-thieno[3″,2″:4′,5′]pyrimido[2′,1′:3,4]pyrazino[1,2-<i>a</i>]indol-4-one (<b>15ab</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid: 0.21 g (yield 62%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.76 (s, 1H), 7.81 (d, <i>J</i> = 5.3 Hz, 1H), 7.20 (d, <i>J</i> = 8.7 Hz, 1H), 6.95 (d, <i>J</i> = 5.3 Hz, 1H), 6.84 (d, <i>J</i> = 2.2 Hz, 1H), 6.67 (dd, <i>J</i> = 8.7, 2.3 Hz, 1H), 6.29 (s, 1H), 6.22 (s, 1H), 4.53–4.56 (m, 1H), 4.15–4.17 (m, 1H), 3.89–3.95 (m, 1H), 3.43–3.48 (m, 1H), 3.08 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 161.78, 154.57, 151.97, 134.55, 133.77, 131.67, 128.27, 118.66, 112.31, 110.37, 109.17, 104.77, 98.59, 72.30, 37.43, 29.47; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>17</sub>H<sub>16</sub>N<sub>3</sub>O<sub>2</sub>S [M + H]<sup>+</sup>, 326.0958; found, 326.0957.</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Methyl (<i>Z</i>)-2-Azido-3-(3,4,5-trimethoxyphenyl)acrylate (<b>18a</b>)</h4><div class="NLM_p last">To a well-stirred solution containing Na (1.70 g, 73.60 mmol) in dry MeOH (20 mL) were dropwise added a solution of 3,4,5-trimethoxybenzaldehyde (2.90 g, 14.70 mmol) and ethyl 2-azidoacetate (9.5 g, 73.60 mmol) in dry MeOH (20 mL) at −10 °C under nitrogen. After stirring at 0 °C for 4 h, the mixture was poured into water, and the precipitated product was filtered off, washed with water, and dried to give intermediate <b>18a</b> (3.30 g, yield 72%) as a yellow solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.10 (s, 2H), 6.85 (s, 1H), 3.92 (s, 3H), 3.89–3.90 (m, 9H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 164.03, 152.94, 128.56, 125.63, 124.45, 108.10, 60.95, 56.20, 52.90; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>13</sub>H<sub>15</sub>N<sub>3</sub>NaO<sub>5</sub> [M + Na]<sup>+</sup>, 316.0904; found, 316.0907. The synthetic method for accessing intermediate <b>18b</b> was similar to that used to prepare intermediate <b>18a</b>.</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Methyl (<i>Z</i>)-2-Azido-3-(4-(methylthio)phenyl)acrylate (<b>18b</b>)</h4><div class="NLM_p last">It was obtained as a white solid 0.35 g (yield 72%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.74 (d, <i>J</i> = 8.3, 2H), 7.23 (d, <i>J</i> = 7.2, 2H), 8.87 (s, 1H), 3.90 (s, 3H), 2.50 (s, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 164.06, 141.03, 130.93, 129.71, 125.60, 125.18, 124.54, 52.86, 15.13; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>11</sub>H<sub>10</sub>N<sub>3</sub>O<sub>2</sub>S [M – H]<sup>−</sup>, 248.0499, found, 248.0502.</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> Ethyl 5,6,7-Trimethoxy-1<i>H</i>-indole-2-carboxylate (<b>19a</b>)</h4><div class="NLM_p last">Intermediate <b>18</b> (3.00 g, 9.8 mmol) was dissolved in 1,2-dichlorobenzene (50 mL) and stirred at reflux for 2 h. After cooling to room temperature, the mixture was concentrated in vacuo and the residue was taken up in PE (100 mL). The suspension was filtered, and the solid was washed with PE to yield intermediate <b>19a</b> (2.10 g, yield 78%) as a brown solid, which was used directly in the next step without purification. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.10 (s, 2H), 6.85 (s, 1H), 3.92 (s, 3H), 3.89–3.90 (m, 9H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 162.14, 150.22, 140.58, 138.88, 126.82, 126.53, 123.11, 108.87, 97.75, 61.44, 61.11, 56.24, 51.90; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>13</sub>H<sub>15</sub>NNaO<sub>5</sub> [M + Na]<sup>+</sup>, 288.0842; found, 288.0855. The synthetic method for accessing intermediate <b>19b</b> was similar to that used to prepare intermediate <b>19a</b>.</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Methyl 1-(2-Cyanopropan-2-yl)-5-(methylthio)-1<i>H</i>-indole-2-carboxylate (<b>19b</b>)</h4><div class="NLM_p">It was obtained as a white solid 0.36 g (yield 78%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 9.13 (s, 1H), 7.58 (d, <i>J</i> = 9.1 Hz, 1H), 7.28 (s, 1H), 7.17 (s, 1H), 7.10 (d, <i>J</i> = 8.6 Hz, 1H), 3.95 (s, 1H), 2.5 (s, 1H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 162.54, 137.57, 126.79, 125.39, 122.80, 121.12, 109.30, 108.97; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>11</sub>H<sub>12</sub>NO<sub>2</sub>S [M + H]<sup>+</sup>, 222.0583; found, 222.0591.</div><div class="NLM_p last">Starting from intermediate <b>19a</b>, compounds <b>23a–c</b> were obtained following the synthetic method used to prepare compound <b>15b</b>.</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2,3,4-Trimethoxy-14-methyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>23a</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid: 0.12 g (yield 37%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.67 (dd, <i>J</i> = 7.6, 1.5 Hz, 1H), 7.42–7.45 (m, 1H), 6.88 (d, <i>J</i> = 8.3 Hz, 1H), 6.78 (s, 1H), 6.76 (d, <i>J</i> = 7.3 Hz, 1H), 6.26 (s, 1H), 6.21 (s, 1H), 4.65 (dd, <i>J</i> = 13.7, 4.6 Hz, 1H), 4.43–4.46 (m, 1H), 4.11–4.16 (m, 1H), 3.89 (s, 3H), 3.73 (s, 6H), 3.54–3.57 (m, 1H), 3.19 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.66, 148.79, 147.31, 139.91, 138.48, 135.32, 134.18, 127.78, 124.39, 123.55, 117.79, 115.29, 113.15, 98.56, 97.90, 71.11, 61.76, 60.71, 55.94, 42.19, 41.26, 36.66; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>22</sub>H<sub>24</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 394.1761; found, 394.1762.</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 11-Fluoro-14-methyl-3-(methylthio)-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>23b</b>)</h4><div class="NLM_p last">It was obtained as a white solid: 0.03 g (yield 36%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.42 (dd, <i>J</i> = 8.3, 0.4 Hz, 1H), 7.38 (dd, <i>J</i> = 8.9, 3.1 Hz, 1H), 7.31–7.35 (m, 2H), 6.99 (dd, <i>J</i> = 8.3, 1.7 Hz, 1H), 6.96 (dd, <i>J</i> = 9.0, 4.3 Hz, 1H), 6.34 (s, 1H), 6.31 (d, <i>J</i> = 1.0 Hz, 1H), 4.69 (dd, <i>J</i> = 13.56, 4.3 Hz, 1H), 4.23–4.26 (m, 1H), 3.98–4.03 (m, 1H), 3.57–3.62 (m, 1H), 3.15 (s, 3H), 2.49 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.28, 155.82, 144.83, 137.44, 134.81, 131.21, 125.49, 121.73, 121.26, 120.85, 120.71, 117.22, 116.50, 113.86, 113.71, 108.60, 98.63, 71.46, 41.21, 37.44, 16.78; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>20</sub>H<sub>19</sub>FN<sub>3</sub>OS [M + H]<sup>+</sup>, 368.1277; found, 368.1279.</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 2,11,12-Trimethoxy-14-methyl-6,7,14,14a-tetrahydro-9<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9-one (<b>23c</b>)</h4><div class="NLM_p last">It was obtained as a white solid: 0.05 g (yield 26%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.30 (d, <i>J</i> = 4.0 Hz, 1H), 7.17 (s, 1H), 7.00 (d, <i>J</i> = 2.4 Hz, 1H), 6.79 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 6.53 (s, 1H), 6.28 (s, 1H), 6.20 (s, 1H), 4.66 (dd, <i>J</i> = 13.7, 4.7 Hz, 1H), 4.19 (dd, <i>J</i> = 12.2, 4.7 Hz, 1H), 3.99–3.94 (m, 1H), 3.87 (s, 3H), 3.72 (s, 3H), 3.66 (s, 3H), 3.56–3.51 (m, 1H), 3.10 (s, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz): δ 164.44, 154.73, 154.53, 144.46, 142.84, 135.57, 132.01, 127.98, 111.84, 110.77, 110.68, 108.85, 102.67, 99.52, 98.31, 71.60, 56.27, 56.24, 55.80, 37.58. HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>22</sub>H<sub>24</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 394.1761; found, 394.1767.</div></div><div id="sec5_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 2-Hydroxy-14-methyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>24</b>)</h4><div class="NLM_p last">To a stirred solution of compound <b>15b</b> (0.20 g, 0.6 mmol) in DCM (20 mL) was dropwise added BBr<sub>3</sub> (0.2 mL) at −78 °C under nitrogen, and the mixture was stirred for 2 h at room temperature. After the addition of methanol (0.2 mL) and DCM (30 mL), the solution was washed with saturated NaHCO<sub>3</sub> aqueous solution (60 mL) and brine (40 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed under reduced pressure. The residue was purified by column chromatography on SiO<sub>2</sub> (PE/EtOAc = 2:1) to give compound <b>24</b> (0.08 g, yield 43%) as a yellow solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.80 (s, 1H), 7.65 (dd, <i>J</i> = 7.7, 1.6 Hz, 1H), 7.41–7.44 (m, 1H), 7.16 (d, <i>J</i> = 8.6 Hz, 1H), 6.87 (d, <i>J</i> = 8.3 Hz, 1H), 6.79 (d, <i>J</i> = 2.3 Hz, 1H), 6.75 (t, <i>J</i> = 7.6 Hz, 1H), 6.64 (dd, <i>J</i> = 8.6, 2.3 Hz, 1H), 6.29 (s, 1H), 6.16 (s, 1H), 4.71 (dd, <i>J</i> = 13.5, 5.6 Hz, 1H), 4.08–4.11 (m, 1H), 3.90–3.95 (m, 1H), 3.56–3.59 (m, 1H), 3.23 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.77, 151.49, 147.27, 147.23, 135.42, 134.23, 131.09, 127.76, 117.67, 115.12, 113.03, 111.69, 109.80, 104.29, 96.88, 71.23, 40.91, 36.40; HRMS (ESI, negative) <i>m</i>/<i>z</i>: calcd for C<sub>19</sub>H<sub>16</sub>N<sub>3</sub>O<sub>2</sub> [M – H]<sup>−</sup>, 318.1248; found, 318.1247.</div></div><div id="sec5_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 15-Bromo-2,14-dimethyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>25a</b>)</h4><div class="NLM_p last">Compound <b>15b</b> (0.10 g, 0.25 mmol), AIBN (5.00 mg, 0.03 mmol), and NBS (56.00 mg, 0.3 mmol) were suspended in CCl<sub>4</sub> (10 mL) with stirring, and the mixture was heated for 4 h. The product mixture was then cooled and filtered to remove the succinimide. The residue was purified by column chromatography on SiO<sub>2</sub> (PE/EtOAc = 3:1) to give compound <b>25a</b> (0.03 g, yield 24%) as a white solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.78 (d, <i>J</i> = 7.7 Hz, 1H), 7.47–7.50 (m, 1H), 7.43 (d, <i>J</i> = 8.5 Hz, 1H), 7.23 (s, 1H), 7.11 (d, <i>J</i> = 8.4 Hz, 1H), 7.08 (d, <i>J</i> = 8.3 Hz, 1H), 6.97 (t, <i>J</i> = 7.5 Hz, 1H), 6.13 (s, 1H), 4.64 (dd, <i>J</i> = 13.4, 3.5 Hz, 1H), 4.40–4.42 (m, 1H), 4.03–4.08 (m, 1H), 3.35–3.38 (m, 1H), 2.87 (s, 3H), 2.40 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO, <i>d</i><sub>6</sub>): δ 164.07, 149.38, 134.71, 130.43, 128.49, 126.65, 125.38, 120.69, 118.38, 117.81, 110.61, 69.08, 41.63, 36.90, 21.52; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>20</sub>H<sub>19</sub>BrN<sub>3</sub>O [M + H]<sup>+</sup>, 396.0706; found, 396.0705.</div></div><div id="sec5_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 15-Bromo-11-fluoro-2-methoxy-14-methyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>25b</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid: 0.02 g (yield 26%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.57 (dd, <i>J</i> = 8.8, 3.0 Hz, 1H), 7.53 (d, <i>J</i> = 8.9 Hz, 1H), 7.26 (td, <i>J</i> = 8.76, 3.1 Hz, 1H), 7.26 (m, 1H), 6.98 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 6.93 (d, <i>J</i> = 2.4 Hz, 1H), 6.17 (s, 1H), 4.66–4.69 (m, 1H), 4.49–4.52 (m, 1H), 4.08–4.13 (m, 1H), 3.84 (s, 3H), 3.37–3.43 (m, 1H), 2.78 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.97, 157.41, 155.32, 146.41, 131.12, 126.90, 121.68, 121.47, 121.32, 114.31, 113.82, 113.66, 112.00, 99.97, 68.74, 55.93, 41.70, 40.54, 36.96; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>20</sub>H<sub>18</sub>BrFN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 430.0561; found, 430.0562.</div></div><div id="sec5_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 11-Fluoro-2-methoxy-14-methyl-15-((4-methylpiperazin-1-yl)methyl)-6,7,14,14a-tetrahydro-9<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9-one (<b>26</b>)</h4><div class="NLM_p last">Compound <b>28a</b> (0.10 g, 0.28 mmol) was dissolved in DCM (10 mL) and CH<sub>3</sub>COOH (0.06 mg, 0.001 mmol) was slowly added dropwise. After stirring for 30 min at room temperature, methylpiperazine was added. Then, the mixture was stirred for 2 h. The reaction mixture was concentrated, and the residue was purified by column chromatography on silica gel (DCM/MeOH = 100:1) to afford compound <b>26</b> (0.06 g, yield 25%) as a yellow solid. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.77 (dd, <i>J</i> = 8.9, 2.9 Hz, 1H), 7.34 (s, 1H), 7.24 (d, <i>J</i> = 9.0 Hz, 1H), 7.19–7.23 (m, 1H), 7.11 (dd, <i>J</i> = 8.9, 4.5 Hz, 1H), 6.95 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 6.16 (s, 1H), 4.84–4.91 (m, 1H), 4.32–4.38 (m, 1H), 4.07 (td, <i>J</i> = 12.2, 3.5 Hz, 1H), 3.89 (s, 3H), 3.78–3.87 (m, 1H), 3.70–3.75 (m, 1H), 3.31 (td, <i>J</i> = 12.9, 3.8 Hz, 1H), 2.16–2.80 (m, 14H); <sup>13</sup>C NMR (CDCl<sub>3</sub>, 150 MHz): δ 163.39, 159.67, 158.05, 154.51, 147.01, 131.20, 128.40, 123.70, 120.81, 114.60, 112.90, 109.67, 102.18, 68.18, 55.97, 55.17, 52.71, 52.29, 45.71, 41.49, 38.92, 36.27, 26.91; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>26</sub>H<sub>31</sub>FN<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 464.2456; found, 464.2493.</div></div><div id="sec5_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 2-Fluoro-14-methyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazoline-9(7<i>H</i>)-thione (<b>27</b>)</h4><div class="NLM_p last">To a stirred solution of compound <b>15e</b> (0.10 g, 0.30 mmol) in toluene (10 mL) was added Lawesson’s reagent (0.06 g, 0.15 mmol), and the mixture was stirred for 4 h at 110 °C. Then, the solvent was removed under reduced pressure. The residue was purified by column chromatography on silica gel (PE/EtOAc = 5:1) to afford compound <b>27</b> (0.04 g, yield 37%) as a yellow solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.20 (dd, <i>J</i> = 8.0, 1.3 Hz, 1H), 7.44–7.48 (m, 2H), 7.29 (dd, <i>J</i> = 9.7, 2.3 Hz, 1H), 7.03 (dt, <i>J</i> = 9.0, 2.5 Hz, 1H), 6.96 (d, <i>J</i> = 8.1 Hz, 1H), 6.82 (t, <i>J</i> = 7.2 Hz, 1H), 6.53 (s, 1H), 6.43 (s, 1H), 5.56 (dd, <i>J</i> = 13.6, 5.0 Hz, 1H), 4.36–4.39 (m, 1H), 4.23–4.28 (m, 1H), 4.02–4.08 (m, 1H), 3.15 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 190.72, 157.80, 143.70, 136.12, 134.96, 133.60, 133.09, 127.76, 121.92, 119.15, 114.49, 111.31, 110.49, 105.80, 105.64, 99.38, 71.83, 48.60, 36.74; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>19</sub>H<sub>17</sub>FN<sub>3</sub>S [M + H]<sup>+</sup>, 338.1122; found, 338.1123.</div></div><div id="sec5_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 11-Fluoro-2-methoxy-14-methyl-9-oxo-7,9,14,14a-tetrahydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazoline-15-carbaldehyde (<b>28a</b>)</h4><div class="NLM_p last">To a stirred solution of compound <b>15j</b> (0.10 g, 0.3 mmol) in DMF (10 mL) was added POCl<sub>3</sub> (50 μL), and the mixture was stirred for 3 h at room temperature. Then, the mixture was poured into water (10 mL), and the pH of the solution was adjusted to 7 with 2 M NaOH solution. The precipitated product was filtered off, washed with water, and dried to give compound <b>28a</b> (0.09 g, 86%) as a white solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.17 (s, 1H), 7.67 (d, <i>J</i> = 2.5 Hz, 1H), 7.58 (dd, <i>J</i> = 8.9, 2.9 Hz, 1H), 7.56 (d, <i>J</i> = 8.9 Hz, 1H), 7.44 (td, <i>J</i> = 8.7, 3.0 Hz, 1H), 7.35–7.38 (m, 1H), 6.97 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 6.64 (s, 1H), 4.67 (dd, <i>J</i> = 13.6, 2.8 Hz, 1H), 4.55 (d, <i>J</i> = 12.0 Hz, 1H), 4.12–4.17 (m, 1H), 3.79 (s, 3H), 3.44–3.49 (m, 1H), 2.61 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 184.97, 162.63, 158.43, 157.05, 146.88, 131.19, 125.71, 124.83, 121.53, 121.37, 113.97, 113.91, 113.67, 112.08, 103.17, 68.17, 55.79, 41.40, 38.60; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>21</sub>H<sub>19</sub>FN<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 380.1405; found, 380.1406.</div></div><div id="sec5_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 2-Methoxy-11,14-dimethyl-9-oxo-7,9,14,14a-tetrahydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazoline-15-carbaldehyde (<b>28b</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid: 0.11 g (yield 82%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.17 (s, 1H), 7.68 (s, 1H), 7.67 (d, <i>J</i> = 2.5 Hz, 1H), 7.55 (d, <i>J</i> = 8.9 Hz, 1H), 7.36–7.38 (m, 1H), 7.18 (d, <i>J</i> = 8.2 Hz, 1H), 6.97 (d, <i>J</i> = 8.9, 2.5 Hz, 1H), 6.59 (s, 1H), 4.66–4.70 (m, 1H), 4.51–4.55 (m, 1H), 4.12–4.17 (m, 1H), 3.79 (s, 3H), 3.44–3.49 (m, 1H), 2.65 (s, 3H), 2.30 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 185.16, 163.88, 157.11, 148.13, 135.01, 132.79, 131.31, 128.26, 125.82, 122.10, 121.81, 113.97, 112.12, 103.29, 68.59, 55.88, 41.46, 38.71, 20.78; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>22</sub>H<sub>22</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 376.1656; found, 376.1655.</div></div><div id="sec5_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 11-Fluoro-15-(hydroxymethyl)-2-methoxy-14-methyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>29a</b>)</h4><div class="NLM_p last">To a stirred solution of compound <b>28a</b> (50.00 mg, 0.15 mol) in MeOH (10 mL) was added NaBH<sub>4</sub> (6.00 mg, 0.30 mmol), and the mixture was stirred for 1 h at room temperature. Then, the mixture was poured into water (10 mL), and the precipitated product was filtered off, washed with water, and dried to give compound <b>29a</b> (0.05 g, 92%) as a white solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.55 (dd, <i>J</i> = 8.8, 3.1 Hz, 1H), 7.36–7.41 (m, 2H), 7.22–7.25 (m, 1H), 7.20 (d, <i>J</i> = 2.4 Hz, 1H), 6.84 (dd, <i>J</i> = 8.7, 2.3 Hz, 1H), 6.22 (s, 1H), 4.64–4.71 (m, 3H), 4.58–4.61 (m, 1H), 4.41–4.44 (m, 1H), 3.99 (td, <i>J</i> = 11.8, 3.7 Hz, 1H), 3.77 (s, 3H), 3.26–3.30 (m, 1H), 2.57 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.36, 157.94, 156.36, 153.81, 146.60, 130.93, 127.14, 126.97, 122.08, 120.72, 114.00, 113.25, 112.25, 110.35, 101.11, 67.65, 55.36, 53.42, 40.87, 39.13, 35.86; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>21</sub>H<sub>21</sub>FN<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 382.1561; found, 382.1560.</div></div><div id="sec5_1_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 15-(Hydroxymethyl)-2-methoxy-11,14-dimethyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>29b</b>)</h4><div class="NLM_p last">It was obtained as a white solid: 0.09 g (yield 93%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.66 (s, 1H), 7.37 (d, <i>J</i> = 8.8 Hz, 1H), 7.33 (d, <i>J</i> = 8.9 Hz, 1H), 7.20 (d, <i>J</i> = 2.3 Hz, 1H), 7.07 (d, <i>J</i> = 8.2 Hz, 1H), 6.84 (dd, <i>J</i> = 8.8, 2.3 Hz, 1H), 6.17 (s, 1H), 4.64–4.70 (m, 3H), 4.62 (d, <i>J</i> = 13.8 Hz, 1H), 4.42 (d, <i>J</i> = 10.1 Hz, 1H), 3.99 (dt, <i>J</i> = 8.8, 2.3 Hz, 1H), 3.77 (s, 3H), 3.22–3.27 (m, 1H), 2.59 (s, 3H), 2.29 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.93, 154.31, 148.31, 134.69, 131.49, 131.05, 128.4, 127.70, 120.98, 119.90, 114.39, 112.67, 110.83, 101.62, 68.36, 55.88, 53.97, 41.48, 36.31, 20.72; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>22</sub>H<sub>24</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 378.1812; found, 378.1811.</div></div><div id="sec5_1_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 11-Fluoro-2-methoxy-14,15-dimethyl-6,7,14,14a-tetrahydro-9<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9-one (<b>30</b>)</h4><div class="NLM_p last">It was obtained as a white solid: 0.09 g (yield 42%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.57 (dd, <i>J</i> = 8.9, 3.1 Hz, 1H), 7.39–7.43 (m, 1H), 7.37 (d, <i>J</i> = 8.9 Hz, 1H), 7.23–7.27 (m, 1H), 7.06 (d, <i>J</i> = 2.3 Hz, 1H), 6.85 (dd, <i>J</i> = 8.9, 2.4 Hz, 1H), 6.15 (s, 1H), 4.57–4.64 (m, 1H), 4.35–4.44 (m, 1H), 3.98–4.00 (m, 1H), 3.79 (s, 3H), 3.25–3.30 (m, 1H), 2.59 (s, 3H), 2.96 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.95, 158.37, 156.79, 154.21, 147.08, 131.50, 128.39, 126.92, 122.34, 121.27, 121.11, 113.89, 113.73, 112.66, 111.36, 110.99, 108.99, 100.89, 68.39, 55.91, 41.42, 36.09, 8.87; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>21</sub>H<sub>21</sub>FN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 366.1612; found, 366.1627.</div></div><div id="sec5_1_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Ethyl 1-(Cyanomethyl)-5-methoxy-1<i>H</i>-indole-2-carboxylate (<b>31</b>)</h4><div class="NLM_p last">δ 8.09 (s, 1H), 7.44 (d, <i>J</i> = 9.0 Hz, 1H), 7.13 (s, 1H), 6.94 (m, 2H), 6.15 (t, <i>J</i> = 5.8 Hz, 2H), 3.76 (s, 3H), 3.62 (m, 1H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 161.82, 155.57, 134.10, 126.97, 126.86, 117.62, 114.96, 112.12, 110.51, 103.43, 61.13, 55.75, 32.44, 14.29; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>14</sub>H<sub>15</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 259.1077; found, 259.1076.</div></div><div id="sec5_1_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> Ethyl 1-(2-Cyanopropan-2-yl)-5-methoxy-1<i>H</i>-indole-2-carboxylate (<b>32</b>)</h4><div class="NLM_p last">To a solution of intermediate <b>31</b> (2.00 g, 7.70 mmol) in THF (60 mL) was added methyl iodide (2.00 g, 7.70 mmol) at 0 °C. A 1 M solution of sodium bis(trimethylsilyl)amide in THF (20.4 mL) was added at 0 °C. The reaction mixture was warmed to room temperature and stirred for 24 h. The reaction was quenched with saturated aqueous NH<sub>4</sub>Cl solution and diluted with EtOAc (100 mL). The aqueous phase was separated and extracted twice with EtOAc. The combined organic layers were washed with brine, dried over sodium sulfate, and concentrated in vacuo. The residue was purified by column chromatography on silica gel (PE/EtOAc = 8:1) to afford intermediate <b>32</b> (1.2 g, yield 44%) as a white solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.74 (d, <i>J</i> = 4.2 Hz, 1H), 7.17 (d, <i>J</i> = 2.6 Hz, 1H), 7.15 (s, 1H), 6.99 (dd, <i>J</i> = 9.3, 2.7 Hz, 1H), 4.31 (q, <i>J</i> = 7.1 Hz, 2H), 3.77 (s, 3H), 2.17 (s, 6H), 1.33 (t, <i>J</i> = 5.1 Hz, 3H).</div></div><div id="sec5_1_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 8-Methoxy-4,4-dimethyl-3,4-dihydropyrazino[1,2-<i>a</i>]indol-1(2<i>H</i>)-one (<b>33</b>)</h4><div class="NLM_p last">It was obtained as a white solid: 0.20 g (yield 36%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.09 (s, 1H), 7.69 (d, <i>J</i> = 9.1 Hz, 1H), 7.15 (d, <i>J</i> = 2.4 Hz, 1H), 7.00 (s, 1H), 6.90 (dd, <i>J</i> = 2.4, 9.1 Hz, 1H), 3.77 (s, 3H), 3.43 (d, <i>J</i> = 2.2 Hz, 2H), 1.63 (s, 6H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 160.49, 154.13, 131.41, 130.79, 128.41, 115.40, 114.09, 105.69, 103.15, 55.74, 55.68, 52.19, 25.28.</div></div><div id="sec5_1_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Methyl 5-Fluoro-2-(methylamino)benzoate (<b>34b</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.50 (dd, <i>J</i> = 9.9, 3.2 Hz, 1H), 7.35–7.41 (m, 1H), 7.30–7.35 (m, 1H), 6.73 (dd, <i>J</i> = 9.3, 4.5 Hz, 1H), 3.80 (s, 1H), 2.84 (d, <i>J</i> = 5.13 Hz, 3H).</div></div><div id="sec5_1_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 2-Methoxy-6,6,14-trimethyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>36a</b>)</h4><div class="NLM_p last">It was obtained as a white solid: 0.09 g (yield 35%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.67 (dd, <i>J</i> = 7.7, 1.7 Hz, 1H), 7.52 (d, <i>J</i> = 9.1 Hz, 1H), 7.40–7.44 (m, 1H), 6.98 (d, <i>J</i> = 2.5 Hz, 1H), 6.87 (d, <i>J</i> = 8.0 Hz, 1H), 6.77 (td, <i>J</i> = 7.5, 0.9 Hz, 1H), 6.72 (dd, <i>J</i> = 9.1, 2.6 Hz, 1H), 6.29 (s, 1H), 6.24 (s, 1H), 4.68 (d, <i>J</i> = 13.7 Hz, 1H), 3.70 (s, 3H), 3.35 (d, <i>J</i> = 13.8 Hz, 1H), 3.18 (s, 3H), 1.76 (s, 3H), 1.47 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.43, 153.91, 147.58, 136.12, 134.53, 130.67, 129.25, 128.33, 118.31, 115.77, 114.01, 113.67, 111.62, 103.06, 98.18, 57.66, 55.71, 53.61, 37.52, 26.99, 26.58; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>22</sub>H<sub>24</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 362.1863; found, 362.1863.</div></div><div id="sec5_1_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 11-Fluoro-2-methoxy-6,6,14-trimethyl-14,14a-dihydro-6<i>H</i>-indolo[2′,1′:3,4]pyrazino[2,1-<i>b</i>]quinazolin-9(7<i>H</i>)-one (<b>36b</b>)</h4><div class="NLM_p last">It was obtained as a brown solid: 0.06 g (yield 44%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.71 (dd, <i>J</i> = 8.7, 2.8 Hz, 1H), 7.49 (d, <i>J</i> = 9.0 Hz, 1H), 7.18 (td, <i>J</i> = 8.6, 3.0 Hz, 1H), 7.07 (d, <i>J</i> = 2.4 Hz, 1H), 6.96 (dd, <i>J</i> = 9.0, 4.3 Hz, 1H), 6.87 (dd, <i>J</i> = 9.1, 2.5 Hz, 1H), 6.47 (s, 1H), 6.00 (s, 1H), 4.66 (d, <i>J</i> = 13.6 Hz, 1H), 3.85 (s, 3H), 3.27 (d, <i>J</i> = 13.6 Hz, 1H), 2.78 (s, 3H), 1.85 (s, 3H), 1.67 (s, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 161.77, 155.84, 153.96, 144.74, 135.37, 130.66, 129.28, 121.47, 117.53, 116.68, 114.01, 113.88, 111.73, 103.03, 98.64, 71.23, 57.50, 55.68, 53.38, 37.75, 26.87, 26.42; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>22</sub>H<sub>23</sub>FN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 380.1769; found, 380.1768.</div></div><div id="sec5_1_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Ethyl 1-(2-Cyanoethyl)-5-methoxy-1<i>H</i>-indole-2-carboxylate (<b>39</b>)</h4><div class="NLM_p">To a solution of intermediate <b>37</b> (1.00 g, 4.60 mmol) in 1,4-dioxane (20 mL) was slowly added benzyltrimethylammonium hydroxide at 0 °C, and after stirring for 0.5 h, acrylonitrile (0.48 g, 9.10 mmol) was added. The mixture was refluxed for 1 h and then poured into ice water (150 mL). Then, the aqueous layer was extracted with ethyl acetate (3 × 50 mL), and the combined organic layers were washed with brine, dried over sodium sulfate, and concentrated under reduced pressure. The crude product was purified by column chromatography on silica gel (PE/EtOAc = 8:1) to afford intermediate <b>3</b> (0.89 g, yield 72%) as a white solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.65 (d, <i>J</i> = 8.6 Hz, 1H), 7.22 (s, 1H), 7.15 (d, <i>J</i> = 2.3 Hz, 1H), 7.02 (dd, <i>J</i> = 9.2, 2.5 Hz, 1H), 4.82 (t, <i>J</i> = 6.3 Hz, 2H), 4.32 (q, <i>J</i> = 7.3 Hz, 2H), 3.78 (s, 3H), 2.98 (t, <i>J</i> = 6.7 Hz, 2H), 1.34 (t, <i>J</i> = 7.1 Hz, 3H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 161.56, 154.96, 134.53, 127.52, 126.30, 119.04, 117.00, 112.56, 110.80, 102.94, 60.92, 55.79, 19.00, 14.59; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>15</sub>H<sub>17</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 273.1234; found, 273.1236.</div><div class="NLM_p last">Starting from intermediates <b>32</b> and <b>39</b>, compounds <b>36a</b>, <b>36b</b>, and <b>42</b> were obtained following the synthetic method used to prepare compound <b>15b</b>.</div></div><div id="sec5_1_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 9-Methoxy-2,3,4,5-tetrahydro-1<i>H</i>-[1,4]diazepino[1,2-<i>a</i>]indole (<b>40</b>)</h4><div class="NLM_p last">It was obtained as a white solid: 0.30 g (yield 36%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.64 (d, <i>J</i> = 8.7 Hz, 1H), 7.22 (s, 1H), 7.16 (d, <i>J</i> = 2.4 Hz, 1H), 7.03 (dd, <i>J</i> = 2.4, 9.0 Hz, 1H), 4.61 (t, <i>J</i> = 6.9 Hz, 2H), 4.33 (q, <i>J</i> = 7.1 Hz, 2H), 3.79 (s, 3H), 2.75 (s, 1H), 1.94–2.06 (m, 2H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 160.64, 154.58, 132.11, 130.52, 127.27, 115.54, 112.04, 104.08, 102.86, 55.76, 40.58; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>13</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 231.1128; found, 231.1138.</div></div><div id="sec5_1_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 2-Methoxy-15-methyl-7,8,15,15a-tetrahydroindolo[2′,1′:3,4][1,4]diazepino[2,1-<i>b</i>]quinazolin-10(6<i>H</i>)-one (<b>42</b>)</h4><div class="NLM_p last">It was obtained as a white solid: 0.12 g (yield 32%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.60 (dd, <i>J</i> = 7.6, 1.5 Hz, 1H), 7.46–7.49 (m, 1H), 7.36 (d, <i>J</i> = 9.0 Hz, 1H), 6.94 (d, <i>J</i> = 8.2 Hz, 1H), 6.88 (d, <i>J</i> = 2.4 Hz, 1H), 6.77 (t, <i>J</i> = 7.6 Hz, 1H), 6.73 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 6.34 (s, 1H), 5.56 (s, 1H), 4.62–4.66 (m, 2H), 4.14 (dd, <i>J</i> = 14.2, 12.3 Hz, 1H), 3.66 (s, 3H), 3.21 (d, <i>J</i> = 13.9 Hz, 1H), 3.18 (s, 3H), 2.07 (d, <i>J</i> = 12.7, 1H), 1.55–1.64 (m, 1H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 161.19, 153.42, 147.47, 138.58, 133.85, 132.04, 127.81, 126.12, 117.18, 115.92, 111.52, 111.45, 110.21, 102.02, 99.18, 71.63, 55.24, 45.29, 43.25, 36.33, 28.33; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>21</sub>H<sub>22</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 348.1707; found, 348.1706.</div></div><div id="sec5_1_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 2-Hydroxy-15-methyl-7,8,15,15a-tetrahydroindolo[2′,1′:3,4][1,4]diazepino[2,1-<i>b</i>]quinazolin-10(6<i>H</i>)-one (<b>43</b>)</h4><div class="NLM_p last">It was obtained as a yellow solid: 0.12 g (yield 48%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.67 (s, 1H), 7.60 (dd, <i>J</i> = 7.6, 1.5 Hz, 1H), 7.46–7.49 (m, 1H), 7.24 (d, <i>J</i> = 8.9 Hz, 1H), 6.93 (d, <i>J</i> = 8.3 Hz, 1H), 6.76 (t, <i>J</i> = 14.9 Hz, 1H), 6.66 (d, <i>J</i> = 2.2 Hz, 1H), 6.60 (dd, <i>J</i> = 8.8, 2.3 Hz, 1H), 6.31 (s, 1H), 5.55 (s, 1H), 4.57–4.64 (m, 2H), 4.08–4.13 (m, 2H), 3.17 (s, 3H), 2.05 (d, <i>J</i> = 12.4 Hz, 1H), 1.57–1.64 (m, 1H); <sup>13</sup>C NMR (150 MHz, DMSO-<i>d</i><sub>6</sub>): δ 161.19, 150.78, 147.43, 138.36, 133.84, 131.51, 127.80, 126.50, 117.11, 115.86, 111.60, 111.52, 109.82, 104.04, 71.67, 48.55, 45.30, 43.14, 36.34, 28.37; HRMS (ESI, positive) <i>m</i>/<i>z</i>: calcd for C<sub>20</sub>H<sub>20</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 334.1550; found, 334.1551.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> In Vitro Cytotoxicity Assay</h3><div class="NLM_p last">Cells were plated in 96-well microtiter plates at a density of 7 × 10<sup>3</sup>/well and incubated in a humidified atmosphere with 5% CO<sub>2</sub> at 37 °C for 24 h. The test compounds were added to triplicate wells at different concentrations, and 0.1% DMSO was used as the control. After incubation for 72 h, 20 μL of CCK8 was added to each well, and the plate was incubated for an additional 1 h. The absorbance (OD) was read on a WellscanMK-2 microplate reader (Labsystems) at 450 nm. The concentration causing 50% inhibition of cell growth (IC<sub>50</sub>) was determined by the Logit method.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> All experiments were performed in triplicate.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> Apoptosis Detection Assay</h3><div class="NLM_p last">HCT116 cells (5 × 10<sup>5</sup> cells/mL) were seeded in six-well plates and treated with the test compounds at 0.04, 0.20, and 1 μM for 24 h. The cells were then harvested by trypsinization and washed twice with cold phosphate-buffered saline (PBS). After centrifugation and removal of the supernatant, the cells were resuspended in 400 μL of 1× binding buffer, and this mixture was then added to 5 μL of annexin V-FITC and incubated at room temperature for 15 min. After adding 10 μL of PI, the cells were incubated at room temperature for another 15 min in the dark. The stained cells were analyzed by a flow cytometer (BD Accuri C6).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> Top1 Inhibitory Activity Assay</h3><div class="NLM_p last">The Top1 inhibition assay was performed according to the procedure described in our previous studies.<a onclick="showRef(event, 'ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16">(14−16)</a> Briefly, the assay mixture contained 35 mM Tris-HCl (pH 8.0), 72 mM KCl, 5 mM MgCl<sub>2</sub>, 5 mM dithiothreitol, 5 mM spermidine, 0.1% bovine serum albumin (BSA), pBR322 plasmid DNA (0.25 μg), the drug at the indicated concentration (1% DMSO), and 1 unit of Top1 (TaKaRa Biotechnology Co., Ltd., Dalian) in a final volume of 20 μL. The assay mixtures were incubated for 15 min at 37 °C, and the reaction was stopped by the addition of 2 μL of 10× loading buffer [0.9% sodium dodecyl sulfate (SDS), 0.05% bromophenol blue, and 50% glycerol]. Electrophoresis was carried out in a 0.8% agarose gel in TAE (Tris-acetate-EDTA) at 8 V/cm for 1 h. Gels were stained with ethidium bromide (EB) (0.5 μg/mL) for 60 min, and the DNA band was visualized with UV light and photographed with a Gel Doc EZ imager (Bio-Rad Laboratories Ltd.).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> Top2 Inhibitory Activity Assay</h3><div class="NLM_p last">The DNA Top2α inhibition assay was performed according to the procedure described in our previous study.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Briefly, the assay mixture contained 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 10 mM MgCl<sub>2</sub>, 5 mM dithiothreitol, 30 μg/mL BSA, 2 mM ATP, pBR322 plasmid DNA (0.25), the drug at the indicated concentration (1% DMSO), and 0.75 units of Top2α (TopoGEN, Inc.) in a final volume of 20 μL. The reaction mixtures were incubated for 30 min at 37 °C, and the reaction was stopped by the addition of 2 μL of 10% SDS. Then, 2 μL of 10× gel loading buffer (0.25% bromophenol blue and 50% glycerol) was added. Electrophoresis was carried out in a 1% agarose gel in TAE at 8 V/cm for 1 h. The gels were stained with EB (0.5 μg/mL) for 60 min, and the DNA band was visualized with UV light and photographed with a Gel Doc EZ imager (Bio-Rad Laboratories Ltd.).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> Tubulin Polymerization Inhibitory Activity Assay</h3><div class="NLM_p last">The tubulin polymerization assay was performed according to the literature.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> A purified brain tubulin polymerization kit was purchased from Cytoskeleton (BK006P, Denver, CO). The final assay buffer, which contained 0.1 M MES (pH 6.6), 10 mM MgCl<sub>2</sub>, 1 mM GTP, 1 mM EGTA, and 3.4 M glycerol, was cooled to 0 °C. Compound <b>15j</b> was added at different concentrations, and the reaction was initiated by the addition of tubulin to a final concentration of 10 mM with warming to 37 °C. Colchicine was used as a positive control under similar experimental conditions. The optical density at 340 nm was measured at 1 min intervals for 15–30 min with a BioTek’s Synergy 4 multifunction microplate reader. Assays were performed twice, and the average of the values was used to calculate the IC<sub>50</sub> values and prepare the figures.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> Top1-Mediated DNA Cleavage Assay</h3><div class="NLM_p last">The DNA cleavage assay was performed as previously described.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> A solution containing 10× buffer, pUC19 plasmid DNA (0.25 μg), 0.1% BSA, 4 units of Top1 [TaKaRa Biotechnology (Dalian) Co., Ltd.], deionized water, and the drug at the indicated concentrations (1% DMSO) with a final volume of 20 μL was incubated for 30 min at 37 °C. The reaction was stopped by adding 2 μL of 10% SDS followed by the addition of proteinase K (200 μg/mL final concentration), and the samples were incubated at 50 °C for 20 min. Then, 2 μL of 10× gel loading buffer (0.25% bromophenol blue and 50% glycerol) was added. The samples were analyzed on 1% agarose with 0.5 μg/mL EB at 8 V/cm for 1 h, and TAE was used as the running buffer. The DNA bands were visualized with UV light and photographed with a Gel Doc EZ imager (Bio-Rad Laboratories, Ltd.)</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> Laser Fluorescence Confocal Microscopy</h3><div class="NLM_p last">Laser fluorescence confocal microscopy was performed according to the protocol described in our previous study.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> HCT116 cells were seeded in a glass-bottom dish and incubated in a humidified atmosphere with 5% CO<sub>2</sub> at 37 °C for 24 h. Compounds in DMSO or DMSO alone (vehicle) (0.2% DMSO final) were added to the cells at 70% confluency, and the samples were incubated for an additional 12 h. After briefly washing three times in PBS, the cells were stained with 4% paraformaldehyde. Then, the cells were rinsed three times with a solution of 0.5% Triton X-100 (Solarbio) in PBS and blocked for 20 min in 10% goat serum (Solarbio). Anti-α-tubulin (Abcam) was added at a 1:500 dilution in PBS, and the cells were incubated for 2 h at 37 °C and then washed for 3 × 10 min in PBS. The goat anti-mouse IgG/Alexa Fluor 488 (Abcam) conjugate was diluted 1:200 in PBS and incubated with cells for 2 h. After washing three times with PBS, the cells were stained with 10% DAPI (Solarbio) and then washed four times with PBS. The samples were immediately visualized with a Leica TCS SP8 laser scanning confocal microscope. Wide-field images were acquired by moving the stage to 10–15 random locations on each slide and then only adjusting the stage in the <i>z</i>-direction to maximize the number of cells in focus.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> In Vivo Antitumor Activity</h3><div class="NLM_p">The in vivo antitumor activities of compound <b>15j</b> at a dose of 4 mg/kg and compound <b>15js</b> at a dose of 16 mg/kg were evaluated. Nude male mice (certificate SCXK-2007-0005, weighing 18–20 g) were obtained from the Shanghai Experimental Animal Center, Chinese Academy of Sciences. Suspensions of HCT116 colon cancer cells were implanted subcutaneously into the right axilla region of the mice. Treatment began when the implanted tumors reached a volume of approximately 100–300 mm<sup>3</sup> (after 10 days). The animals were randomized into the appropriate groups (six animals/treatment and ten animals/control group), and the treatments were administered by ip injection for 21 consecutive days once per day starting 10 days after implantation of cells. Observations were made for 21 days starting after the first injection. Tumor volumes were determined by using calipers to measure the length and width and calculating the volume using the formula TV = (<i>AB</i><sup>2</sup>)/2, where <i>A</i> is the tumor length and <i>B</i> is the width. Tumor volumes and body weights were monitored every 2 or 4 days over the course of treatment. Mice were sacrificed on day 31 after implantation of the cells, and tumors were removed and analyzed.</div><div class="NLM_p last">The experimental procedures and the animal use and care protocols were approved by the Committee on Ethics of Biomedicine, Second Military Medical University.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i89"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01626" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52613" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52613" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b01626?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01626</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Biological assays of compound <b>15j</b> against a panel of 30 antitumor targets and HPLC chromatograms of compounds <b>15j</b> and <b>15js</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01626/suppl_file/jm9b01626_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings of the target compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01626/suppl_file/jm9b01626_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Molecular docking of compound <b>15j</b> with Top1 (15j_1T8I.pdb) (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01626/suppl_file/jm9b01626_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Molecular docking of compound <b>15j</b> with tubulin (15J_1SA0.pdb) (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01626/suppl_file/jm9b01626_si_004.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01626/suppl_file/jm9b01626_si_001.pdf">jm9b01626_si_001.pdf (339.92 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01626/suppl_file/jm9b01626_si_002.csv">jm9b01626_si_002.csv (2.85 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01626/suppl_file/jm9b01626_si_003.pdb">jm9b01626_si_003.pdb (2.13 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01626/suppl_file/jm9b01626_si_004.pdb">jm9b01626_si_004.pdb (900.33 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01626" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10447" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10447" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guoqiang Dong</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6e0a091f43565f2e5f585d400d0103"><span class="__cf_email__" data-cfemail="680c0f1945505928595e5b460b0705">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shanchao Wu</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#324547415a535c515a535d02056d00720300041c515d5f"><span class="__cf_email__" data-cfemail="5f282a2c373e313c373e306f68006d1f6e6d69713c3032">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chunquan Sheng</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Fujian University of Traditional
Chinese Medicine, 1 Qiuyang
Road, Fuzhou, Fujian 350122, China</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9489-804X" title="Orcid link">http://orcid.org/0000-0001-9489-804X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6c1f0409020b0f1d2c1f01011942090819420f02"><span class="__cf_email__" data-cfemail="43302b262d24203203302e2e366d2627366d202d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lei Wang</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Fujian University of Traditional
Chinese Medicine, 1 Qiuyang
Road, Fuzhou, Fujian 350122, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kun Fang</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Junfei Cheng</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yu Li</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yahui Huang</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuqiang Chen</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>L.W., K.F., and J.C. contributed equally to this work. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i91">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54216" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54216" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported in part by the National Natural Science Foundation of China (grants 81725020 to C.S., 21807113 to S.W. and 81872742 to G.D.), Science and Technology Commission of Shanghai (grant 18ZR1449200 to S.W.), Shanghai Sailing Program (18YF1429100 to S.W.), and the Innovation Program of Shanghai Municipal Education Commission (2019-01-07-00-07-E00073 to C.S.).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">NPs</td><td class="NLM_def"><p class="first last">natural products</p></td></tr><tr><td class="NLM_term">CPT</td><td class="NLM_def"><p class="first last">camptothecin</p></td></tr><tr><td class="NLM_term">TPT</td><td class="NLM_def"><p class="first last">topotecan</p></td></tr><tr><td class="NLM_term">IRT</td><td class="NLM_def"><p class="first last">irinotecan</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">Top1</td><td class="NLM_def"><p class="first last">topoisomerase I</p></td></tr><tr><td class="NLM_term">Top2</td><td class="NLM_def"><p class="first last">topoisomerase II</p></td></tr><tr><td class="NLM_term">Eto</td><td class="NLM_def"><p class="first last">etoposide</p></td></tr><tr><td class="NLM_term">IP</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">TGI</td><td class="NLM_def"><p class="first last">tumor growth inhibitor</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i93">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63214" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63214" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 26 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris-Natschke, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.-H.</span></span> <span> </span><span class="NLM_article-title">Strategies for the optimization of natural leads to anticancer drugs or drug candidates</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1002/med.21377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.1002%2Fmed.21377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=26359649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVagsb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=32-91&author=Z.+Xiaoauthor=S.+L.+Morris-Natschkeauthor=K.-H.+Lee&title=Strategies+for+the+optimization+of+natural+leads+to+anticancer+drugs+or+drug+candidates&doi=10.1002%2Fmed.21377"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates</span></div><div class="casAuthors">Xiao, Zhiyan; Morris-Natschke, Susan L.; Lee, Kuo-Hsiung</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-91</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Natural products have made significant contribution to cancer chemotherapy over the past decades and remain an indispensable source of mol. and mechanistic diversity for anticancer drug discovery.  More often than not, natural products may serve as leads for further drug development rather than as effective anticancer drugs by themselves.  Generally, optimization of natural leads into anticancer drugs or drug candidates should not only address drug efficacy, but also improve absorption, distribution, metab., excretion, and toxicity (ADMET) profiles and chem. accessibility assocd. with the natural leads.  Optimization strategies involve direct chem. manipulation of functional groups, structure-activity relationship directed optimization and pharmacophore-oriented mol. design based on the natural templates.  Both fundamental medicinal chem. principles (e.g., bioisosterism) and state-of-the-art computer-aided drug design techniques (e.g., structure-based design) can be applied to facilitate optimization efforts.  In this review, the strategies to optimize natural leads to anticancer drugs or drug candidates are illustrated with examples and described according to their purposes.  Furthermore, successful case studies on lead optimization of bioactive compds. performed in the Natural Products Research Labs. at UNC are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6SGKXSp6ip7Vg90H21EOLACvtfcHk0ljWN2kIOoCbXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVagsb%252FJ&md5=dc8c68d23f1f8e9ff6e98847a69558c4</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fmed.21377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21377%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DMorris-Natschke%26aufirst%3DS.%2BL.%26aulast%3DLee%26aufirst%3DK.-H.%26atitle%3DStrategies%2520for%2520the%2520optimization%2520of%2520natural%2520leads%2520to%2520anticancer%2520drugs%2520or%2520drug%2520candidates%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2016%26volume%3D36%26spage%3D32%26epage%3D91%26doi%3D10.1002%2Fmed.21377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cragg, G. M.</span></span> <span> </span><span class="NLM_article-title">Natural products as sources of new drugs from 1981 to 2014</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">629</span>– <span class="NLM_lpage">661</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.5b01055</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.5b01055" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit1Kqu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=629-661&author=D.+J.+Newmanauthor=G.+M.+Cragg&title=Natural+products+as+sources+of+new+drugs+from+1981+to+2014&doi=10.1021%2Facs.jnatprod.5b01055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Products as Sources of New Drugs from 1981 to 2014</span></div><div class="casAuthors">Newman, David J.; Cragg, Gordon M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">629-661</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">This contribution is a completely updated and expanded version of the four prior analogous reviews that were published in this journal in 1997, 2003, 2007, and 2012.  In the case of all approved therapeutic agents, the time frame has been extended to cover the 34 years from Jan. 1, 1981, to Dec. 31, 2014, for all diseases worldwide, and from 1950 (earliest so far identified) to Dec. 2014 for all approved antitumor drugs worldwide.  As mentioned in the 2012 review, we have continued to utilize our secondary subdivision of a "natural product mimic", or "NM", to join the original primary divisions and the designation "natural product botanical", or "NB", to cover those botanical "defined mixts." now recognized as drug entities by the U.S. FDA (and similar organizations).  From the data presented in this review, the utilization of natural products and/or their novel structures, in order to discover and develop the final drug entity, is still alive and well.  For example, in the area of cancer, over the time frame from around the 1940s to the end of 2014, of the 175 small mols. approved, 131, or 75%, are other than "S" (synthetic), with 85, or 49%, actually being either natural products or directly derived therefrom.  In other areas, the influence of natural product structures is quite marked, with, as expected from prior information, the anti-infective area being dependent on natural products and their structures.  We wish to draw the attention of readers to the rapidly evolving recognition that a significant no. of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated", and therefore it is considered that this area of natural product research should be expanded significantly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMgEvq9fVY8bVg90H21EOLACvtfcHk0ljWN2kIOoCbXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit1Kqu7k%253D&md5=c9f2a44ab6b66331b7ef6ca64029328a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.5b01055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.5b01055%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26aulast%3DCragg%26aufirst%3DG.%2BM.%26atitle%3DNatural%2520products%2520as%2520sources%2520of%2520new%2520drugs%2520from%25201981%2520to%25202014%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2016%26volume%3D79%26spage%3D629%26epage%3D661%26doi%3D10.1021%2Facs.jnatprod.5b01055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kingsbury, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakas, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holden, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hecht, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallagher, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caranfa, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCabe, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faucette, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertzberg, R. P.</span></span> <span> </span><span class="NLM_article-title">Synthesis of water-soluble (aminoalkyl) camptothecin analogs: inhibition of topoisomerase I and antitumor activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">98</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1021/jm00105a017</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00105a017" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADyaK3MXktlaktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=98-107&author=W.+D.+Kingsburyauthor=J.+C.+Boehmauthor=D.+R.+Jakasauthor=K.+G.+Holdenauthor=S.+M.+Hechtauthor=G.+Gallagherauthor=M.+J.+Caranfaauthor=F.+L.+McCabeauthor=L.+F.+Faucetteauthor=R.+K.+Johnsonauthor=R.+P.+Hertzberg&title=Synthesis+of+water-soluble+%28aminoalkyl%29+camptothecin+analogs%3A+inhibition+of+topoisomerase+I+and+antitumor+activity&doi=10.1021%2Fjm00105a017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of water-soluble (aminoalkyl)camptothecin analogs:  inhibition of topoisomerase I and antitumor activity</span></div><div class="casAuthors">Kingsbury, William D.; Boehm, Jeffrey C.; Jakas, Dalia R.; Holden, Kenneth G.; Hecht, Sidney M.; Gallagher, Gregory; Caranfa, Mary Jo; McCabe, Francis L.; Faucette, Leo F.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">98-107</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Water-sol. analogs of the antitumor alkaloid camptothecin were prepd. in which aminoalkyl groups were introduced into ring A or B.  Most of the analogs were prepd. by oxidn. of camptothecin to 10-hydroxycamptothecin (I) followed by a Mannich reaction to give N-substituted 9-(aminomethyl)-10-hydroxycamptothecins or by subsequent modification of Mannich product II.  Others were obtained by modification of the hydroxyl group of I or by total synthesis.  These analogs, as well as some of their synthetic precursors, were evaluated for inhibition of topoisomerase I, cytotoxicity, and antitumor activity.  Although there was not a quant. correlation between these assays, compds. that inhibited topoisomerase I were also cytotoxic and demonstrated antitumor activity in vivo.  Further evaluation of the most active water-sol. analog led to the selection of II for development as an antitumor agent.  In addn. to its water soly., ease of synthesis from natural camptothecin, and high potency, II demonstrated broad-spectrum activity in preclin. tumor models and is currently undergoing Phase I clin. trials in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIrxMTdr7yNrVg90H21EOLACvtfcHk0lgZ1zLuaKJvXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXktlaktg%253D%253D&md5=01531a5e188592cdac8ab803995128ab</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm00105a017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00105a017%26sid%3Dliteratum%253Aachs%26aulast%3DKingsbury%26aufirst%3DW.%2BD.%26aulast%3DBoehm%26aufirst%3DJ.%2BC.%26aulast%3DJakas%26aufirst%3DD.%2BR.%26aulast%3DHolden%26aufirst%3DK.%2BG.%26aulast%3DHecht%26aufirst%3DS.%2BM.%26aulast%3DGallagher%26aufirst%3DG.%26aulast%3DCaranfa%26aufirst%3DM.%2BJ.%26aulast%3DMcCabe%26aufirst%3DF.%2BL.%26aulast%3DFaucette%26aufirst%3DL.%2BF.%26aulast%3DJohnson%26aufirst%3DR.%2BK.%26aulast%3DHertzberg%26aufirst%3DR.%2BP.%26atitle%3DSynthesis%2520of%2520water-soluble%2520%2528aminoalkyl%2529%2520camptothecin%2520analogs%253A%2520inhibition%2520of%2520topoisomerase%2520I%2520and%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D98%26epage%3D107%26doi%3D10.1021%2Fjm00105a017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Carbonero, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supko, J.</span></span> <span> </span><span class="NLM_article-title">Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">641</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.1385%2F1592591604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=11895891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BD38XislOqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=641&author=R.+Garcia-Carboneroauthor=J.+Supko&title=Current+perspectives+on+the+clinical+experience%2C+pharmacology%2C+and+continued+development+of+the+camptothecins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins</span></div><div class="casAuthors">Garcia-Carbonero, Rocio; Supko, Jeffrey G.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">641-661</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review, discussing the pharmacol. and antitumor activities of the camptothecin analogs that are approved for clin. use and those investigational agents undergoing clin. evaluation.  Camptothecin is a naturally occurring cytotoxic alkaloid that has a unique intracellular target, topoisomerase I, a nuclear enzyme that reduces the torsional stress of supercoiled DNA during the replication, recombination, transcription, and repair of DNA.  Topotecan and irinotecan are synthetic analogs designed to facilitate parenteral administration of the active lactone form of the compd. by introducing functional groups to enhance soly.  They are now well-established components in the chemotherapeutic management of several neoplasms.  Topotecan has modest activity in previously treated patients with ovarian and small-cell lung cancer and is currently approved for use in the United States as 2nd-line therapy in these diseases.  Preliminary evidence of activity against hematol. malignancies is also promising.  Irinotecan is a prodrug that undergoes enzymic conversion to the biol. active metabolite 7-ethyl-10-hydroxycamptothecin.  It is presently the treatment of choice when used in combination with fluoropyrimidines as 1st-line therapy for patients with advanced colorectal cancer or as a single agent after failure of 5-fluorouracil-based chemotherapy.  Encouraging preliminary results suggest that irinotecan may have an increasing role in the treatment of other solid tumors, including small- and non-small-cell lung cancer, cervical cancer, ovarian cancer, gastric cancer, and malignant gliomas.  Several addnl. camptothecin analogs are in various stages of clin. development, including 9-aminocamptothecin, 9-nitrocamptothecin, 7-(4-methylpiperazinomethylene)-10,11-ethylenedioxy-20(S)-camptothecin, exatecan mesylate, and karenitecin.  Efforts to further optimize therapeutic effectiveness through drug-delivery strategies that prolong tumor exposure to these S phase-specific agents, such as improving oral bioavailability through structure modification and innovative formulation approaches, alternative parenteral dosage forms, and administration schedules, are being actively pursued.  Combining camptothecins with other anticancer drugs and treatment modalities, as well as gaining a better understanding of the factors contributing to tumor sensitivity and resistance, continues to be of considerable interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrarJT9tdw_17Vg90H21EOLACvtfcHk0lgZ1zLuaKJvXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XislOqt70%253D&md5=6ef49a8a00a46110224d01506043f0bb</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1385%2F1592591604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252F1592591604%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Carbonero%26aufirst%3DR.%26aulast%3DSupko%26aufirst%3DJ.%26atitle%3DCurrent%2520perspectives%2520on%2520the%2520clinical%2520experience%252C%2520pharmacology%252C%2520and%2520continued%2520development%2520of%2520the%2520camptothecins%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2002%26volume%3D8%26spage%3D641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">The structural modification of natural products for novel drug discovery</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">140</span>, <span class="refDoi"> DOI: 10.1080/17460441.2016.1272757</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.1080%2F17460441.2016.1272757" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=28006993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivVek" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=121-140&author=H.+Yaoauthor=J.+Liuauthor=S.+Xuauthor=Z.+Zhuauthor=J.+Xu&title=The+structural+modification+of+natural+products+for+novel+drug+discovery&doi=10.1080%2F17460441.2016.1272757"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The structural modification of natural products for novel drug discovery</span></div><div class="casAuthors">Yao, Hong; Liu, Junkai; Xu, Shengtao; Zhu, Zheying; Xu, Jinyi</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-140</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Throughout history, natural products (NPs) have provided a rich source of compds. that have wide applications in the fields of medicine, health sciences, pharmacy and biol.  Although naturally active substances are good lead compds. for the discovery of new drugs, most of them suffer from various deficiencies or shortcomings, such as complex structures, poor stability and soly.  Therefore, structural modification of NPs is needed to develop novel compds. with specific properties.: This article presents an overview on the structural modifications of NPs in drug development.  The application of multiple classes of NPs to the treatment of conditions such as cancers, infection, Alzheimer's and diabetes are discussed.  This article also reveals that modification of NPs is a versatile approach to explore their mode of actions, which may lead to the discovery of novel drugs.: NPs are usually described by structural diversity and complexity.  The use of isolated NPs as scaffolds for modification is a good approach to drug discovery and development.  Despite many limitations assocd. with NPs, the total synthesis, semisynthetic modification, SAR-based modification, sometimes even a single atom alteration, may lead to the discovery of a novel drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6S_a4H8DIPLVg90H21EOLACvtfcHk0lgZ1zLuaKJvXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivVek&md5=46b49696429d04c7982c315339a2c9bb</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1080%2F17460441.2016.1272757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17460441.2016.1272757%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DThe%2520structural%2520modification%2520of%2520natural%2520products%2520for%2520novel%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2017%26volume%3D12%26spage%3D121%26epage%3D140%26doi%3D10.1080%2F17460441.2016.1272757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">Insights into drug discovery from natural products through structural modification</span>. <i>Fitoterapia</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">241</span>, <span class="refDoi"> DOI: 10.1016/j.fitote.2015.04.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.1016%2Fj.fitote.2015.04.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=25917513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC2MXns1KitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2015&pages=231-241&author=J.+Chenauthor=W.+Liauthor=H.+Yaoauthor=J.+Xu&title=Insights+into+drug+discovery+from+natural+products+through+structural+modification&doi=10.1016%2Fj.fitote.2015.04.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into drug discovery from natural products through structural modification</span></div><div class="casAuthors">Chen, Jichao; Li, Wenlong; Yao, Hequan; Xu, Jinyi</div><div class="citationInfo"><span class="NLM_cas:title">Fitoterapia</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">231-241</span>CODEN:
                <span class="NLM_cas:coden">FTRPAE</span>;
        ISSN:<span class="NLM_cas:issn">0367-326X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Natural products (NPs) have played a key role in drug discovery and are still a prolific source of novel lead compds. or pharmacophores for medicinal chem.  Pharmacol. activity and druggability are two indispensable components advancing NPs from leads to drugs.  Although naturally active substances are usually good lead compds., most of them can hardly satisfy the demands for druggability.  Hence, these structural phenotypes have to be modified and optimized to overcome existing deficiencies and shortcomings.  This review illustrates druggability optimization of NPs through structural modification with some successful examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0oWk_7Gmxc7Vg90H21EOLACvtfcHk0lj-z3caffYn3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXns1KitrY%253D&md5=937e7f5bae8e613feb1929dfdcc239b8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.fitote.2015.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fitote.2015.04.012%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DYao%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DInsights%2520into%2520drug%2520discovery%2520from%2520natural%2520products%2520through%2520structural%2520modification%26jtitle%3DFitoterapia%26date%3D2015%26volume%3D103%26spage%3D231%26epage%3D241%26doi%3D10.1016%2Fj.fitote.2015.04.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span> <span> </span><span class="NLM_article-title">The modification of natural products for medical use</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2016.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.1016%2Fj.apsb.2016.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=28303218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A280%3ADC%252BC1czntFOhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=119-136&author=Z.+Guo&title=The+modification+of+natural+products+for+medical+use&doi=10.1016%2Fj.apsb.2016.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The modification of natural products for medical use</span></div><div class="casAuthors">Guo Zongru</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-136</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">Drug innovation is characterized by painstaking molecular-level syntheses and modifications as the basic components of research and development.  Similarly, natural products are chemically tailored and modified based upon their structural and biological properties.  To some extent, the modification of natural products is quite different from de novo structure-based drug discovery.  This review describes the general strategies and principles for the modification of natural products to drugs, as illustrated by several successful medicines that originated from natural products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQyitwjIggyreqrn-c4Of3KfW6udTcc2eaP8_W9Ws5XD7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czntFOhtg%253D%253D&md5=332caaec62ecd152633c7c35475affa6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2016.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2016.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DZ.%26atitle%3DThe%2520modification%2520of%2520natural%2520products%2520for%2520medical%2520use%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2017%26volume%3D7%26spage%3D119%26epage%3D136%26doi%3D10.1016%2Fj.apsb.2016.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Castro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sankar, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K.</span></span> <span> </span><span class="NLM_article-title">Scaffold diversity synthesis and its application in probe and drug discovery</span>. <i>Angew. Chem., Int. Ed. Engl.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7586</span>– <span class="NLM_lpage">7605</span>, <span class="refDoi"> DOI: 10.1002/anie.201508818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.1002%2Fanie.201508818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=27187638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252Fgt1Ciug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=7586-7605&author=M.+Garcia-Castroauthor=S.+Zimmermannauthor=M.+G.+Sankarauthor=K.+Kumar&title=Scaffold+diversity+synthesis+and+its+application+in+probe+and+drug+discovery&doi=10.1002%2Fanie.201508818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Scaffold Diversity Synthesis and Its Application in Probe and Drug Discovery</span></div><div class="casAuthors">Garcia-Castro Miguel; Zimmermann Stefan; Sankar Muthukumar G; Kumar Kamal</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie (International ed. in English)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">7586-605</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Scaffold diversity is a crucial feature of compound collections that has a huge impact on their success in biological screenings.  The synthesis of highly complex and diverse scaffolds, which could be based on natural products, for example, is an arduous task that requires expertise in various aspects of organic synthesis and structural analysis.  This challenge has been addressed by a number of synthesis designs, which employ natural products as a source of scaffold diversity, transform suitably designed common intermediates into various molecular frameworks, or entail highly concise synthetic routes to a number of distinct and complex scaffolds.  In this Minireview, we highlight recent synthetic developments towards the construction of diverse and complex scaffolds and the application of the resulting compound collections in drug and probe discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSBYg9cK4kfOjAEfvC7EH1LfW6udTcc2eaP8_W9Ws5XD7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252Fgt1Ciug%253D%253D&md5=323899c5e7d7d1d949c4bcc598007813</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fanie.201508818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201508818%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Castro%26aufirst%3DM.%26aulast%3DZimmermann%26aufirst%3DS.%26aulast%3DSankar%26aufirst%3DM.%2BG.%26aulast%3DKumar%26aufirst%3DK.%26atitle%3DScaffold%2520diversity%2520synthesis%2520and%2520its%2520application%2520in%2520probe%2520and%2520drug%2520discovery%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D2016%26volume%3D55%26spage%3D7586%26epage%3D7605%26doi%3D10.1002%2Fanie.201508818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span> <span> </span><span class="NLM_article-title">Pharmacological actions of multi-target-directed evodiamine</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1826</span>– <span class="NLM_lpage">1843</span>, <span class="refDoi"> DOI: 10.3390/molecules18021826</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.3390%2Fmolecules18021826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=23434865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivVegtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=1826-1843&author=H.+Yuauthor=H.+Jinauthor=W.+Gongauthor=Z.+Wangauthor=H.+Liang&title=Pharmacological+actions+of+multi-target-directed+evodiamine&doi=10.3390%2Fmolecules18021826"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological actions of multi-target-directed evodiamine</span></div><div class="casAuthors">Yu, Hui; Jin, Hongwei; Gong, Wuzhuang; Wang, Zhanli; Liang, Huaping</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1826-1843</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Evodiamine, a naturally occurring indole alkaloid, is one of the main bioactive ingredients of Evodiae fructus.  With respect to the pharmacol. actions of evodiamine, more attention has been paid to beneficial effects in insults involving cancer, obesity, nociception, inflammation, cardiovascular diseases, Alzheimer's disease, infectious diseases and themoregulative effects.  Evodiamine has evolved a superior ability to bind various proteins, so we also argue that it is good starting point for multi-target drugs.  This review is primarily addressed to the description of the recent advances in the biol. activity studies of evodiamine, with a focus on pharmacol. mechanism.  The present review also includes the pharmacokinetics and the detailed exploration of target-binding properties of evodiamine in an attempt to provide a direction for further multi-target drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGlSdsWLVJb7Vg90H21EOLACvtfcHk0lgRPzAZSWcZ9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivVegtLk%253D&md5=798185966dcdbf033ffda501e09faad3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3390%2Fmolecules18021826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules18021826%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DGong%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLiang%26aufirst%3DH.%26atitle%3DPharmacological%2520actions%2520of%2520multi-target-directed%2520evodiamine%26jtitle%3DMolecules%26date%3D2013%26volume%3D18%26spage%3D1826%26epage%3D1843%26doi%3D10.3390%2Fmolecules18021826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, F.</span></span> <span> </span><span class="NLM_article-title">Antiproliferative effects of alkaloid evodiamine and its derivatives</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3403</span>– <span class="NLM_lpage">3433</span>, <span class="refDoi"> DOI: 10.3390/ijms19113403</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.3390%2Fijms19113403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnsVKls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=3403-3433&author=X.+Huauthor=D.+Liauthor=C.+Chuauthor=X.+Liauthor=X.+Wangauthor=Y.+Jiaauthor=H.+Huaauthor=F.+Xu&title=Antiproliferative+effects+of+alkaloid+evodiamine+and+its+derivatives&doi=10.3390%2Fijms19113403"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Antiproliferative effects of alkaloid evodiamine and its derivatives</span></div><div class="casAuthors">Hu, Xu; Li, Dahong; Chu, Chun; Li, Xu; Wang, Xianhua; Jia, Ying; Hua, Huiming; Xu, Fanxing</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3403/1-3403/31</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Alkaloids, a category of natural products with ring structures and nitrogen atoms, include most U.S.  Food and Drug Administration approved plant derived anti-cancer agents.  Evodiamine is an alkaloid with attractive multitargeting antiproliferative activity.  Its high content in the natural source ensures its adequate supply on the market and guarantees further medicinal study.  To the best of our knowledge, there is no systematic review about the antiproliferative effects of evodiamine derivs.  Therefore, in this article the review of the antiproliferative activities of evodiamine will be updated.  More importantly, the antiproliferative activities of structurally modified new analogs of evodiamine will be summarized for the first time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3DA4y8FaINLVg90H21EOLACvtfcHk0lgRPzAZSWcZ9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnsVKls7o%253D&md5=b9081f47f9cb3fe1dee9dd740ab132f5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3390%2Fijms19113403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19113403%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DChu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DHua%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DF.%26atitle%3DAntiproliferative%2520effects%2520of%2520alkaloid%2520evodiamine%2520and%2520its%2520derivatives%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26spage%3D3403%26epage%3D3433%26doi%3D10.3390%2Fijms19113403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, C.</span></span> <span> </span><span class="NLM_article-title">Evodiamine: a novel anti-cancer alkaloid from Evodia rutaecarpa</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1852</span>– <span class="NLM_lpage">1859</span>, <span class="refDoi"> DOI: 10.3390/molecules14051852</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.3390%2Fmolecules14051852" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=19471205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvVCmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=1852-1859&author=J.+Jiangauthor=C.+Hu&title=Evodiamine%3A+a+novel+anti-cancer+alkaloid+from+Evodia+rutaecarpa&doi=10.3390%2Fmolecules14051852"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Evodiamine: a novel anti-cancer alkaloid from Evodia rutaecarpa</span></div><div class="casAuthors">Jiang, Junlin; Hu, Changping</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1852-1859</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">A review.  Traditional Chinese herbs are regarded as a new and promising source of potential anti-cancer remedies and new chemotherapy adjuvants to enhance the efficacy of chemotherapy and/or to ameliorate its side effects.  Extensive investigations have been undertaken both in the exptl. and clin. studies over the years to augment the efficacy of chemotherapy.  Evodia rutaecarpa is a very popular multi-purpose herb traditionally used in China for the treatment of headaches, abdominal pain, postpartum hemorrhage, dysentery and amenorrhea.  The major constituents of Evodia rutaecarpa are evodiamine and rutaecarpine.  Growing evidence demonstrates that evodiamine possesses anti-cancer activities both in vitro and in vivo by inhibiting proliferation, invasion and metastasis, inducing apoptosis of a variety of tumor cell lines.  This review is aimed to summarize the recent researches on evodiamine focusing on anti-cancer activity and to highlight mol. mechanisms during the past ten years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrygUJ8nEBYU7Vg90H21EOLACvtfcHk0lgRPzAZSWcZ9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvVCmtbw%253D&md5=ce11dc87f32f3db73b2462180521e9fa</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3390%2Fmolecules14051852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules14051852%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DC.%26atitle%3DEvodiamine%253A%2520a%2520novel%2520anti-cancer%2520alkaloid%2520from%2520Evodia%2520rutaecarpa%26jtitle%3DMolecules%26date%3D2009%26volume%3D14%26spage%3D1852%26epage%3D1859%26doi%3D10.3390%2Fmolecules14051852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span> <span> </span><span class="NLM_article-title">Pharmacological actions of multi-target-directed evodiamine</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1826</span>– <span class="NLM_lpage">1843</span>, <span class="refDoi"> DOI: 10.3390/molecules18021826</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.3390%2Fmolecules18021826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=23434865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivVegtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=1826-1843&author=H.+Yuauthor=H.+Jinauthor=W.+Gongauthor=Z.+Wangauthor=H.+Liang&title=Pharmacological+actions+of+multi-target-directed+evodiamine&doi=10.3390%2Fmolecules18021826"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological actions of multi-target-directed evodiamine</span></div><div class="casAuthors">Yu, Hui; Jin, Hongwei; Gong, Wuzhuang; Wang, Zhanli; Liang, Huaping</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1826-1843</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Evodiamine, a naturally occurring indole alkaloid, is one of the main bioactive ingredients of Evodiae fructus.  With respect to the pharmacol. actions of evodiamine, more attention has been paid to beneficial effects in insults involving cancer, obesity, nociception, inflammation, cardiovascular diseases, Alzheimer's disease, infectious diseases and themoregulative effects.  Evodiamine has evolved a superior ability to bind various proteins, so we also argue that it is good starting point for multi-target drugs.  This review is primarily addressed to the description of the recent advances in the biol. activity studies of evodiamine, with a focus on pharmacol. mechanism.  The present review also includes the pharmacokinetics and the detailed exploration of target-binding properties of evodiamine in an attempt to provide a direction for further multi-target drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGlSdsWLVJb7Vg90H21EOLACvtfcHk0lgRPzAZSWcZ9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivVegtLk%253D&md5=798185966dcdbf033ffda501e09faad3</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3390%2Fmolecules18021826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules18021826%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DGong%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLiang%26aufirst%3DH.%26atitle%3DPharmacological%2520actions%2520of%2520multi-target-directed%2520evodiamine%26jtitle%3DMolecules%26date%3D2013%26volume%3D18%26spage%3D1826%26epage%3D1843%26doi%3D10.3390%2Fmolecules18021826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Novel fluorescent probes of 10-hydroxyevodiamine: autophagy and apoptosis-inducing anticancer mechanisms</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">144</span>– <span class="NLM_lpage">156</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2018.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.1016%2Fj.apsb.2018.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=30766786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A280%3ADC%252BB3cfjsleitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=144-156&author=S.+Chenauthor=G.+Dongauthor=S.+Wuauthor=N.+Liuauthor=W.+Zhangauthor=C.+Sheng&title=Novel+fluorescent+probes+of+10-hydroxyevodiamine%3A+autophagy+and+apoptosis-inducing+anticancer+mechanisms&doi=10.1016%2Fj.apsb.2018.08.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Novel fluorescent probes of 10-hydroxyevodiamine: autophagy and apoptosis-inducing anticancer mechanisms</span></div><div class="casAuthors">Chen Shuqiang; Dong Guoqiang; Wu Shanchao; Liu Na; Zhang Wannian; Sheng Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">144-156</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">Natural product evodiamine and its derivatives represent a promising class of multi-target antitumor agents.  However, the clinical development of these compounds has been hampered by a poor understanding of their antitumor mechanisms.  To tackle this obstacle, herein, novel fluorescent probes were designed to elucidate the antitumor mode of action of 10-hydroxyevodiamine.  This compound was proven to be distributed in the mitochondria and lysosomes and to act by autophagy and apoptosis mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRNezzR2Kp6Cj69zv1FsJFMfW6udTcc2eZNp3FjuxeqLrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cfjsleitw%253D%253D&md5=1c612ecb4a68e60dd4ceaf23f46f8e62</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2018.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2018.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DNovel%2520fluorescent%2520probes%2520of%252010-hydroxyevodiamine%253A%2520autophagy%2520and%2520apoptosis-inducing%2520anticancer%2520mechanisms%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2019%26volume%3D9%26spage%3D144%26epage%3D156%26doi%3D10.1016%2Fj.apsb.2018.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">Selection of evodiamine as a novel topoisomerase I inhibitor by structure-based virtual screening and hit optimization of evodiamine derivatives as antitumor agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7521</span>– <span class="NLM_lpage">7531</span>, <span class="refDoi"> DOI: 10.1021/jm100387d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100387d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1yktL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7521-7531&author=G.+Dongauthor=C.+Shengauthor=S.+Wangauthor=Z.+Miaoauthor=J.+Yaoauthor=W.+Zhang&title=Selection+of+evodiamine+as+a+novel+topoisomerase+I+inhibitor+by+structure-based+virtual+screening+and+hit+optimization+of+evodiamine+derivatives+as+antitumor+agents&doi=10.1021%2Fjm100387d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Selection of Evodiamine as a Novel Topoisomerase I Inhibitor by Structure-Based Virtual Screening and Hit Optimization of Evodiamine Derivatives as Antitumor Agents</span></div><div class="casAuthors">Dong, Guoqiang; Sheng, Chunquan; Wang, Shengzheng; Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7521-7531</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human topoisomerase I (TopoI) is recognized as a valuable target for the development of effective antitumor agents.  Structure-based virtual screening was applied to the discovery of structurally diverse TopoI inhibitors.  From 23 compds. selected by virtual screening, a total of 14 compds. were found to be TopoI inhibitors.  Five hits (compds. 1, 14, 20, 21, and 23) also showed moderate to good in vitro antitumor activity.  These novel structures can be considered as good starting points for the development of new antitumor lead compds.  Hit 20 (evodiamine) was chosen for preliminary structure-activity relationship studies.  Various groups, including alkyl, benzoyl, benzyl and ester, were introduced to the indole nitrogen atom of evodiamine.  The substituted benzoyl groups were found to be favorable for the antitumor activity and spectrum.  The 4-Cl benzoyl deriv., compd. 29u, was the most active one with IC50 values in the range 0.049-2.6 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouVyzcTgLm57Vg90H21EOLACvtfcHk0lggU-sfVa-7-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1yktL3F&md5=4661573b99e3b902393b7710b2d5695c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm100387d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100387d%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DG.%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DSelection%2520of%2520evodiamine%2520as%2520a%2520novel%2520topoisomerase%2520I%2520inhibitor%2520by%2520structure-based%2520virtual%2520screening%2520and%2520hit%2520optimization%2520of%2520evodiamine%2520derivatives%2520as%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7521%26epage%3D7531%26doi%3D10.1021%2Fjm100387d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">New tricks for an old natural product: discovery of highly potent evodiamine derivatives as novel antitumor agents by systemic structure–activity relationship analysis and biological evaluations</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7593</span>– <span class="NLM_lpage">7613</span>, <span class="refDoi"> DOI: 10.1021/jm300605m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300605m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFClurfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7593-7613&author=G.+Dongauthor=S.+Wangauthor=Z.+Miaoauthor=J.+Yaoauthor=Y.+Zhangauthor=Z.+Guoauthor=W.+Zhangauthor=C.+Sheng&title=New+tricks+for+an+old+natural+product%3A+discovery+of+highly+potent+evodiamine+derivatives+as+novel+antitumor+agents+by+systemic+structure%E2%80%93activity+relationship+analysis+and+biological+evaluations&doi=10.1021%2Fjm300605m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">New Tricks for an Old Natural Product: Discovery of Highly Potent Evodiamine Derivatives as Novel Antitumor Agents by Systemic Structure-Activity Relationship Analysis and Biological Evaluations</span></div><div class="casAuthors">Dong, Guoqiang; Wang, Shengzheng; Miao, Zhenyuan; Yao, Jianzhong; Zhang, Yongqiang; Guo, Zizhao; Zhang, Wannian; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7593-7613</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Evodiamine is a quinazolinocarboline alkaloid isolated from the fruits of traditional Chinese herb Evodiae fructus.  Herein, a library of novel evodiamine derivs. bearing various substitutions or modified scaffold were synthesized.  Among them, a no. of evodiamine derivs. showed substantial increase of the antitumor activity, with GI50 values lower than 3 nM.  Moreover, these highly potent compds. can effectively induce the apoptosis of A549 cells.  Interestingly, further computational target prediction calcns. in combination with biol. assays confirmed that the evodiamine derivs. acted by dual inhibition of topoisomerases I and II.  Moreover, several hydroxyl derivs., such as 10-hydroxyevodiamine and 3-amino-10-hydroxyevodiamine, also showed good in vivo antitumor efficacy and low toxicity at the dose of 1 mg/kg or 2 mg/kg.  They represent promising candidates for the development of novel antitumor agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocJjv8REdBnrVg90H21EOLACvtfcHk0lggU-sfVa-7-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFClurfP&md5=6e7d03671ac1be56b8bd68dc0fc03062</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm300605m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300605m%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DNew%2520tricks%2520for%2520an%2520old%2520natural%2520product%253A%2520discovery%2520of%2520highly%2520potent%2520evodiamine%2520derivatives%2520as%2520novel%2520antitumor%2520agents%2520by%2520systemic%2520structure%25E2%2580%2593activity%2520relationship%2520analysis%2520and%2520biological%2520evaluations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7593%26epage%3D7613%26doi%3D10.1021%2Fjm300605m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Scaffold diversity inspired by the natural product evodiamine: discovery of highly potent and multitargeting antitumor agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6678</span>– <span class="NLM_lpage">6696</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00910</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00910" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Gms7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6678-6696&author=S.+Wangauthor=K.+Fangauthor=G.+Dongauthor=S.+Chenauthor=N.+Liuauthor=Z.+Miaoauthor=J.+Yaoauthor=J.+Liauthor=W.+Zhangauthor=C.+Sheng&title=Scaffold+diversity+inspired+by+the+natural+product+evodiamine%3A+discovery+of+highly+potent+and+multitargeting+antitumor+agents&doi=10.1021%2Facs.jmedchem.5b00910"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Scaffold diversity inspired by the natural product evodiamine: discovery of highly potent and multitargeting antitumor agents</span></div><div class="casAuthors">Wang, Shengzheng; Fang, Kun; Dong, Guoqiang; Chen, Shuqiang; Liu, Na; Miao, Zhenyuan; Yao, Jianzhong; Li, Jian; Zhang, Wannian; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6678-6696</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A crit. question in natural product-based drug discovery is how to translate the product into drug-like mols. with optimal pharmacol. properties.  The generation of natural product-inspired scaffold diversity is an effective but challenging strategy to investigate the broader chem. space and identify promising drug leads.  Extending the efforts to the natural product evodiamine, a diverse library contg. 11 evodiamine-inspired novel scaffolds and their derivs. were designed and synthesized.  Most of them showed good to excellent antitumor activity against various human cancer cell lines.  In particular, 3-chloro-10-hydroxyl thio-evodiamine I showed excellent in vitro and in vivo antitumor efficacy with good tolerability and low toxicity.  Antitumor mechanism and target profiling studies indicate that compd. I is the first-in-class triple topoisomerase I/topoisomerase II/tubulin inhibitor.  Overall, this study provided an effective strategy for natural product-based drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFmWoZPbDbVrVg90H21EOLACvtfcHk0lgoyzlCnGnMGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Gms7%252FO&md5=eac1cb75b532b53aada4cbc25c0de4bf</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00910%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DK.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DScaffold%2520diversity%2520inspired%2520by%2520the%2520natural%2520product%2520evodiamine%253A%2520discovery%2520of%2520highly%2520potent%2520and%2520multitargeting%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6678%26epage%3D6696%26doi%3D10.1021%2Facs.jmedchem.5b00910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Netz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opatz, T.</span></span> <span> </span><span class="NLM_article-title">A modular formal total synthesis of (+/-)-cycloclavine</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">1723</span>– <span class="NLM_lpage">1730</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.5b02815</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.5b02815" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVGku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2016&pages=1723-1730&author=N.+Netzauthor=T.+Opatz&title=A+modular+formal+total+synthesis+of+%28%2B%2F-%29-cycloclavine&doi=10.1021%2Facs.joc.5b02815"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A Modular Formal Total Synthesis of (±)-Cycloclavine</span></div><div class="casAuthors">Netz, Natalie; Opatz, Till</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1723-1730</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cycloclavine (I) is a clavine-type Ergot alkaloid noteworthy for its unique pentacyclic skeleton featuring a 3-azabicyclo[3.1.0]hexane substructure.  A short convergent route to the racemic alkaloid is described which comprises only eight linear steps and requires only four chromatog. purifications.  The two key building blocks can be prepd. in high yield from com. available starting materials.  Two consecutive coupling reactions, namely a selective alkylation of a dienolate and a Heck reaction, are the key steps of the reaction sequence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaGeM_Kuh1CLVg90H21EOLACvtfcHk0lgoyzlCnGnMGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVGku7g%253D&md5=6519c4d28e2b7fcd069bf5ed091c40af</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.5b02815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.5b02815%26sid%3Dliteratum%253Aachs%26aulast%3DNetz%26aufirst%3DN.%26aulast%3DOpatz%26aufirst%3DT.%26atitle%3DA%2520modular%2520formal%2520total%2520synthesis%2520of%2520%2528%252B%252F-%2529-cycloclavine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2016%26volume%3D81%26spage%3D1723%26epage%3D1730%26doi%3D10.1021%2Facs.joc.5b02815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cogan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deleon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruenbaum, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashem, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netherton, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pargellis, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellati, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skow, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torcellini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werneburg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Z.</span></span> <span> </span><span class="NLM_article-title">Pyrazinoindolone inhibitors of MAPKAP-K2</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">938</span>– <span class="NLM_lpage">941</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.12.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.1016%2Fj.bmcl.2007.12.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=18221871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=938-941&author=D.+R.+Goldbergauthor=Y.+Choiauthor=D.+Coganauthor=M.+Corsonauthor=R.+Deleonauthor=A.+Gaoauthor=L.+Gruenbaumauthor=M.+H.+Haoauthor=D.+Josephauthor=M.+A.+Kashemauthor=C.+Millerauthor=N.+Mossauthor=M.+R.+Nethertonauthor=C.+P.+Pargellisauthor=J.+Pelletierauthor=R.+Sellatiauthor=D.+Skowauthor=C.+Torcelliniauthor=Y.-C.+Tsengauthor=J.+Wangauthor=R.+Wastiauthor=B.+Werneburgauthor=J.+P.+Wuauthor=Z.+Xiong&title=Pyrazinoindolone+inhibitors+of+MAPKAP-K2&doi=10.1016%2Fj.bmcl.2007.12.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazinoindolone inhibitors of MAPKAP-K2</span></div><div class="casAuthors">Goldberg, D. R.; Choi, Y.; Cogan, D.; Corson, M.; DeLeon, R.; Gao, A.; Gruenbaum, L.; Hao, M. H.; Joseph, D.; Kashem, M. A.; Miller, C.; Moss, N.; Netherton, M. R.; Pargellis, C. P.; Pelletier, J.; Sellati, R.; Skow, D.; Torcellini, C.; Tseng, Y.-C.; Wang, J.; Wasti, R.; Werneburg, B.; Wu, J. P.; Xiong, Z.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">938-941</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Optimization of pyrazinoindolone inhibitors of MAPKAP-K2 (MK2) provides a reasonable balance of cellular potency and physicochem. properties.  Mechanistic studies support the inhibition of MK2 which is responsible for the sub-micromolar cellular efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHMw6FxuAeyLVg90H21EOLACvtfcHk0lhSgBIIZnzZqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWkt7w%253D&md5=55a46852c9ccf52c8350d0a26de3e41d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.037%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DD.%2BR.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DCogan%26aufirst%3DD.%26aulast%3DCorson%26aufirst%3DM.%26aulast%3DDeleon%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DA.%26aulast%3DGruenbaum%26aufirst%3DL.%26aulast%3DHao%26aufirst%3DM.%2BH.%26aulast%3DJoseph%26aufirst%3DD.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DMiller%26aufirst%3DC.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DNetherton%26aufirst%3DM.%2BR.%26aulast%3DPargellis%26aufirst%3DC.%2BP.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DSellati%26aufirst%3DR.%26aulast%3DSkow%26aufirst%3DD.%26aulast%3DTorcellini%26aufirst%3DC.%26aulast%3DTseng%26aufirst%3DY.-C.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWasti%26aufirst%3DR.%26aulast%3DWerneburg%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DJ.%2BP.%26aulast%3DXiong%26aufirst%3DZ.%26atitle%3DPyrazinoindolone%2520inhibitors%2520of%2520MAPKAP-K2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D938%26epage%3D941%26doi%3D10.1016%2Fj.bmcl.2007.12.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortolozzi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basso, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viola, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferlin, M. G.</span></span> <span> </span><span class="NLM_article-title">Novel 3-substituted 7-phenylpyrrolo[3,2-<i>f</i>]quinolin-9(6<i>H</i>)-ones as single entities with multitarget antiproliferative activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7991</span>– <span class="NLM_lpage">8010</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00805</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00805" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFKqsr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7991-8010&author=D.+Cartaauthor=R.+Bortolozziauthor=E.+Hamelauthor=G.+Bassoauthor=S.+Moroauthor=G.+Violaauthor=M.+G.+Ferlin&title=Novel+3-substituted+7-phenylpyrrolo%5B3%2C2-f%5Dquinolin-9%286H%29-ones+as+single+entities+with+multitarget+antiproliferative+activity&doi=10.1021%2Facs.jmedchem.5b00805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 3-Substituted 7-Phenylpyrrolo[3,2-f]quinolin-9(6H)-ones as Single Entities with Multitarget Antiproliferative Activity</span></div><div class="casAuthors">Carta, Davide; Bortolozzi, Roberta; Hamel, Ernest; Basso, Giuseppe; Moro, Stefano; Viola, Giampietro; Ferlin, Maria Grazia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7991-8010</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of chem. modified 7-phenylpyrrolo[3,2-f]quinolinones was synthesized and evaluated as anticancer agents.  Among them, the most cytotoxic (subnanomolar GI50 values) amidic deriv. I was shown to act as an inhibitor of tubulin polymn. (IC50, 0.99 μM) by binding to the colchicine site with high affinity.  Moreover, I induced cell cycle arrest in the G2/M phase of the cell cycle in a concn. dependent manner, followed by caspase-dependent apoptotic cell death.  Compd. I also showed lower toxicity in nontumoral cells, suggesting selectivity toward cancer cells.  Addnl. expts. revealed that I inhibited the enzymic activity of multiple kinases, including AURKA, FLT3, GSK3A, MAP3K, MEK, RSK2, RSK4, PLK4, ULK1, and JAK1.  Computational studies showed that I can be properly accommodated in the colchicine binding site of tubulin as well as in the ATP binding clefts of all examd. kinases.  Our data indicate that the excellent antiproliferative profile of I may be derived from its interactions with multiple cellular targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDexCP1OpxdbVg90H21EOLACvtfcHk0lhSgBIIZnzZqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFKqsr7F&md5=d2b5ac90567a747e81b9ca3cbd3778d1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00805%26sid%3Dliteratum%253Aachs%26aulast%3DCarta%26aufirst%3DD.%26aulast%3DBortolozzi%26aufirst%3DR.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DBasso%26aufirst%3DG.%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DViola%26aufirst%3DG.%26aulast%3DFerlin%26aufirst%3DM.%2BG.%26atitle%3DNovel%25203-substituted%25207-phenylpyrrolo%255B3%252C2-f%255Dquinolin-9%25286H%2529-ones%2520as%2520single%2520entities%2520with%2520multitarget%2520antiproliferative%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7991%26epage%3D8010%26doi%3D10.1021%2Facs.jmedchem.5b00805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of novel antitumor spirodihydrothiopyran-oxindole derivatives</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1636</span>– <span class="NLM_lpage">1642</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2019.04.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.1016%2Fj.bmcl.2019.04.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=31047751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC1MXos12gs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=1636-1642&author=W.+Liuauthor=S.+Chenauthor=F.+Zhangauthor=S.+Heauthor=S.+Wangauthor=C.+Sheng&title=Design%2C+synthesis+and+biological+evaluation+of+novel+antitumor+spirodihydrothiopyran-oxindole+derivatives&doi=10.1016%2Fj.bmcl.2019.04.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of novel antitumor spirodihydrothiopyran-oxindole derivatives</span></div><div class="casAuthors">Liu, Wei; Chen, Shuqiang; Zhang, Fan; He, Shipeng; Wang, Shengzheng; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1636-1642</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sulfur contg. spiroheterocyclic oxindoles are promising privileged scaffolds in medicinal chem. and drug discovery.  Previously, we identified a new class of spirodihydrothiopyran-oxindoles with good in vitro antitumor activity against A549 lung cancer cell line.  Herein, various spirooxindole-dihydrothiopyrans with diverse substitutions were synthesized and assayed to investigate the structure-activity relationships.  Among the derivs., compds. 4b, 4i, 4m, 4n and 4q (I - V, resp.) displayed superior or comparable antitumor activity to nutlin-3.  Mol. mechanism study revealed this scaffold displayed moderate MDM2 inhibitory activity, significantly induced cancer cell apoptosis and arrested cell cycle at G0/G1 phase, which represented a good lead compd. for antitumor drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMRU5jSAbLuLVg90H21EOLACvtfcHk0lhSgBIIZnzZqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXos12gs7s%253D&md5=dde420d46c2fc321d70bfcdc1a86a8cc</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.04.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.04.037%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520antitumor%2520spirodihydrothiopyran-oxindole%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26spage%3D1636%26epage%3D1642%26doi%3D10.1016%2Fj.bmcl.2019.04.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rudolf, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cervinka, M.</span></span> <span> </span><span class="NLM_article-title">Topoisomerases and tubulin inhibitors: a promising combination for cancer treatment</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">429</span>, <span class="refDoi"> DOI: 10.2174/1568011033482242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.2174%2F1568011033482242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotFOns7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=421-429&author=E.+Rudolfauthor=M.+Cervinka&title=Topoisomerases+and+tubulin+inhibitors%3A+a+promising+combination+for+cancer+treatment&doi=10.2174%2F1568011033482242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Topoisomerases and tubulin inhibitors: A promising combination for cancer treatment</span></div><div class="casAuthors">Rudolf, E.; Cervinka, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry: Anti-Cancer Agents</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">421-429</span>CODEN:
                <span class="NLM_cas:coden">CMCACI</span>;
        ISSN:<span class="NLM_cas:issn">1568-0118</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Modern approaches to treatment of cancer seek to activate the internal suicide program in the malignant cells, and thereby effectively eliminate them without engaging most of other bodily systems.  Many currently used cytostatics are known to induce apoptosis and efforts are being paid to develop new ones with better and more effective proapoptotic potential.  Nevertheless, despite recent developments in this field, there are still numerous malignancies showing a varying degree of resistance to cell death due to the corrupted signaling pathways and genetic alterations, often in conjunction with expansive proliferation rate.  It has been shown that topoisomerase inhibiting agents such as etoposide, camptothecin and others represent a powerful and dynamic group of cytostatic chems. used in exptl. and clin. conditions.  So, it is a group of microtubule targeting poisons comprising classical colchicines on the one hand and new taxanes on the other hand.  Since several members of both groups have been evidenced as apoptosis inducers operating via distinct mechanism, their combination should theor. enhance the final therapeutic outcome.  This minireview focuses on the possibilities of such a combinational approach with respect to possible benefits and hazards of this strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJiCqrOtqGHLVg90H21EOLACvtfcHk0ljbhbxosLvnUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotFOns7s%253D&md5=2ecc33565f5b54921de17a2fac21e916</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F1568011033482242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568011033482242%26sid%3Dliteratum%253Aachs%26aulast%3DRudolf%26aufirst%3DE.%26aulast%3DCervinka%26aufirst%3DM.%26atitle%3DTopoisomerases%2520and%2520tubulin%2520inhibitors%253A%2520a%2520promising%2520combination%2520for%2520cancer%2520treatment%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D421%26epage%3D429%26doi%3D10.2174%2F1568011033482242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diana, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martorana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barraja, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montalbano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dattolo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirrincione, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dall’Acqua, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvador, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedaldi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basso, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viola, G.</span></span> <span> </span><span class="NLM_article-title">Isoindolo[2, 1-<i>a</i>]quinoxaline derivatives, novel potent antitumor agents with dual inhibition of tubulin polymerization and topoisomerase I</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2387</span>– <span class="NLM_lpage">2399</span>, <span class="refDoi"> DOI: 10.1021/jm070834t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070834t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjvFeis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2387-2399&author=P.+Dianaauthor=A.+Martoranaauthor=P.+Barrajaauthor=A.+Montalbanoauthor=G.+Dattoloauthor=G.+Cirrincioneauthor=F.+Dall%E2%80%99Acquaauthor=A.+Salvadorauthor=D.+Vedaldiauthor=G.+Bassoauthor=G.+Viola&title=Isoindolo%5B2%2C+1-a%5Dquinoxaline+derivatives%2C+novel+potent+antitumor+agents+with+dual+inhibition+of+tubulin+polymerization+and+topoisomerase+I&doi=10.1021%2Fjm070834t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Isoindolo[2,1-a]quinoxaline Derivatives, Novel Potent Antitumor Agents with Dual Inhibition of Tubulin Polymerization and Topoisomerase I</span></div><div class="casAuthors">Diana, Patrizia; Martorana, Annamaria; Barraja, Paola; Montalbano, Alessandra; Dattolo, Gaetano; Cirrincione, Girolamo; Dall'Acqua, Francesco; Salvador, Alessia; Vedaldi, Daniela; Basso, Giuseppe; Viola, Giampietro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2387-2399</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Isoindoloquinoxalines I (R1 = R2 = R3 = R4 = R5 = H; R1 = Me, R2 = R3 = R4 = R5 = H; R2 = MeO, R1 = R3 = R4 = R5 = H; R2 = R3 = MeO, Cl, R1 = R4 = R5 = H ) and II (same R1, R2, R3, R4, R5) were obtained by refluxing 2-(2'-aminoaryl)-1-cyanoisoindoles in acetic or formic acid.  All derivs. were screened by the National Cancer Institute (Bethesda, MD) for the in vitro one dose primary anticancer assay against a 3-cell line panel.  Compds. I, screened against a panel of about 60 human tumor cell lines, showed remarkable antineoplastic activity; they had GI50 values in the low micromolar or submicromolar range and reached, in the case of I (III; R1 = Me, R2 = R3 = R4 = R5 = H), nanomolar concns. on 88% of the 59 tested cell lines.  Flow cytometric anal. of cell cycle after treatment with III demonstrated an arrest of the cell cycle in G2/M phase.  This effect was accompanied with apoptosis of the cells, mitochondrial depolarization, generation of reactive oxygen species, and activation of caspase-3 and caspase-9.  Moreover, III induced a clear increase in the mitotic index, inhibited microtubule assembly in vitro, and interestingly also acted as a topoisomerase I inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwpVL48HGKi7Vg90H21EOLACvtfcHk0ljbhbxosLvnUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjvFeis78%253D&md5=2b5998c7fd48a1cfdadfdf2d454823d3</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm070834t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070834t%26sid%3Dliteratum%253Aachs%26aulast%3DDiana%26aufirst%3DP.%26aulast%3DMartorana%26aufirst%3DA.%26aulast%3DBarraja%26aufirst%3DP.%26aulast%3DMontalbano%26aufirst%3DA.%26aulast%3DDattolo%26aufirst%3DG.%26aulast%3DCirrincione%26aufirst%3DG.%26aulast%3DDall%25E2%2580%2599Acqua%26aufirst%3DF.%26aulast%3DSalvador%26aufirst%3DA.%26aulast%3DVedaldi%26aufirst%3DD.%26aulast%3DBasso%26aufirst%3DG.%26aulast%3DViola%26aufirst%3DG.%26atitle%3DIsoindolo%255B2%252C%25201-a%255Dquinoxaline%2520derivatives%252C%2520novel%2520potent%2520antitumor%2520agents%2520with%2520dual%2520inhibition%2520of%2520tubulin%2520polymerization%2520and%2520topoisomerase%2520I%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2387%26epage%3D2399%26doi%3D10.1021%2Fjm070834t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linghua, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liping, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caihua, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ming, L. J.</span></span> <span> </span><span class="NLM_article-title">A series of α-heterocyclic carboxaldehyde thiosemicarbazones inhibit topoisomerase IIalpha catalytic activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3048</span>– <span class="NLM_lpage">3064</span>, <span class="refDoi"> DOI: 10.1021/jm9014394</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9014394" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3048-3064&author=H.+Heauthor=C.+Qinauthor=K.+Xinauthor=M.+Linghuaauthor=L.+Lipingauthor=W.+Xiangauthor=Z.+Caihuaauthor=W.+Yiauthor=C.+Zhiauthor=L.+J.+Ming&title=A+series+of+%CE%B1-heterocyclic+carboxaldehyde+thiosemicarbazones+inhibit+topoisomerase+IIalpha+catalytic+activity&doi=10.1021%2Fjm9014394"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm9014394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9014394%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DH.%26aulast%3DQin%26aufirst%3DC.%26aulast%3DXin%26aufirst%3DK.%26aulast%3DLinghua%26aufirst%3DM.%26aulast%3DLiping%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DW.%26aulast%3DCaihua%26aufirst%3DZ.%26aulast%3DYi%26aufirst%3DW.%26aulast%3DZhi%26aufirst%3DC.%26aulast%3DMing%26aufirst%3DL.%2BJ.%26atitle%3DA%2520series%2520of%2520%25CE%25B1-heterocyclic%2520carboxaldehyde%2520thiosemicarbazones%2520inhibit%2520topoisomerase%2520IIalpha%2520catalytic%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3048%26epage%3D3064%26doi%3D10.1021%2Fjm9014394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shelanski, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaskin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantor, C. R.</span></span> <span> </span><span class="NLM_article-title">Microtubule assembly in the absence of added nucleotides</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">765</span>– <span class="NLM_lpage">768</span>, <span class="refDoi"> DOI: 10.1073/pnas.70.3.765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.1073%2Fpnas.70.3.765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=4514990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADyaE3sXhsVCgtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1973&pages=765-768&author=M.+L.+Shelanskiauthor=F.+Gaskinauthor=C.+R.+Cantor&title=Microtubule+assembly+in+the+absence+of+added+nucleotides&doi=10.1073%2Fpnas.70.3.765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule assembly in the absence of added nucleotides</span></div><div class="casAuthors">Shelanski, Michael L.; Gaskin, Felicia; Cantor, Charles R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">765-8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Microtubule assembly was enhanced by the addn. of M sucrose or 4 M glycerol to the reassembly mixt.  Tubulin was purified from guinea pig brain readily and in good yield by tycles of assembly in glycerol-contg. solns  The tubules assembled in glycerol and sucrose were more stable than tubules formed in the absence of these compds.  Assembly occurred in glycerol or sucrose in he absence of ATP or GT but was greatly accelerated by their presence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVpPUVyzxhcbVg90H21EOLACvtfcHk0ljbhbxosLvnUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXhsVCgtrs%253D&md5=c0eb0f728884f0a0eba421d633c9031b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1073%2Fpnas.70.3.765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.70.3.765%26sid%3Dliteratum%253Aachs%26aulast%3DShelanski%26aufirst%3DM.%2BL.%26aulast%3DGaskin%26aufirst%3DF.%26aulast%3DCantor%26aufirst%3DC.%2BR.%26atitle%3DMicrotubule%2520assembly%2520in%2520the%2520absence%2520of%2520added%2520nucleotides%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1973%26volume%3D70%26spage%3D765%26epage%3D768%26doi%3D10.1073%2Fpnas.70.3.765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Routier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peixoto, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mérour, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coudert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dias, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierré, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Léonce, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caignard, D.-H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel naphthocarbazoles as potential anticancer agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1401</span>– <span class="NLM_lpage">1413</span>, <span class="refDoi"> DOI: 10.1021/jm049213f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049213f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yhsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1401-1413&author=S.+Routierauthor=P.+Peixotoauthor=J.-Y.+M%C3%A9rourauthor=G.+Coudertauthor=N.+Diasauthor=C.+Baillyauthor=A.+Pierr%C3%A9author=S.+L%C3%A9onceauthor=D.-H.+Caignard&title=Synthesis+and+biological+evaluation+of+novel+naphthocarbazoles+as+potential+anticancer+agents&doi=10.1021%2Fjm049213f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of novel naphthocarbazoles as potential anticancer agents</span></div><div class="casAuthors">Routier, Sylvain; Peixoto, Paul; Merour, Jean-Yves; Coudert, Gerard; Dias, Nathalie; Bailly, Christian; Pierre, Alain; Leonce, Stephane; Caignard, Daniel-Henry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1401-1413</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The efficient synthesis involving palladium-catalyzed reactions and biol. evaluation of naphthocarbazoles, e.g., I, designed as potential anticancer agents, are reported.  The use of 5- and 6-benzyloxyindoles generated three substitution sites which were successively exploited to introduce several hydrophilic side chains.  The cytotoxicity of the designed compds. was evaluated on three cell lines.  Several compds. showed a marked cytotoxicity with IC50 values in the sub-micromolar range.  This was the case for I, bearing a dimethylaminoethyl side chain, which was extremely cytotoxic to L1210 and DU145 cells (IC50: 36 nM, 108 nM) and induced an accumulation of L1210 cells in the G2+M phases of the cell cycle.  Some of the most cytotoxic compds. were tested for inhibition of CDK-5, GSK-3 and topoisomerase I, and their interaction with DNA was also evaluated.  Interaction with DNA was detected, suggesting that nucleic acids represent a privileged target for these mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-kpQ081wFm7Vg90H21EOLACvtfcHk0lhWejxzPNWOuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yhsL4%253D&md5=820aff5d15c2ece73089a50ca86fdfd0</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm049213f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049213f%26sid%3Dliteratum%253Aachs%26aulast%3DRoutier%26aufirst%3DS.%26aulast%3DPeixoto%26aufirst%3DP.%26aulast%3DM%25C3%25A9rour%26aufirst%3DJ.-Y.%26aulast%3DCoudert%26aufirst%3DG.%26aulast%3DDias%26aufirst%3DN.%26aulast%3DBailly%26aufirst%3DC.%26aulast%3DPierr%25C3%25A9%26aufirst%3DA.%26aulast%3DL%25C3%25A9once%26aufirst%3DS.%26aulast%3DCaignard%26aufirst%3DD.-H.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520naphthocarbazoles%2520as%2520potential%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1401%26epage%3D1413%26doi%3D10.1021%2Fjm049213f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of cyclopropylamide analogues of combretastatin-A4 as novel microtubule-stabilizing agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">685</span>– <span class="NLM_lpage">699</span>, <span class="refDoi"> DOI: 10.1021/jm301864s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301864s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFaqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=685-699&author=H.+Chenauthor=Y.+Liauthor=C.+Shengauthor=Z.+Lvauthor=G.+Dongauthor=T.+Wangauthor=J.+Liuauthor=M.+Zhangauthor=L.+Liauthor=T.+Zhangauthor=D.+Gengauthor=C.+Niuauthor=K.+Li&title=Design+and+synthesis+of+cyclopropylamide+analogues+of+combretastatin-A4+as+novel+microtubule-stabilizing+agents&doi=10.1021%2Fjm301864s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Cyclopropylamide Analogues of Combretastatin-A4 as Novel Microtubule-Stabilizing Agents</span></div><div class="casAuthors">Chen, Huan; Li, Yongmei; Sheng, Chunquan; Lv, Zhiliang; Dong, Guoqiang; Wang, Tiantian; Liu, Jia; Zhang, Mingfeng; Li, Lingzhen; Zhang, Tao; Geng, Dongping; Niu, Chunjuan; Li, Ke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">685-699</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of novel cyclopropylamide analogs of combretastatin-A4 (CA-4) were designed and synthesized.  Most of them had significant in vitro antiproliferative activities.  Moreover, compd. I was also equally potent against paclitaxel resistant cancer cells.  Interestingly, the novel cyclopropylamide analogs had different binding mechanisms from CA-4.  Instead of inhibiting tubulin polymn., these CA-4 derivs. were able to stimulate tubulin polymn.  Flow cytometry revealed that compd. I arrested A549 cancer cells in the G2/M phase and resulted in cellular apoptosis.  Further immunofluorescence assays revealed that compd. I induced mitotic arrest in A549 cells through disrupting microtubule dynamics.  In addn., compd. I also effectively inhibited the tumor growth in the A549 xenograft model without causing significant loss of body wt.  Compd. I represents a novel class of microtubule-stabilizing agent and can be used as a promising lead for the development of new antitumor agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcQqkKQT1ImbVg90H21EOLACvtfcHk0lhWejxzPNWOuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFaqtLw%253D&md5=63f76583efba1c8902844c97afa6da73</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm301864s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301864s%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DLv%26aufirst%3DZ.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DGeng%26aufirst%3DD.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DK.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520cyclopropylamide%2520analogues%2520of%2520combretastatin-A4%2520as%2520novel%2520microtubule-stabilizing%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D685%26epage%3D699%26doi%3D10.1021%2Fjm301864s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Wen Shuai, Guan Wang, Yiwen Zhang, Faqian Bu, Sicheng Zhang, Duane D. Miller, Wei Li, Liang Ouyang, <span class="NLM_string-name hlFld-ContribAuthor">Yuxi Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress on Tubulin Inhibitors with Dual Targeting Capabilities for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 7963-7990. <a href="https://doi.org/10.1021/acs.jmedchem.1c00100" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00100%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BProgress%252Bon%252BTubulin%252BInhibitors%252Bwith%252BDual%252BTargeting%252BCapabilities%252Bfor%252BCancer%252BTherapy%26aulast%3DShuai%26aufirst%3DWen%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D19012021%26date%3D08062021%26volume%3D64%26issue%3D12%26spage%3D7963%26epage%3D7990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, Farid Hashemi, Ebrahim Rahmani Moghadam, Mehdi Raei, Mahshad Kalantari, Shima Tavakol, Reza Mohammadinejad, Masoud Najafi, Franklin R. Tay, <span class="NLM_string-name hlFld-ContribAuthor">Pooyan Makvandi</span>. </span><span class="cited-content_cbyCitation_article-title">Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2020,</strong> <em>22 </em>
                                    (12)
                                     , 669-700. <a href="https://doi.org/10.1021/acscombsci.0c00099" title="DOI URL">https://doi.org/10.1021/acscombsci.0c00099</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.0c00099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.0c00099%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DProgress%252Bin%252BNatural%252BCompounds%25252FsiRNA%252BCo-delivery%252BEmploying%252BNanovehicles%252Bfor%252BCancer%252BTherapy%26aulast%3DAshrafizadeh%26aufirst%3DMilad%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D21052020%26date%3D05102020%26date%3D23102020%26volume%3D22%26issue%3D12%26spage%3D669%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sheng-Ge Li, Yue-Tong Wang, Qin Zhang, Kai-Bo Wang, Jing-Jing Xue, Da-Hong Li, Yong-Kui Jing, Bin Lin, <span class="NLM_string-name hlFld-ContribAuthor">Hui-Ming Hua</span>. </span><span class="cited-content_cbyCitation_article-title">Pegaharmols A–B, Axially Chiral β-Carboline-quinazoline Dimers from the Roots of Peganum harmala. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (19)
                                     , 7522-7525. <a href="https://doi.org/10.1021/acs.orglett.0c02709" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c02709</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c02709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c02709%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPegaharmols%252BA%2525E2%252580%252593B%25252C%252BAxially%252BChiral%252B%2525CE%2525B2-Carboline-quinazoline%252BDimers%252Bfrom%252Bthe%252BRoots%252Bof%252BPeganum%252Bharmala%26aulast%3DLi%26aufirst%3DSheng-Ge%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14082020%26date%3D16092020%26volume%3D22%26issue%3D19%26spage%3D7522%26epage%3D7525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaohong  Fan</span>, <span class="hlFld-ContribAuthor ">Jiedan  Deng</span>, <span class="hlFld-ContribAuthor ">Tao  Shi</span>, <span class="hlFld-ContribAuthor ">Huaixiu  Wen</span>, <span class="hlFld-ContribAuthor ">Junfang  Li</span>, <span class="hlFld-ContribAuthor ">Ziyi  Liang</span>, <span class="hlFld-ContribAuthor ">Fang  Lei</span>, <span class="hlFld-ContribAuthor ">Dan  Liu</span>, <span class="hlFld-ContribAuthor ">Honghua  Zhang</span>, <span class="hlFld-ContribAuthor ">Yan  Liang</span>, <span class="hlFld-ContribAuthor ">Xiangyong  Hao</span>, <span class="hlFld-ContribAuthor ">Zhen  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and bioactivity study of evodiamine derivatives as multifunctional agents for the treatment of hepatocellular carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>114 </em>, 105154. <a href="https://doi.org/10.1016/j.bioorg.2021.105154" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105154</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105154%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbioactivity%252Bstudy%252Bof%252Bevodiamine%252Bderivatives%252Bas%252Bmultifunctional%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252Bhepatocellular%252Bcarcinoma%26aulast%3DFan%26aufirst%3DXiaohong%26date%3D2021%26volume%3D114%26spage%3D105154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cui  Ye</span>, <span class="hlFld-ContribAuthor ">Nan  Zhang</span>, <span class="hlFld-ContribAuthor ">Qian  Zhao</span>, <span class="hlFld-ContribAuthor ">Xin  Xie</span>, <span class="hlFld-ContribAuthor ">Xiang  Li</span>, <span class="hlFld-ContribAuthor ">Hong‐Ping  Zhu</span>, <span class="hlFld-ContribAuthor ">Cheng  Peng</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Bo  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Evodiamine alleviates lipopolysaccharide‐induced pulmonary inflammation and fibrosis by activating apelin pathway. </span><span class="cited-content_cbyCitation_journal-name">Phytotherapy Research</span><span> <strong>2021,</strong> <em>35 </em>
                                    (6)
                                     , 3406-3417. <a href="https://doi.org/10.1002/ptr.7062" title="DOI URL">https://doi.org/10.1002/ptr.7062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ptr.7062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fptr.7062%26sid%3Dliteratum%253Aachs%26jtitle%3DPhytotherapy%2520Research%26atitle%3DEvodiamine%252Balleviates%252Blipopolysaccharide%2525E2%252580%252590induced%252Bpulmonary%252Binflammation%252Band%252Bfibrosis%252Bby%252Bactivating%252Bapelin%252Bpathway%26aulast%3DYe%26aufirst%3DCui%26date%3D2021%26date%3D2021%26volume%3D35%26issue%3D6%26spage%3D3406%26epage%3D3417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zonglin  Ma</span>, <span class="hlFld-ContribAuthor ">Yahui  Huang</span>, <span class="hlFld-ContribAuthor ">Kun  Wan</span>, <span class="hlFld-ContribAuthor ">Fugui  Zhu</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>, <span class="hlFld-ContribAuthor ">Shuqiang  Chen</span>, <span class="hlFld-ContribAuthor ">Dan  Liu</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">Structural simplification of evodiamine: Discovery of novel tetrahydro-β-carboline derivatives as potent antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>40 </em>, 127954. <a href="https://doi.org/10.1016/j.bmcl.2021.127954" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.127954</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.127954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.127954%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructural%252Bsimplification%252Bof%252Bevodiamine%25253A%252BDiscovery%252Bof%252Bnovel%252Btetrahydro-%2525CE%2525B2-carboline%252Bderivatives%252Bas%252Bpotent%252Bantitumor%252Bagents%26aulast%3DMa%26aufirst%3DZonglin%26date%3D2021%26volume%3D40%26spage%3D127954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong-Jun  Fu</span>, <span class="hlFld-ContribAuthor ">Jun  Li</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Annual review of LSD1/KDM1A inhibitors in 2020. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>214 </em>, 113254. <a href="https://doi.org/10.1016/j.ejmech.2021.113254" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113254</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113254%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAnnual%252Breview%252Bof%252BLSD1%25252FKDM1A%252Binhibitors%252Bin%252B2020%26aulast%3DFu%26aufirst%3DDong-Jun%26date%3D2021%26volume%3D214%26spage%3D113254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arindam  Talukdar</span>, <span class="hlFld-ContribAuthor ">Sourav  Pal</span>. </span><span class="cited-content_cbyCitation_article-title">Computational Approaches Toward Development of Topoisomerase I Inhibitor: A Clinically Validated Target. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 441-462. <a href="https://doi.org/10.1016/B978-0-12-822312-3.00018-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-822312-3.00018-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-822312-3.00018-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-822312-3.00018-7%26sid%3Dliteratum%253Aachs%26atitle%3DComputational%252BApproaches%252BToward%252BDevelopment%252Bof%252BTopoisomerase%252BI%252BInhibitor%25253A%252BA%252BClinically%252BValidated%252BTarget%26aulast%3DTalukdar%26aufirst%3DArindam%26date%3D2021%26spage%3D441%26epage%3D462%26pub%3DElsevier%26atitle%3DMolecular%252BDocking%252Bfor%252BComputer-Aided%252BDrug%252BDesign%26date%3D2021%26volume%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yichao  Wan</span>, <span class="hlFld-ContribAuthor ">Jiabing  Long</span>, <span class="hlFld-ContribAuthor ">Han  Gao</span>, <span class="hlFld-ContribAuthor ">Zilong  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">2-Aminothiazole: A privileged scaffold for the discovery of anti-cancer agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>210 </em>, 112953. <a href="https://doi.org/10.1016/j.ejmech.2020.112953" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112953</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112953%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D2-Aminothiazole%25253A%252BA%252Bprivileged%252Bscaffold%252Bfor%252Bthe%252Bdiscovery%252Bof%252Banti-cancer%252Bagents%26aulast%3DWan%26aufirst%3DYichao%26date%3D2021%26volume%3D210%26spage%3D112953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiang  Sun</span>, <span class="hlFld-ContribAuthor ">Long  Xie</span>, <span class="hlFld-ContribAuthor ">Jiawen  Song</span>, <span class="hlFld-ContribAuthor ">Xiaofang  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Evodiamine: A review of its pharmacology, toxicity, pharmacokinetics and preparation researches. </span><span class="cited-content_cbyCitation_journal-name">Journal of Ethnopharmacology</span><span> <strong>2020,</strong> <em>262 </em>, 113164. <a href="https://doi.org/10.1016/j.jep.2020.113164" title="DOI URL">https://doi.org/10.1016/j.jep.2020.113164</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jep.2020.113164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jep.2020.113164%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Ethnopharmacology%26atitle%3DEvodiamine%25253A%252BA%252Breview%252Bof%252Bits%252Bpharmacology%25252C%252Btoxicity%25252C%252Bpharmacokinetics%252Band%252Bpreparation%252Bresearches%26aulast%3DSun%26aufirst%3DQiang%26date%3D2020%26volume%3D262%26spage%3D113164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01626&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of evodiamine, oxo-, and thio-evodiamine derivatives and indolopyrazinoquinazolinone <b>15a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01626&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01626&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) EtOH, H<sub>2</sub>SO<sub>4</sub>, reflux, 10 h; (b) BrCH<sub>2</sub>CN, NaH, DMF, rt, overnight, yield 45–62% over two steps; (c) NaBH<sub>4</sub>, CoCl<sub>2</sub>, MeOH, THF, reflux, 6 h, yield 39–55%; (d) MeOH, SOCl<sub>2</sub>, reflux, overnight; (e) (Boc)<sub>2</sub>O, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, rt, overnight, yield 31–56%; (f) MeI, NaH, DMF, rt, 6 h, yield 61–85%; (g) CF<sub>3</sub>COOH, CH<sub>2</sub>Cl<sub>2</sub>, rt, 2 h, yield 82–96%; (h) POCl<sub>3</sub>, toluene, microwave, 130 °C, 45 min; and (i) NaBH<sub>4</sub>, EtOH, rt, 1 h, yield 23–62% over two steps.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01626&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Na, MeOH, 0 °C, 6 h, yield 53–72%; (b) 1,2-dichlorobenzene, 180 °C, 2 h, yield 65–78%. (c) BrCH<sub>2</sub>CN, NaH, DMF, rt, overnight; NaBH<sub>4</sub>, CoCl<sub>2</sub>, MeOH, THF, reflux, 6 h, yield 45–62% over two steps; (d) POCl<sub>3</sub>, toluene, microwave, 130 °C, 45 min; and (e) NaBH<sub>4</sub>, EtOH, rt, 1 h, yield 36–37% over two steps.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01626&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C, 2.5 h, yield 43%; (b) benzoyl peroxide, NBS, CCl<sub>4</sub>, reflux, 3.5 h, yield 24–26%; (c) Lawesson’s reagent, toluene, reflux, 4 h, yield 37%; (d) POCl<sub>3</sub>, DMF, rt, 2 h, yield 82–86%; (e) NaBH<sub>4</sub>, MeOH, rt, 1 h, yield 92–93%; and (f) methylpiperazine, NaBH<sub>3</sub>CN, CH<sub>3</sub>COOH, DCM, rt, overnight, yield 63%.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01626&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (Me<sub>3</sub>Si)<sub>2</sub>NHNa, MeI, THF, rt, overnight, yield 44%; (b) NaBH<sub>4</sub>, CoCl<sub>2</sub>, MeOH, THF, reflux, 6 h, yield 36%; (c) POCl<sub>3</sub>, toluene, microwave, 130 °C, 45 min; and (d) NaBH<sub>4</sub>, EtOH, rt, 1 h, yield 32–35% over two steps.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01626&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) benzyltrimethylammonium hydroxide, 1,4-dioxane, reflux, 1 h, yield 72%; (b) NaBH<sub>4</sub>, CoCl<sub>2</sub>, MeOH, THF, reflux, 6 h, yield 36%; (c) POCl<sub>3</sub>, toluene, microwave, 130 °C, 45 min; (d) NaBH<sub>4</sub>, EtOH, rt, 1 h, yield 32% over two steps; and (e) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C, 2.5 h, yield 48%.</p></p></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of indolopyrazinoquinazolinone derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01626&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Summary of the SARs of indolopyrazinoquinazolinone derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01626&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Top1 and Top2 inhibitory activities of the selected indolopyrazinoquinazolinone derivatives. Inhibition of Top1 relaxation activity at 100 μM: Lane 1, supercoiled plasmid DNA; lane 2, DNA + Top1; lane 3, DNA + Top1 + CPT; lanes 4–7, DNA + Top1 + test compound (<b>15a</b>, <b>15j</b>, <b>15e</b>, and <b>15f</b>, respectively). Inhibition of Top2 relaxation activity at 100 μM: lane 1, supercoiled plasmid DNA; lane 2, DNA + Top2; lane 3, DNA + Top2 + Eto; lanes 4–7, DNA + Top2 + test compound (<b>15a</b>, <b>15j</b>, <b>15e</b>, and <b>15f</b>, respectively). (B) Top1-mediated DNA cleavage assay gel of compound <b>15j</b> using supercoiled pUC19. Lane 1, supercoiled plasmid DNA (pUC19); lane 2, DNA + Top1; lane 3, DNA + Top1 + CPT (100 μM); lanes 4–7, DNA + Top1 + <b>15j</b> (100, 50, 25, and 12.5 μM). (C) Tubulin inhibitory activities of compound <b>15j</b> and colchicine. Following treatment with different concentrations of <b>15j</b> and colchicine, the in vitro polymerization of tubulin at 37 °C was continuously monitored by recording the absorbance at 340 nm over 20 min. The data are the average of two independent experiments. Compound <b>15j</b> showed concentration-dependent inhibition of tubulin polymerization. (D) Tubulin polymerization inhibitory effects of <b>15j</b> by immunostaining assay. HCT116 cells were treated with paclitaxel and <b>15j</b> at different concentrations for 12 h. The nuclei were stained with DAPI (blue), and the microtubules were stained with mouse anti-α-tubulin (green). The images were taken using a TSC SP8 laser confocal microscope (Leica, Germany).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01626&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Inhibition rates of compound <b>15j</b> against a panel of 30 antitumor targets. G9a, lysine methyltransferase G9a; Sirtuin1, NAD-dependent deacetylase sirtuin-1; TNKS1, tankyrase 1; TNKS2, tankyrase 2; PARP, poly-ADP-ribose polymerase; JMJD3, jumonji domain-containing 3; SHP2, phosphatase shatterproof 2; DNMT3a/3L, DNA methyltransferase 3a/3L; PRMT1, protein arginine N-methyltransferase 1; EZH2, enhancer of zeste homologue 2; SET8, lysine methyltransferase enzyme SET8; CDK, cell cycle-dependent kinase; MMP, matrix metalloproteinase; PKAC-α, protein kinase A catalytic subunit α; HDAC3, histone deacetylase 3; Abl, Abelson tyrosine kinase; PLK1, polo-like kinase 1; EGFR, epidermal growth factor receptor; JMJD2A, jumonji domain-containing protein 2A; PI3K (p110α/p85α), phosphoinositide-3-kinase (p110α/p85α); FAK, focal adhesion kinase; PDE4A1A, phosphodiesterase 4A1A; PDE4D7, phosphodiesterase 4D7; PDE4A4, phosphodiesterase 4A4. (B) Proposed binding modes for compound <b>15j</b> with the Top1–DNA complex (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T8I">1T8I</a>). (C) Proposed binding modes for compound <b>15j</b> with the colchicine-binding domain of tubulin (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SA0">1SA0</a>). The figures were generated using Pymol (<a href="http://www.pymol.org/" class="extLink">http://www.pymol.org/</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01626&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Induction of apoptosis and cell-cycle arrest by compound <b>15j</b> in HCT116 cells. (A) Effects of compound <b>15j</b> on the induction of apoptosis. The cells were exposed to increasing concentrations of the test compound for 24 h and analyzed by annexin V/propidium iodide double staining. The data are representative of two independent experiments. (B) The effect of compound <b>15j</b> on the cell cycle as determined by flow cytometry. HCT116 cells were treated with compound <b>15j</b> at 4, 12, or 36 nM for 24 h. The data are representative of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01626&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/medium/jm9b01626_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Antitumor efficacies of compounds <b>15j</b> and <b>15js</b> in the xenograft model. (A) Efficacy of compound <b>15j</b> in the HCT116 xenograft model at a dose of 4 mg/kg. (B) Change in the body weight of nude mice treated with compound <b>15j</b>. (C) Efficacy of compound <b>15js</b> in the HCT116 xenograft model at a dose of 16 mg/kg. (D) Change in the body weight of nude mice treated with compound <b>15js</b>. Data are presented as the mean ± SEM; <i>n</i> = 6 nude mice per group: (*) <i>P</i> < 0.05, (**) <i>P</i> < 0.01, (***) <i>P</i> < 0.001 vs the control group, determined with Student’s <i>t</i>-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-2/acs.jmedchem.9b01626/20200115/images/large/jm9b01626_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01626&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i93">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08310" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08310" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 26 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris-Natschke, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.-H.</span></span> <span> </span><span class="NLM_article-title">Strategies for the optimization of natural leads to anticancer drugs or drug candidates</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">32</span>– <span class="NLM_lpage">91</span>, <span class="refDoi"> DOI: 10.1002/med.21377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.1002%2Fmed.21377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=26359649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVagsb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=32-91&author=Z.+Xiaoauthor=S.+L.+Morris-Natschkeauthor=K.-H.+Lee&title=Strategies+for+the+optimization+of+natural+leads+to+anticancer+drugs+or+drug+candidates&doi=10.1002%2Fmed.21377"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates</span></div><div class="casAuthors">Xiao, Zhiyan; Morris-Natschke, Susan L.; Lee, Kuo-Hsiung</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-91</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Natural products have made significant contribution to cancer chemotherapy over the past decades and remain an indispensable source of mol. and mechanistic diversity for anticancer drug discovery.  More often than not, natural products may serve as leads for further drug development rather than as effective anticancer drugs by themselves.  Generally, optimization of natural leads into anticancer drugs or drug candidates should not only address drug efficacy, but also improve absorption, distribution, metab., excretion, and toxicity (ADMET) profiles and chem. accessibility assocd. with the natural leads.  Optimization strategies involve direct chem. manipulation of functional groups, structure-activity relationship directed optimization and pharmacophore-oriented mol. design based on the natural templates.  Both fundamental medicinal chem. principles (e.g., bioisosterism) and state-of-the-art computer-aided drug design techniques (e.g., structure-based design) can be applied to facilitate optimization efforts.  In this review, the strategies to optimize natural leads to anticancer drugs or drug candidates are illustrated with examples and described according to their purposes.  Furthermore, successful case studies on lead optimization of bioactive compds. performed in the Natural Products Research Labs. at UNC are highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6SGKXSp6ip7Vg90H21EOLACvtfcHk0lhTXDfJl92ong"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVagsb%252FJ&md5=dc8c68d23f1f8e9ff6e98847a69558c4</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2Fmed.21377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21377%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DMorris-Natschke%26aufirst%3DS.%2BL.%26aulast%3DLee%26aufirst%3DK.-H.%26atitle%3DStrategies%2520for%2520the%2520optimization%2520of%2520natural%2520leads%2520to%2520anticancer%2520drugs%2520or%2520drug%2520candidates%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2016%26volume%3D36%26spage%3D32%26epage%3D91%26doi%3D10.1002%2Fmed.21377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cragg, G. M.</span></span> <span> </span><span class="NLM_article-title">Natural products as sources of new drugs from 1981 to 2014</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">629</span>– <span class="NLM_lpage">661</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.5b01055</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.5b01055" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit1Kqu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=629-661&author=D.+J.+Newmanauthor=G.+M.+Cragg&title=Natural+products+as+sources+of+new+drugs+from+1981+to+2014&doi=10.1021%2Facs.jnatprod.5b01055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Products as Sources of New Drugs from 1981 to 2014</span></div><div class="casAuthors">Newman, David J.; Cragg, Gordon M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">629-661</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">This contribution is a completely updated and expanded version of the four prior analogous reviews that were published in this journal in 1997, 2003, 2007, and 2012.  In the case of all approved therapeutic agents, the time frame has been extended to cover the 34 years from Jan. 1, 1981, to Dec. 31, 2014, for all diseases worldwide, and from 1950 (earliest so far identified) to Dec. 2014 for all approved antitumor drugs worldwide.  As mentioned in the 2012 review, we have continued to utilize our secondary subdivision of a "natural product mimic", or "NM", to join the original primary divisions and the designation "natural product botanical", or "NB", to cover those botanical "defined mixts." now recognized as drug entities by the U.S. FDA (and similar organizations).  From the data presented in this review, the utilization of natural products and/or their novel structures, in order to discover and develop the final drug entity, is still alive and well.  For example, in the area of cancer, over the time frame from around the 1940s to the end of 2014, of the 175 small mols. approved, 131, or 75%, are other than "S" (synthetic), with 85, or 49%, actually being either natural products or directly derived therefrom.  In other areas, the influence of natural product structures is quite marked, with, as expected from prior information, the anti-infective area being dependent on natural products and their structures.  We wish to draw the attention of readers to the rapidly evolving recognition that a significant no. of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated", and therefore it is considered that this area of natural product research should be expanded significantly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMgEvq9fVY8bVg90H21EOLACvtfcHk0lgI5s0EQrBJxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit1Kqu7k%253D&md5=c9f2a44ab6b66331b7ef6ca64029328a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.5b01055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.5b01055%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26aulast%3DCragg%26aufirst%3DG.%2BM.%26atitle%3DNatural%2520products%2520as%2520sources%2520of%2520new%2520drugs%2520from%25201981%2520to%25202014%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2016%26volume%3D79%26spage%3D629%26epage%3D661%26doi%3D10.1021%2Facs.jnatprod.5b01055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kingsbury, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakas, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holden, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hecht, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallagher, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caranfa, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCabe, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faucette, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertzberg, R. P.</span></span> <span> </span><span class="NLM_article-title">Synthesis of water-soluble (aminoalkyl) camptothecin analogs: inhibition of topoisomerase I and antitumor activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">98</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1021/jm00105a017</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00105a017" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADyaK3MXktlaktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=98-107&author=W.+D.+Kingsburyauthor=J.+C.+Boehmauthor=D.+R.+Jakasauthor=K.+G.+Holdenauthor=S.+M.+Hechtauthor=G.+Gallagherauthor=M.+J.+Caranfaauthor=F.+L.+McCabeauthor=L.+F.+Faucetteauthor=R.+K.+Johnsonauthor=R.+P.+Hertzberg&title=Synthesis+of+water-soluble+%28aminoalkyl%29+camptothecin+analogs%3A+inhibition+of+topoisomerase+I+and+antitumor+activity&doi=10.1021%2Fjm00105a017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of water-soluble (aminoalkyl)camptothecin analogs:  inhibition of topoisomerase I and antitumor activity</span></div><div class="casAuthors">Kingsbury, William D.; Boehm, Jeffrey C.; Jakas, Dalia R.; Holden, Kenneth G.; Hecht, Sidney M.; Gallagher, Gregory; Caranfa, Mary Jo; McCabe, Francis L.; Faucette, Leo F.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">98-107</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Water-sol. analogs of the antitumor alkaloid camptothecin were prepd. in which aminoalkyl groups were introduced into ring A or B.  Most of the analogs were prepd. by oxidn. of camptothecin to 10-hydroxycamptothecin (I) followed by a Mannich reaction to give N-substituted 9-(aminomethyl)-10-hydroxycamptothecins or by subsequent modification of Mannich product II.  Others were obtained by modification of the hydroxyl group of I or by total synthesis.  These analogs, as well as some of their synthetic precursors, were evaluated for inhibition of topoisomerase I, cytotoxicity, and antitumor activity.  Although there was not a quant. correlation between these assays, compds. that inhibited topoisomerase I were also cytotoxic and demonstrated antitumor activity in vivo.  Further evaluation of the most active water-sol. analog led to the selection of II for development as an antitumor agent.  In addn. to its water soly., ease of synthesis from natural camptothecin, and high potency, II demonstrated broad-spectrum activity in preclin. tumor models and is currently undergoing Phase I clin. trials in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIrxMTdr7yNrVg90H21EOLACvtfcHk0lgI5s0EQrBJxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXktlaktg%253D%253D&md5=01531a5e188592cdac8ab803995128ab</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm00105a017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00105a017%26sid%3Dliteratum%253Aachs%26aulast%3DKingsbury%26aufirst%3DW.%2BD.%26aulast%3DBoehm%26aufirst%3DJ.%2BC.%26aulast%3DJakas%26aufirst%3DD.%2BR.%26aulast%3DHolden%26aufirst%3DK.%2BG.%26aulast%3DHecht%26aufirst%3DS.%2BM.%26aulast%3DGallagher%26aufirst%3DG.%26aulast%3DCaranfa%26aufirst%3DM.%2BJ.%26aulast%3DMcCabe%26aufirst%3DF.%2BL.%26aulast%3DFaucette%26aufirst%3DL.%2BF.%26aulast%3DJohnson%26aufirst%3DR.%2BK.%26aulast%3DHertzberg%26aufirst%3DR.%2BP.%26atitle%3DSynthesis%2520of%2520water-soluble%2520%2528aminoalkyl%2529%2520camptothecin%2520analogs%253A%2520inhibition%2520of%2520topoisomerase%2520I%2520and%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D98%26epage%3D107%26doi%3D10.1021%2Fjm00105a017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Carbonero, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supko, J.</span></span> <span> </span><span class="NLM_article-title">Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">641</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.1385%2F1592591604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=11895891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BD38XislOqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=641&author=R.+Garcia-Carboneroauthor=J.+Supko&title=Current+perspectives+on+the+clinical+experience%2C+pharmacology%2C+and+continued+development+of+the+camptothecins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins</span></div><div class="casAuthors">Garcia-Carbonero, Rocio; Supko, Jeffrey G.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">641-661</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review, discussing the pharmacol. and antitumor activities of the camptothecin analogs that are approved for clin. use and those investigational agents undergoing clin. evaluation.  Camptothecin is a naturally occurring cytotoxic alkaloid that has a unique intracellular target, topoisomerase I, a nuclear enzyme that reduces the torsional stress of supercoiled DNA during the replication, recombination, transcription, and repair of DNA.  Topotecan and irinotecan are synthetic analogs designed to facilitate parenteral administration of the active lactone form of the compd. by introducing functional groups to enhance soly.  They are now well-established components in the chemotherapeutic management of several neoplasms.  Topotecan has modest activity in previously treated patients with ovarian and small-cell lung cancer and is currently approved for use in the United States as 2nd-line therapy in these diseases.  Preliminary evidence of activity against hematol. malignancies is also promising.  Irinotecan is a prodrug that undergoes enzymic conversion to the biol. active metabolite 7-ethyl-10-hydroxycamptothecin.  It is presently the treatment of choice when used in combination with fluoropyrimidines as 1st-line therapy for patients with advanced colorectal cancer or as a single agent after failure of 5-fluorouracil-based chemotherapy.  Encouraging preliminary results suggest that irinotecan may have an increasing role in the treatment of other solid tumors, including small- and non-small-cell lung cancer, cervical cancer, ovarian cancer, gastric cancer, and malignant gliomas.  Several addnl. camptothecin analogs are in various stages of clin. development, including 9-aminocamptothecin, 9-nitrocamptothecin, 7-(4-methylpiperazinomethylene)-10,11-ethylenedioxy-20(S)-camptothecin, exatecan mesylate, and karenitecin.  Efforts to further optimize therapeutic effectiveness through drug-delivery strategies that prolong tumor exposure to these S phase-specific agents, such as improving oral bioavailability through structure modification and innovative formulation approaches, alternative parenteral dosage forms, and administration schedules, are being actively pursued.  Combining camptothecins with other anticancer drugs and treatment modalities, as well as gaining a better understanding of the factors contributing to tumor sensitivity and resistance, continues to be of considerable interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrarJT9tdw_17Vg90H21EOLACvtfcHk0lgI5s0EQrBJxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XislOqt70%253D&md5=6ef49a8a00a46110224d01506043f0bb</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1385%2F1592591604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252F1592591604%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Carbonero%26aufirst%3DR.%26aulast%3DSupko%26aufirst%3DJ.%26atitle%3DCurrent%2520perspectives%2520on%2520the%2520clinical%2520experience%252C%2520pharmacology%252C%2520and%2520continued%2520development%2520of%2520the%2520camptothecins%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2002%26volume%3D8%26spage%3D641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">The structural modification of natural products for novel drug discovery</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">140</span>, <span class="refDoi"> DOI: 10.1080/17460441.2016.1272757</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.1080%2F17460441.2016.1272757" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=28006993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivVek" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=121-140&author=H.+Yaoauthor=J.+Liuauthor=S.+Xuauthor=Z.+Zhuauthor=J.+Xu&title=The+structural+modification+of+natural+products+for+novel+drug+discovery&doi=10.1080%2F17460441.2016.1272757"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The structural modification of natural products for novel drug discovery</span></div><div class="casAuthors">Yao, Hong; Liu, Junkai; Xu, Shengtao; Zhu, Zheying; Xu, Jinyi</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-140</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Throughout history, natural products (NPs) have provided a rich source of compds. that have wide applications in the fields of medicine, health sciences, pharmacy and biol.  Although naturally active substances are good lead compds. for the discovery of new drugs, most of them suffer from various deficiencies or shortcomings, such as complex structures, poor stability and soly.  Therefore, structural modification of NPs is needed to develop novel compds. with specific properties.: This article presents an overview on the structural modifications of NPs in drug development.  The application of multiple classes of NPs to the treatment of conditions such as cancers, infection, Alzheimer's and diabetes are discussed.  This article also reveals that modification of NPs is a versatile approach to explore their mode of actions, which may lead to the discovery of novel drugs.: NPs are usually described by structural diversity and complexity.  The use of isolated NPs as scaffolds for modification is a good approach to drug discovery and development.  Despite many limitations assocd. with NPs, the total synthesis, semisynthetic modification, SAR-based modification, sometimes even a single atom alteration, may lead to the discovery of a novel drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6S_a4H8DIPLVg90H21EOLACvtfcHk0lix8aQMnOwPuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivVek&md5=46b49696429d04c7982c315339a2c9bb</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1080%2F17460441.2016.1272757&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17460441.2016.1272757%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DThe%2520structural%2520modification%2520of%2520natural%2520products%2520for%2520novel%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2017%26volume%3D12%26spage%3D121%26epage%3D140%26doi%3D10.1080%2F17460441.2016.1272757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">Insights into drug discovery from natural products through structural modification</span>. <i>Fitoterapia</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">241</span>, <span class="refDoi"> DOI: 10.1016/j.fitote.2015.04.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.1016%2Fj.fitote.2015.04.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=25917513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC2MXns1KitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2015&pages=231-241&author=J.+Chenauthor=W.+Liauthor=H.+Yaoauthor=J.+Xu&title=Insights+into+drug+discovery+from+natural+products+through+structural+modification&doi=10.1016%2Fj.fitote.2015.04.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into drug discovery from natural products through structural modification</span></div><div class="casAuthors">Chen, Jichao; Li, Wenlong; Yao, Hequan; Xu, Jinyi</div><div class="citationInfo"><span class="NLM_cas:title">Fitoterapia</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">231-241</span>CODEN:
                <span class="NLM_cas:coden">FTRPAE</span>;
        ISSN:<span class="NLM_cas:issn">0367-326X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Natural products (NPs) have played a key role in drug discovery and are still a prolific source of novel lead compds. or pharmacophores for medicinal chem.  Pharmacol. activity and druggability are two indispensable components advancing NPs from leads to drugs.  Although naturally active substances are usually good lead compds., most of them can hardly satisfy the demands for druggability.  Hence, these structural phenotypes have to be modified and optimized to overcome existing deficiencies and shortcomings.  This review illustrates druggability optimization of NPs through structural modification with some successful examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0oWk_7Gmxc7Vg90H21EOLACvtfcHk0lix8aQMnOwPuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXns1KitrY%253D&md5=937e7f5bae8e613feb1929dfdcc239b8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.fitote.2015.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fitote.2015.04.012%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DYao%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DInsights%2520into%2520drug%2520discovery%2520from%2520natural%2520products%2520through%2520structural%2520modification%26jtitle%3DFitoterapia%26date%3D2015%26volume%3D103%26spage%3D231%26epage%3D241%26doi%3D10.1016%2Fj.fitote.2015.04.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span> <span> </span><span class="NLM_article-title">The modification of natural products for medical use</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2016.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.1016%2Fj.apsb.2016.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=28303218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A280%3ADC%252BC1czntFOhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=119-136&author=Z.+Guo&title=The+modification+of+natural+products+for+medical+use&doi=10.1016%2Fj.apsb.2016.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The modification of natural products for medical use</span></div><div class="casAuthors">Guo Zongru</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-136</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">Drug innovation is characterized by painstaking molecular-level syntheses and modifications as the basic components of research and development.  Similarly, natural products are chemically tailored and modified based upon their structural and biological properties.  To some extent, the modification of natural products is quite different from de novo structure-based drug discovery.  This review describes the general strategies and principles for the modification of natural products to drugs, as illustrated by several successful medicines that originated from natural products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQyitwjIggyreqrn-c4Of3KfW6udTcc2ebQkrnE4W8xQrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czntFOhtg%253D%253D&md5=332caaec62ecd152633c7c35475affa6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2016.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2016.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DZ.%26atitle%3DThe%2520modification%2520of%2520natural%2520products%2520for%2520medical%2520use%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2017%26volume%3D7%26spage%3D119%26epage%3D136%26doi%3D10.1016%2Fj.apsb.2016.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Castro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sankar, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K.</span></span> <span> </span><span class="NLM_article-title">Scaffold diversity synthesis and its application in probe and drug discovery</span>. <i>Angew. Chem., Int. Ed. Engl.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7586</span>– <span class="NLM_lpage">7605</span>, <span class="refDoi"> DOI: 10.1002/anie.201508818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.1002%2Fanie.201508818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=27187638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252Fgt1Ciug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=7586-7605&author=M.+Garcia-Castroauthor=S.+Zimmermannauthor=M.+G.+Sankarauthor=K.+Kumar&title=Scaffold+diversity+synthesis+and+its+application+in+probe+and+drug+discovery&doi=10.1002%2Fanie.201508818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Scaffold Diversity Synthesis and Its Application in Probe and Drug Discovery</span></div><div class="casAuthors">Garcia-Castro Miguel; Zimmermann Stefan; Sankar Muthukumar G; Kumar Kamal</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie (International ed. in English)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">7586-605</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Scaffold diversity is a crucial feature of compound collections that has a huge impact on their success in biological screenings.  The synthesis of highly complex and diverse scaffolds, which could be based on natural products, for example, is an arduous task that requires expertise in various aspects of organic synthesis and structural analysis.  This challenge has been addressed by a number of synthesis designs, which employ natural products as a source of scaffold diversity, transform suitably designed common intermediates into various molecular frameworks, or entail highly concise synthetic routes to a number of distinct and complex scaffolds.  In this Minireview, we highlight recent synthetic developments towards the construction of diverse and complex scaffolds and the application of the resulting compound collections in drug and probe discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSBYg9cK4kfOjAEfvC7EH1LfW6udTcc2ebQkrnE4W8xQrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252Fgt1Ciug%253D%253D&md5=323899c5e7d7d1d949c4bcc598007813</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fanie.201508818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201508818%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Castro%26aufirst%3DM.%26aulast%3DZimmermann%26aufirst%3DS.%26aulast%3DSankar%26aufirst%3DM.%2BG.%26aulast%3DKumar%26aufirst%3DK.%26atitle%3DScaffold%2520diversity%2520synthesis%2520and%2520its%2520application%2520in%2520probe%2520and%2520drug%2520discovery%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D2016%26volume%3D55%26spage%3D7586%26epage%3D7605%26doi%3D10.1002%2Fanie.201508818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span> <span> </span><span class="NLM_article-title">Pharmacological actions of multi-target-directed evodiamine</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1826</span>– <span class="NLM_lpage">1843</span>, <span class="refDoi"> DOI: 10.3390/molecules18021826</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.3390%2Fmolecules18021826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=23434865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivVegtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=1826-1843&author=H.+Yuauthor=H.+Jinauthor=W.+Gongauthor=Z.+Wangauthor=H.+Liang&title=Pharmacological+actions+of+multi-target-directed+evodiamine&doi=10.3390%2Fmolecules18021826"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological actions of multi-target-directed evodiamine</span></div><div class="casAuthors">Yu, Hui; Jin, Hongwei; Gong, Wuzhuang; Wang, Zhanli; Liang, Huaping</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1826-1843</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Evodiamine, a naturally occurring indole alkaloid, is one of the main bioactive ingredients of Evodiae fructus.  With respect to the pharmacol. actions of evodiamine, more attention has been paid to beneficial effects in insults involving cancer, obesity, nociception, inflammation, cardiovascular diseases, Alzheimer's disease, infectious diseases and themoregulative effects.  Evodiamine has evolved a superior ability to bind various proteins, so we also argue that it is good starting point for multi-target drugs.  This review is primarily addressed to the description of the recent advances in the biol. activity studies of evodiamine, with a focus on pharmacol. mechanism.  The present review also includes the pharmacokinetics and the detailed exploration of target-binding properties of evodiamine in an attempt to provide a direction for further multi-target drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGlSdsWLVJb7Vg90H21EOLACvtfcHk0ljCRqKc-rTz3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivVegtLk%253D&md5=798185966dcdbf033ffda501e09faad3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3390%2Fmolecules18021826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules18021826%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DGong%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLiang%26aufirst%3DH.%26atitle%3DPharmacological%2520actions%2520of%2520multi-target-directed%2520evodiamine%26jtitle%3DMolecules%26date%3D2013%26volume%3D18%26spage%3D1826%26epage%3D1843%26doi%3D10.3390%2Fmolecules18021826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, F.</span></span> <span> </span><span class="NLM_article-title">Antiproliferative effects of alkaloid evodiamine and its derivatives</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3403</span>– <span class="NLM_lpage">3433</span>, <span class="refDoi"> DOI: 10.3390/ijms19113403</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.3390%2Fijms19113403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnsVKls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=3403-3433&author=X.+Huauthor=D.+Liauthor=C.+Chuauthor=X.+Liauthor=X.+Wangauthor=Y.+Jiaauthor=H.+Huaauthor=F.+Xu&title=Antiproliferative+effects+of+alkaloid+evodiamine+and+its+derivatives&doi=10.3390%2Fijms19113403"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Antiproliferative effects of alkaloid evodiamine and its derivatives</span></div><div class="casAuthors">Hu, Xu; Li, Dahong; Chu, Chun; Li, Xu; Wang, Xianhua; Jia, Ying; Hua, Huiming; Xu, Fanxing</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3403/1-3403/31</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Alkaloids, a category of natural products with ring structures and nitrogen atoms, include most U.S.  Food and Drug Administration approved plant derived anti-cancer agents.  Evodiamine is an alkaloid with attractive multitargeting antiproliferative activity.  Its high content in the natural source ensures its adequate supply on the market and guarantees further medicinal study.  To the best of our knowledge, there is no systematic review about the antiproliferative effects of evodiamine derivs.  Therefore, in this article the review of the antiproliferative activities of evodiamine will be updated.  More importantly, the antiproliferative activities of structurally modified new analogs of evodiamine will be summarized for the first time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3DA4y8FaINLVg90H21EOLACvtfcHk0ljCRqKc-rTz3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnsVKls7o%253D&md5=b9081f47f9cb3fe1dee9dd740ab132f5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3390%2Fijms19113403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19113403%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DChu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DHua%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DF.%26atitle%3DAntiproliferative%2520effects%2520of%2520alkaloid%2520evodiamine%2520and%2520its%2520derivatives%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26spage%3D3403%26epage%3D3433%26doi%3D10.3390%2Fijms19113403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, C.</span></span> <span> </span><span class="NLM_article-title">Evodiamine: a novel anti-cancer alkaloid from Evodia rutaecarpa</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1852</span>– <span class="NLM_lpage">1859</span>, <span class="refDoi"> DOI: 10.3390/molecules14051852</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.3390%2Fmolecules14051852" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=19471205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvVCmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=1852-1859&author=J.+Jiangauthor=C.+Hu&title=Evodiamine%3A+a+novel+anti-cancer+alkaloid+from+Evodia+rutaecarpa&doi=10.3390%2Fmolecules14051852"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Evodiamine: a novel anti-cancer alkaloid from Evodia rutaecarpa</span></div><div class="casAuthors">Jiang, Junlin; Hu, Changping</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1852-1859</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">A review.  Traditional Chinese herbs are regarded as a new and promising source of potential anti-cancer remedies and new chemotherapy adjuvants to enhance the efficacy of chemotherapy and/or to ameliorate its side effects.  Extensive investigations have been undertaken both in the exptl. and clin. studies over the years to augment the efficacy of chemotherapy.  Evodia rutaecarpa is a very popular multi-purpose herb traditionally used in China for the treatment of headaches, abdominal pain, postpartum hemorrhage, dysentery and amenorrhea.  The major constituents of Evodia rutaecarpa are evodiamine and rutaecarpine.  Growing evidence demonstrates that evodiamine possesses anti-cancer activities both in vitro and in vivo by inhibiting proliferation, invasion and metastasis, inducing apoptosis of a variety of tumor cell lines.  This review is aimed to summarize the recent researches on evodiamine focusing on anti-cancer activity and to highlight mol. mechanisms during the past ten years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrygUJ8nEBYU7Vg90H21EOLACvtfcHk0lhsSYRwtSO9TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvVCmtbw%253D&md5=ce11dc87f32f3db73b2462180521e9fa</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3390%2Fmolecules14051852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules14051852%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DC.%26atitle%3DEvodiamine%253A%2520a%2520novel%2520anti-cancer%2520alkaloid%2520from%2520Evodia%2520rutaecarpa%26jtitle%3DMolecules%26date%3D2009%26volume%3D14%26spage%3D1852%26epage%3D1859%26doi%3D10.3390%2Fmolecules14051852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span> <span> </span><span class="NLM_article-title">Pharmacological actions of multi-target-directed evodiamine</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1826</span>– <span class="NLM_lpage">1843</span>, <span class="refDoi"> DOI: 10.3390/molecules18021826</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.3390%2Fmolecules18021826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=23434865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivVegtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=1826-1843&author=H.+Yuauthor=H.+Jinauthor=W.+Gongauthor=Z.+Wangauthor=H.+Liang&title=Pharmacological+actions+of+multi-target-directed+evodiamine&doi=10.3390%2Fmolecules18021826"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological actions of multi-target-directed evodiamine</span></div><div class="casAuthors">Yu, Hui; Jin, Hongwei; Gong, Wuzhuang; Wang, Zhanli; Liang, Huaping</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1826-1843</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Evodiamine, a naturally occurring indole alkaloid, is one of the main bioactive ingredients of Evodiae fructus.  With respect to the pharmacol. actions of evodiamine, more attention has been paid to beneficial effects in insults involving cancer, obesity, nociception, inflammation, cardiovascular diseases, Alzheimer's disease, infectious diseases and themoregulative effects.  Evodiamine has evolved a superior ability to bind various proteins, so we also argue that it is good starting point for multi-target drugs.  This review is primarily addressed to the description of the recent advances in the biol. activity studies of evodiamine, with a focus on pharmacol. mechanism.  The present review also includes the pharmacokinetics and the detailed exploration of target-binding properties of evodiamine in an attempt to provide a direction for further multi-target drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGlSdsWLVJb7Vg90H21EOLACvtfcHk0lhsSYRwtSO9TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivVegtLk%253D&md5=798185966dcdbf033ffda501e09faad3</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3390%2Fmolecules18021826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules18021826%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DGong%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLiang%26aufirst%3DH.%26atitle%3DPharmacological%2520actions%2520of%2520multi-target-directed%2520evodiamine%26jtitle%3DMolecules%26date%3D2013%26volume%3D18%26spage%3D1826%26epage%3D1843%26doi%3D10.3390%2Fmolecules18021826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Novel fluorescent probes of 10-hydroxyevodiamine: autophagy and apoptosis-inducing anticancer mechanisms</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">144</span>– <span class="NLM_lpage">156</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2018.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.1016%2Fj.apsb.2018.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=30766786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A280%3ADC%252BB3cfjsleitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=144-156&author=S.+Chenauthor=G.+Dongauthor=S.+Wuauthor=N.+Liuauthor=W.+Zhangauthor=C.+Sheng&title=Novel+fluorescent+probes+of+10-hydroxyevodiamine%3A+autophagy+and+apoptosis-inducing+anticancer+mechanisms&doi=10.1016%2Fj.apsb.2018.08.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Novel fluorescent probes of 10-hydroxyevodiamine: autophagy and apoptosis-inducing anticancer mechanisms</span></div><div class="casAuthors">Chen Shuqiang; Dong Guoqiang; Wu Shanchao; Liu Na; Zhang Wannian; Sheng Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">144-156</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">Natural product evodiamine and its derivatives represent a promising class of multi-target antitumor agents.  However, the clinical development of these compounds has been hampered by a poor understanding of their antitumor mechanisms.  To tackle this obstacle, herein, novel fluorescent probes were designed to elucidate the antitumor mode of action of 10-hydroxyevodiamine.  This compound was proven to be distributed in the mitochondria and lysosomes and to act by autophagy and apoptosis mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRNezzR2Kp6Cj69zv1FsJFMfW6udTcc2eYQ47CiHumHrLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cfjsleitw%253D%253D&md5=1c612ecb4a68e60dd4ceaf23f46f8e62</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2018.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2018.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DNovel%2520fluorescent%2520probes%2520of%252010-hydroxyevodiamine%253A%2520autophagy%2520and%2520apoptosis-inducing%2520anticancer%2520mechanisms%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2019%26volume%3D9%26spage%3D144%26epage%3D156%26doi%3D10.1016%2Fj.apsb.2018.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span> <span> </span><span class="NLM_article-title">Selection of evodiamine as a novel topoisomerase I inhibitor by structure-based virtual screening and hit optimization of evodiamine derivatives as antitumor agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">7521</span>– <span class="NLM_lpage">7531</span>, <span class="refDoi"> DOI: 10.1021/jm100387d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100387d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1yktL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7521-7531&author=G.+Dongauthor=C.+Shengauthor=S.+Wangauthor=Z.+Miaoauthor=J.+Yaoauthor=W.+Zhang&title=Selection+of+evodiamine+as+a+novel+topoisomerase+I+inhibitor+by+structure-based+virtual+screening+and+hit+optimization+of+evodiamine+derivatives+as+antitumor+agents&doi=10.1021%2Fjm100387d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Selection of Evodiamine as a Novel Topoisomerase I Inhibitor by Structure-Based Virtual Screening and Hit Optimization of Evodiamine Derivatives as Antitumor Agents</span></div><div class="casAuthors">Dong, Guoqiang; Sheng, Chunquan; Wang, Shengzheng; Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7521-7531</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human topoisomerase I (TopoI) is recognized as a valuable target for the development of effective antitumor agents.  Structure-based virtual screening was applied to the discovery of structurally diverse TopoI inhibitors.  From 23 compds. selected by virtual screening, a total of 14 compds. were found to be TopoI inhibitors.  Five hits (compds. 1, 14, 20, 21, and 23) also showed moderate to good in vitro antitumor activity.  These novel structures can be considered as good starting points for the development of new antitumor lead compds.  Hit 20 (evodiamine) was chosen for preliminary structure-activity relationship studies.  Various groups, including alkyl, benzoyl, benzyl and ester, were introduced to the indole nitrogen atom of evodiamine.  The substituted benzoyl groups were found to be favorable for the antitumor activity and spectrum.  The 4-Cl benzoyl deriv., compd. 29u, was the most active one with IC50 values in the range 0.049-2.6 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouVyzcTgLm57Vg90H21EOLACvtfcHk0lhCc2uUtuFC2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1yktL3F&md5=4661573b99e3b902393b7710b2d5695c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm100387d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100387d%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DG.%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26atitle%3DSelection%2520of%2520evodiamine%2520as%2520a%2520novel%2520topoisomerase%2520I%2520inhibitor%2520by%2520structure-based%2520virtual%2520screening%2520and%2520hit%2520optimization%2520of%2520evodiamine%2520derivatives%2520as%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7521%26epage%3D7531%26doi%3D10.1021%2Fjm100387d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">New tricks for an old natural product: discovery of highly potent evodiamine derivatives as novel antitumor agents by systemic structure–activity relationship analysis and biological evaluations</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7593</span>– <span class="NLM_lpage">7613</span>, <span class="refDoi"> DOI: 10.1021/jm300605m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300605m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFClurfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7593-7613&author=G.+Dongauthor=S.+Wangauthor=Z.+Miaoauthor=J.+Yaoauthor=Y.+Zhangauthor=Z.+Guoauthor=W.+Zhangauthor=C.+Sheng&title=New+tricks+for+an+old+natural+product%3A+discovery+of+highly+potent+evodiamine+derivatives+as+novel+antitumor+agents+by+systemic+structure%E2%80%93activity+relationship+analysis+and+biological+evaluations&doi=10.1021%2Fjm300605m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">New Tricks for an Old Natural Product: Discovery of Highly Potent Evodiamine Derivatives as Novel Antitumor Agents by Systemic Structure-Activity Relationship Analysis and Biological Evaluations</span></div><div class="casAuthors">Dong, Guoqiang; Wang, Shengzheng; Miao, Zhenyuan; Yao, Jianzhong; Zhang, Yongqiang; Guo, Zizhao; Zhang, Wannian; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7593-7613</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Evodiamine is a quinazolinocarboline alkaloid isolated from the fruits of traditional Chinese herb Evodiae fructus.  Herein, a library of novel evodiamine derivs. bearing various substitutions or modified scaffold were synthesized.  Among them, a no. of evodiamine derivs. showed substantial increase of the antitumor activity, with GI50 values lower than 3 nM.  Moreover, these highly potent compds. can effectively induce the apoptosis of A549 cells.  Interestingly, further computational target prediction calcns. in combination with biol. assays confirmed that the evodiamine derivs. acted by dual inhibition of topoisomerases I and II.  Moreover, several hydroxyl derivs., such as 10-hydroxyevodiamine and 3-amino-10-hydroxyevodiamine, also showed good in vivo antitumor efficacy and low toxicity at the dose of 1 mg/kg or 2 mg/kg.  They represent promising candidates for the development of novel antitumor agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocJjv8REdBnrVg90H21EOLACvtfcHk0lhCc2uUtuFC2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFClurfP&md5=6e7d03671ac1be56b8bd68dc0fc03062</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm300605m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300605m%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DNew%2520tricks%2520for%2520an%2520old%2520natural%2520product%253A%2520discovery%2520of%2520highly%2520potent%2520evodiamine%2520derivatives%2520as%2520novel%2520antitumor%2520agents%2520by%2520systemic%2520structure%25E2%2580%2593activity%2520relationship%2520analysis%2520and%2520biological%2520evaluations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7593%26epage%3D7613%26doi%3D10.1021%2Fjm300605m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Scaffold diversity inspired by the natural product evodiamine: discovery of highly potent and multitargeting antitumor agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6678</span>– <span class="NLM_lpage">6696</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00910</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00910" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Gms7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6678-6696&author=S.+Wangauthor=K.+Fangauthor=G.+Dongauthor=S.+Chenauthor=N.+Liuauthor=Z.+Miaoauthor=J.+Yaoauthor=J.+Liauthor=W.+Zhangauthor=C.+Sheng&title=Scaffold+diversity+inspired+by+the+natural+product+evodiamine%3A+discovery+of+highly+potent+and+multitargeting+antitumor+agents&doi=10.1021%2Facs.jmedchem.5b00910"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Scaffold diversity inspired by the natural product evodiamine: discovery of highly potent and multitargeting antitumor agents</span></div><div class="casAuthors">Wang, Shengzheng; Fang, Kun; Dong, Guoqiang; Chen, Shuqiang; Liu, Na; Miao, Zhenyuan; Yao, Jianzhong; Li, Jian; Zhang, Wannian; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6678-6696</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A crit. question in natural product-based drug discovery is how to translate the product into drug-like mols. with optimal pharmacol. properties.  The generation of natural product-inspired scaffold diversity is an effective but challenging strategy to investigate the broader chem. space and identify promising drug leads.  Extending the efforts to the natural product evodiamine, a diverse library contg. 11 evodiamine-inspired novel scaffolds and their derivs. were designed and synthesized.  Most of them showed good to excellent antitumor activity against various human cancer cell lines.  In particular, 3-chloro-10-hydroxyl thio-evodiamine I showed excellent in vitro and in vivo antitumor efficacy with good tolerability and low toxicity.  Antitumor mechanism and target profiling studies indicate that compd. I is the first-in-class triple topoisomerase I/topoisomerase II/tubulin inhibitor.  Overall, this study provided an effective strategy for natural product-based drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFmWoZPbDbVrVg90H21EOLACvtfcHk0lhCc2uUtuFC2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Gms7%252FO&md5=eac1cb75b532b53aada4cbc25c0de4bf</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00910%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DK.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DScaffold%2520diversity%2520inspired%2520by%2520the%2520natural%2520product%2520evodiamine%253A%2520discovery%2520of%2520highly%2520potent%2520and%2520multitargeting%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6678%26epage%3D6696%26doi%3D10.1021%2Facs.jmedchem.5b00910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Netz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opatz, T.</span></span> <span> </span><span class="NLM_article-title">A modular formal total synthesis of (+/-)-cycloclavine</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">1723</span>– <span class="NLM_lpage">1730</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.5b02815</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.5b02815" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVGku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2016&pages=1723-1730&author=N.+Netzauthor=T.+Opatz&title=A+modular+formal+total+synthesis+of+%28%2B%2F-%29-cycloclavine&doi=10.1021%2Facs.joc.5b02815"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A Modular Formal Total Synthesis of (±)-Cycloclavine</span></div><div class="casAuthors">Netz, Natalie; Opatz, Till</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1723-1730</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cycloclavine (I) is a clavine-type Ergot alkaloid noteworthy for its unique pentacyclic skeleton featuring a 3-azabicyclo[3.1.0]hexane substructure.  A short convergent route to the racemic alkaloid is described which comprises only eight linear steps and requires only four chromatog. purifications.  The two key building blocks can be prepd. in high yield from com. available starting materials.  Two consecutive coupling reactions, namely a selective alkylation of a dienolate and a Heck reaction, are the key steps of the reaction sequence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaGeM_Kuh1CLVg90H21EOLACvtfcHk0lgGAoDr1dpxww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVGku7g%253D&md5=6519c4d28e2b7fcd069bf5ed091c40af</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.5b02815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.5b02815%26sid%3Dliteratum%253Aachs%26aulast%3DNetz%26aufirst%3DN.%26aulast%3DOpatz%26aufirst%3DT.%26atitle%3DA%2520modular%2520formal%2520total%2520synthesis%2520of%2520%2528%252B%252F-%2529-cycloclavine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2016%26volume%3D81%26spage%3D1723%26epage%3D1730%26doi%3D10.1021%2Facs.joc.5b02815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cogan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deleon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruenbaum, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashem, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moss, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netherton, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pargellis, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelletier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellati, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skow, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torcellini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werneburg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Z.</span></span> <span> </span><span class="NLM_article-title">Pyrazinoindolone inhibitors of MAPKAP-K2</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">938</span>– <span class="NLM_lpage">941</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.12.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.1016%2Fj.bmcl.2007.12.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=18221871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=938-941&author=D.+R.+Goldbergauthor=Y.+Choiauthor=D.+Coganauthor=M.+Corsonauthor=R.+Deleonauthor=A.+Gaoauthor=L.+Gruenbaumauthor=M.+H.+Haoauthor=D.+Josephauthor=M.+A.+Kashemauthor=C.+Millerauthor=N.+Mossauthor=M.+R.+Nethertonauthor=C.+P.+Pargellisauthor=J.+Pelletierauthor=R.+Sellatiauthor=D.+Skowauthor=C.+Torcelliniauthor=Y.-C.+Tsengauthor=J.+Wangauthor=R.+Wastiauthor=B.+Werneburgauthor=J.+P.+Wuauthor=Z.+Xiong&title=Pyrazinoindolone+inhibitors+of+MAPKAP-K2&doi=10.1016%2Fj.bmcl.2007.12.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazinoindolone inhibitors of MAPKAP-K2</span></div><div class="casAuthors">Goldberg, D. R.; Choi, Y.; Cogan, D.; Corson, M.; DeLeon, R.; Gao, A.; Gruenbaum, L.; Hao, M. H.; Joseph, D.; Kashem, M. A.; Miller, C.; Moss, N.; Netherton, M. R.; Pargellis, C. P.; Pelletier, J.; Sellati, R.; Skow, D.; Torcellini, C.; Tseng, Y.-C.; Wang, J.; Wasti, R.; Werneburg, B.; Wu, J. P.; Xiong, Z.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">938-941</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Optimization of pyrazinoindolone inhibitors of MAPKAP-K2 (MK2) provides a reasonable balance of cellular potency and physicochem. properties.  Mechanistic studies support the inhibition of MK2 which is responsible for the sub-micromolar cellular efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHMw6FxuAeyLVg90H21EOLACvtfcHk0lgGAoDr1dpxww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWkt7w%253D&md5=55a46852c9ccf52c8350d0a26de3e41d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.037%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DD.%2BR.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DCogan%26aufirst%3DD.%26aulast%3DCorson%26aufirst%3DM.%26aulast%3DDeleon%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DA.%26aulast%3DGruenbaum%26aufirst%3DL.%26aulast%3DHao%26aufirst%3DM.%2BH.%26aulast%3DJoseph%26aufirst%3DD.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DMiller%26aufirst%3DC.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DNetherton%26aufirst%3DM.%2BR.%26aulast%3DPargellis%26aufirst%3DC.%2BP.%26aulast%3DPelletier%26aufirst%3DJ.%26aulast%3DSellati%26aufirst%3DR.%26aulast%3DSkow%26aufirst%3DD.%26aulast%3DTorcellini%26aufirst%3DC.%26aulast%3DTseng%26aufirst%3DY.-C.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWasti%26aufirst%3DR.%26aulast%3DWerneburg%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DJ.%2BP.%26aulast%3DXiong%26aufirst%3DZ.%26atitle%3DPyrazinoindolone%2520inhibitors%2520of%2520MAPKAP-K2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D938%26epage%3D941%26doi%3D10.1016%2Fj.bmcl.2007.12.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortolozzi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basso, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viola, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferlin, M. G.</span></span> <span> </span><span class="NLM_article-title">Novel 3-substituted 7-phenylpyrrolo[3,2-<i>f</i>]quinolin-9(6<i>H</i>)-ones as single entities with multitarget antiproliferative activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7991</span>– <span class="NLM_lpage">8010</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00805</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00805" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFKqsr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7991-8010&author=D.+Cartaauthor=R.+Bortolozziauthor=E.+Hamelauthor=G.+Bassoauthor=S.+Moroauthor=G.+Violaauthor=M.+G.+Ferlin&title=Novel+3-substituted+7-phenylpyrrolo%5B3%2C2-f%5Dquinolin-9%286H%29-ones+as+single+entities+with+multitarget+antiproliferative+activity&doi=10.1021%2Facs.jmedchem.5b00805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 3-Substituted 7-Phenylpyrrolo[3,2-f]quinolin-9(6H)-ones as Single Entities with Multitarget Antiproliferative Activity</span></div><div class="casAuthors">Carta, Davide; Bortolozzi, Roberta; Hamel, Ernest; Basso, Giuseppe; Moro, Stefano; Viola, Giampietro; Ferlin, Maria Grazia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7991-8010</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of chem. modified 7-phenylpyrrolo[3,2-f]quinolinones was synthesized and evaluated as anticancer agents.  Among them, the most cytotoxic (subnanomolar GI50 values) amidic deriv. I was shown to act as an inhibitor of tubulin polymn. (IC50, 0.99 μM) by binding to the colchicine site with high affinity.  Moreover, I induced cell cycle arrest in the G2/M phase of the cell cycle in a concn. dependent manner, followed by caspase-dependent apoptotic cell death.  Compd. I also showed lower toxicity in nontumoral cells, suggesting selectivity toward cancer cells.  Addnl. expts. revealed that I inhibited the enzymic activity of multiple kinases, including AURKA, FLT3, GSK3A, MAP3K, MEK, RSK2, RSK4, PLK4, ULK1, and JAK1.  Computational studies showed that I can be properly accommodated in the colchicine binding site of tubulin as well as in the ATP binding clefts of all examd. kinases.  Our data indicate that the excellent antiproliferative profile of I may be derived from its interactions with multiple cellular targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDexCP1OpxdbVg90H21EOLACvtfcHk0lgGAoDr1dpxww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFKqsr7F&md5=d2b5ac90567a747e81b9ca3cbd3778d1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00805%26sid%3Dliteratum%253Aachs%26aulast%3DCarta%26aufirst%3DD.%26aulast%3DBortolozzi%26aufirst%3DR.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DBasso%26aufirst%3DG.%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DViola%26aufirst%3DG.%26aulast%3DFerlin%26aufirst%3DM.%2BG.%26atitle%3DNovel%25203-substituted%25207-phenylpyrrolo%255B3%252C2-f%255Dquinolin-9%25286H%2529-ones%2520as%2520single%2520entities%2520with%2520multitarget%2520antiproliferative%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7991%26epage%3D8010%26doi%3D10.1021%2Facs.jmedchem.5b00805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of novel antitumor spirodihydrothiopyran-oxindole derivatives</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1636</span>– <span class="NLM_lpage">1642</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2019.04.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.1016%2Fj.bmcl.2019.04.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=31047751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC1MXos12gs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=1636-1642&author=W.+Liuauthor=S.+Chenauthor=F.+Zhangauthor=S.+Heauthor=S.+Wangauthor=C.+Sheng&title=Design%2C+synthesis+and+biological+evaluation+of+novel+antitumor+spirodihydrothiopyran-oxindole+derivatives&doi=10.1016%2Fj.bmcl.2019.04.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of novel antitumor spirodihydrothiopyran-oxindole derivatives</span></div><div class="casAuthors">Liu, Wei; Chen, Shuqiang; Zhang, Fan; He, Shipeng; Wang, Shengzheng; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1636-1642</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sulfur contg. spiroheterocyclic oxindoles are promising privileged scaffolds in medicinal chem. and drug discovery.  Previously, we identified a new class of spirodihydrothiopyran-oxindoles with good in vitro antitumor activity against A549 lung cancer cell line.  Herein, various spirooxindole-dihydrothiopyrans with diverse substitutions were synthesized and assayed to investigate the structure-activity relationships.  Among the derivs., compds. 4b, 4i, 4m, 4n and 4q (I - V, resp.) displayed superior or comparable antitumor activity to nutlin-3.  Mol. mechanism study revealed this scaffold displayed moderate MDM2 inhibitory activity, significantly induced cancer cell apoptosis and arrested cell cycle at G0/G1 phase, which represented a good lead compd. for antitumor drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMRU5jSAbLuLVg90H21EOLACvtfcHk0lhNea_N6NVz8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXos12gs7s%253D&md5=dde420d46c2fc321d70bfcdc1a86a8cc</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.04.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.04.037%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520antitumor%2520spirodihydrothiopyran-oxindole%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26spage%3D1636%26epage%3D1642%26doi%3D10.1016%2Fj.bmcl.2019.04.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rudolf, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cervinka, M.</span></span> <span> </span><span class="NLM_article-title">Topoisomerases and tubulin inhibitors: a promising combination for cancer treatment</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">429</span>, <span class="refDoi"> DOI: 10.2174/1568011033482242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.2174%2F1568011033482242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotFOns7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=421-429&author=E.+Rudolfauthor=M.+Cervinka&title=Topoisomerases+and+tubulin+inhibitors%3A+a+promising+combination+for+cancer+treatment&doi=10.2174%2F1568011033482242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Topoisomerases and tubulin inhibitors: A promising combination for cancer treatment</span></div><div class="casAuthors">Rudolf, E.; Cervinka, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry: Anti-Cancer Agents</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">421-429</span>CODEN:
                <span class="NLM_cas:coden">CMCACI</span>;
        ISSN:<span class="NLM_cas:issn">1568-0118</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Modern approaches to treatment of cancer seek to activate the internal suicide program in the malignant cells, and thereby effectively eliminate them without engaging most of other bodily systems.  Many currently used cytostatics are known to induce apoptosis and efforts are being paid to develop new ones with better and more effective proapoptotic potential.  Nevertheless, despite recent developments in this field, there are still numerous malignancies showing a varying degree of resistance to cell death due to the corrupted signaling pathways and genetic alterations, often in conjunction with expansive proliferation rate.  It has been shown that topoisomerase inhibiting agents such as etoposide, camptothecin and others represent a powerful and dynamic group of cytostatic chems. used in exptl. and clin. conditions.  So, it is a group of microtubule targeting poisons comprising classical colchicines on the one hand and new taxanes on the other hand.  Since several members of both groups have been evidenced as apoptosis inducers operating via distinct mechanism, their combination should theor. enhance the final therapeutic outcome.  This minireview focuses on the possibilities of such a combinational approach with respect to possible benefits and hazards of this strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJiCqrOtqGHLVg90H21EOLACvtfcHk0lhNea_N6NVz8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotFOns7s%253D&md5=2ecc33565f5b54921de17a2fac21e916</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F1568011033482242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568011033482242%26sid%3Dliteratum%253Aachs%26aulast%3DRudolf%26aufirst%3DE.%26aulast%3DCervinka%26aufirst%3DM.%26atitle%3DTopoisomerases%2520and%2520tubulin%2520inhibitors%253A%2520a%2520promising%2520combination%2520for%2520cancer%2520treatment%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D421%26epage%3D429%26doi%3D10.2174%2F1568011033482242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diana, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martorana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barraja, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montalbano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dattolo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirrincione, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dall’Acqua, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvador, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedaldi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basso, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viola, G.</span></span> <span> </span><span class="NLM_article-title">Isoindolo[2, 1-<i>a</i>]quinoxaline derivatives, novel potent antitumor agents with dual inhibition of tubulin polymerization and topoisomerase I</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2387</span>– <span class="NLM_lpage">2399</span>, <span class="refDoi"> DOI: 10.1021/jm070834t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070834t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjvFeis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2387-2399&author=P.+Dianaauthor=A.+Martoranaauthor=P.+Barrajaauthor=A.+Montalbanoauthor=G.+Dattoloauthor=G.+Cirrincioneauthor=F.+Dall%E2%80%99Acquaauthor=A.+Salvadorauthor=D.+Vedaldiauthor=G.+Bassoauthor=G.+Viola&title=Isoindolo%5B2%2C+1-a%5Dquinoxaline+derivatives%2C+novel+potent+antitumor+agents+with+dual+inhibition+of+tubulin+polymerization+and+topoisomerase+I&doi=10.1021%2Fjm070834t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Isoindolo[2,1-a]quinoxaline Derivatives, Novel Potent Antitumor Agents with Dual Inhibition of Tubulin Polymerization and Topoisomerase I</span></div><div class="casAuthors">Diana, Patrizia; Martorana, Annamaria; Barraja, Paola; Montalbano, Alessandra; Dattolo, Gaetano; Cirrincione, Girolamo; Dall'Acqua, Francesco; Salvador, Alessia; Vedaldi, Daniela; Basso, Giuseppe; Viola, Giampietro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2387-2399</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Isoindoloquinoxalines I (R1 = R2 = R3 = R4 = R5 = H; R1 = Me, R2 = R3 = R4 = R5 = H; R2 = MeO, R1 = R3 = R4 = R5 = H; R2 = R3 = MeO, Cl, R1 = R4 = R5 = H ) and II (same R1, R2, R3, R4, R5) were obtained by refluxing 2-(2'-aminoaryl)-1-cyanoisoindoles in acetic or formic acid.  All derivs. were screened by the National Cancer Institute (Bethesda, MD) for the in vitro one dose primary anticancer assay against a 3-cell line panel.  Compds. I, screened against a panel of about 60 human tumor cell lines, showed remarkable antineoplastic activity; they had GI50 values in the low micromolar or submicromolar range and reached, in the case of I (III; R1 = Me, R2 = R3 = R4 = R5 = H), nanomolar concns. on 88% of the 59 tested cell lines.  Flow cytometric anal. of cell cycle after treatment with III demonstrated an arrest of the cell cycle in G2/M phase.  This effect was accompanied with apoptosis of the cells, mitochondrial depolarization, generation of reactive oxygen species, and activation of caspase-3 and caspase-9.  Moreover, III induced a clear increase in the mitotic index, inhibited microtubule assembly in vitro, and interestingly also acted as a topoisomerase I inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwpVL48HGKi7Vg90H21EOLACvtfcHk0lhNea_N6NVz8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjvFeis78%253D&md5=2b5998c7fd48a1cfdadfdf2d454823d3</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm070834t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070834t%26sid%3Dliteratum%253Aachs%26aulast%3DDiana%26aufirst%3DP.%26aulast%3DMartorana%26aufirst%3DA.%26aulast%3DBarraja%26aufirst%3DP.%26aulast%3DMontalbano%26aufirst%3DA.%26aulast%3DDattolo%26aufirst%3DG.%26aulast%3DCirrincione%26aufirst%3DG.%26aulast%3DDall%25E2%2580%2599Acqua%26aufirst%3DF.%26aulast%3DSalvador%26aufirst%3DA.%26aulast%3DVedaldi%26aufirst%3DD.%26aulast%3DBasso%26aufirst%3DG.%26aulast%3DViola%26aufirst%3DG.%26atitle%3DIsoindolo%255B2%252C%25201-a%255Dquinoxaline%2520derivatives%252C%2520novel%2520potent%2520antitumor%2520agents%2520with%2520dual%2520inhibition%2520of%2520tubulin%2520polymerization%2520and%2520topoisomerase%2520I%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2387%26epage%3D2399%26doi%3D10.1021%2Fjm070834t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linghua, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liping, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caihua, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ming, L. J.</span></span> <span> </span><span class="NLM_article-title">A series of α-heterocyclic carboxaldehyde thiosemicarbazones inhibit topoisomerase IIalpha catalytic activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3048</span>– <span class="NLM_lpage">3064</span>, <span class="refDoi"> DOI: 10.1021/jm9014394</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9014394" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3048-3064&author=H.+Heauthor=C.+Qinauthor=K.+Xinauthor=M.+Linghuaauthor=L.+Lipingauthor=W.+Xiangauthor=Z.+Caihuaauthor=W.+Yiauthor=C.+Zhiauthor=L.+J.+Ming&title=A+series+of+%CE%B1-heterocyclic+carboxaldehyde+thiosemicarbazones+inhibit+topoisomerase+IIalpha+catalytic+activity&doi=10.1021%2Fjm9014394"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm9014394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9014394%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DH.%26aulast%3DQin%26aufirst%3DC.%26aulast%3DXin%26aufirst%3DK.%26aulast%3DLinghua%26aufirst%3DM.%26aulast%3DLiping%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DW.%26aulast%3DCaihua%26aufirst%3DZ.%26aulast%3DYi%26aufirst%3DW.%26aulast%3DZhi%26aufirst%3DC.%26aulast%3DMing%26aufirst%3DL.%2BJ.%26atitle%3DA%2520series%2520of%2520%25CE%25B1-heterocyclic%2520carboxaldehyde%2520thiosemicarbazones%2520inhibit%2520topoisomerase%2520IIalpha%2520catalytic%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3048%26epage%3D3064%26doi%3D10.1021%2Fjm9014394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shelanski, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaskin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantor, C. R.</span></span> <span> </span><span class="NLM_article-title">Microtubule assembly in the absence of added nucleotides</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">765</span>– <span class="NLM_lpage">768</span>, <span class="refDoi"> DOI: 10.1073/pnas.70.3.765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=10.1073%2Fpnas.70.3.765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=4514990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADyaE3sXhsVCgtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1973&pages=765-768&author=M.+L.+Shelanskiauthor=F.+Gaskinauthor=C.+R.+Cantor&title=Microtubule+assembly+in+the+absence+of+added+nucleotides&doi=10.1073%2Fpnas.70.3.765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule assembly in the absence of added nucleotides</span></div><div class="casAuthors">Shelanski, Michael L.; Gaskin, Felicia; Cantor, Charles R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">765-8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Microtubule assembly was enhanced by the addn. of M sucrose or 4 M glycerol to the reassembly mixt.  Tubulin was purified from guinea pig brain readily and in good yield by tycles of assembly in glycerol-contg. solns  The tubules assembled in glycerol and sucrose were more stable than tubules formed in the absence of these compds.  Assembly occurred in glycerol or sucrose in he absence of ATP or GT but was greatly accelerated by their presence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVpPUVyzxhcbVg90H21EOLACvtfcHk0lhx5XhZdJRcyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXhsVCgtrs%253D&md5=c0eb0f728884f0a0eba421d633c9031b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1073%2Fpnas.70.3.765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.70.3.765%26sid%3Dliteratum%253Aachs%26aulast%3DShelanski%26aufirst%3DM.%2BL.%26aulast%3DGaskin%26aufirst%3DF.%26aulast%3DCantor%26aufirst%3DC.%2BR.%26atitle%3DMicrotubule%2520assembly%2520in%2520the%2520absence%2520of%2520added%2520nucleotides%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1973%26volume%3D70%26spage%3D765%26epage%3D768%26doi%3D10.1073%2Fpnas.70.3.765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Routier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peixoto, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mérour, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coudert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dias, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierré, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Léonce, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caignard, D.-H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel naphthocarbazoles as potential anticancer agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1401</span>– <span class="NLM_lpage">1413</span>, <span class="refDoi"> DOI: 10.1021/jm049213f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049213f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yhsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1401-1413&author=S.+Routierauthor=P.+Peixotoauthor=J.-Y.+M%C3%A9rourauthor=G.+Coudertauthor=N.+Diasauthor=C.+Baillyauthor=A.+Pierr%C3%A9author=S.+L%C3%A9onceauthor=D.-H.+Caignard&title=Synthesis+and+biological+evaluation+of+novel+naphthocarbazoles+as+potential+anticancer+agents&doi=10.1021%2Fjm049213f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of novel naphthocarbazoles as potential anticancer agents</span></div><div class="casAuthors">Routier, Sylvain; Peixoto, Paul; Merour, Jean-Yves; Coudert, Gerard; Dias, Nathalie; Bailly, Christian; Pierre, Alain; Leonce, Stephane; Caignard, Daniel-Henry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1401-1413</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The efficient synthesis involving palladium-catalyzed reactions and biol. evaluation of naphthocarbazoles, e.g., I, designed as potential anticancer agents, are reported.  The use of 5- and 6-benzyloxyindoles generated three substitution sites which were successively exploited to introduce several hydrophilic side chains.  The cytotoxicity of the designed compds. was evaluated on three cell lines.  Several compds. showed a marked cytotoxicity with IC50 values in the sub-micromolar range.  This was the case for I, bearing a dimethylaminoethyl side chain, which was extremely cytotoxic to L1210 and DU145 cells (IC50: 36 nM, 108 nM) and induced an accumulation of L1210 cells in the G2+M phases of the cell cycle.  Some of the most cytotoxic compds. were tested for inhibition of CDK-5, GSK-3 and topoisomerase I, and their interaction with DNA was also evaluated.  Interaction with DNA was detected, suggesting that nucleic acids represent a privileged target for these mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-kpQ081wFm7Vg90H21EOLACvtfcHk0lhx5XhZdJRcyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yhsL4%253D&md5=820aff5d15c2ece73089a50ca86fdfd0</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm049213f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049213f%26sid%3Dliteratum%253Aachs%26aulast%3DRoutier%26aufirst%3DS.%26aulast%3DPeixoto%26aufirst%3DP.%26aulast%3DM%25C3%25A9rour%26aufirst%3DJ.-Y.%26aulast%3DCoudert%26aufirst%3DG.%26aulast%3DDias%26aufirst%3DN.%26aulast%3DBailly%26aufirst%3DC.%26aulast%3DPierr%25C3%25A9%26aufirst%3DA.%26aulast%3DL%25C3%25A9once%26aufirst%3DS.%26aulast%3DCaignard%26aufirst%3DD.-H.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520naphthocarbazoles%2520as%2520potential%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1401%26epage%3D1413%26doi%3D10.1021%2Fjm049213f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of cyclopropylamide analogues of combretastatin-A4 as novel microtubule-stabilizing agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">685</span>– <span class="NLM_lpage">699</span>, <span class="refDoi"> DOI: 10.1021/jm301864s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301864s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFaqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=685-699&author=H.+Chenauthor=Y.+Liauthor=C.+Shengauthor=Z.+Lvauthor=G.+Dongauthor=T.+Wangauthor=J.+Liuauthor=M.+Zhangauthor=L.+Liauthor=T.+Zhangauthor=D.+Gengauthor=C.+Niuauthor=K.+Li&title=Design+and+synthesis+of+cyclopropylamide+analogues+of+combretastatin-A4+as+novel+microtubule-stabilizing+agents&doi=10.1021%2Fjm301864s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Cyclopropylamide Analogues of Combretastatin-A4 as Novel Microtubule-Stabilizing Agents</span></div><div class="casAuthors">Chen, Huan; Li, Yongmei; Sheng, Chunquan; Lv, Zhiliang; Dong, Guoqiang; Wang, Tiantian; Liu, Jia; Zhang, Mingfeng; Li, Lingzhen; Zhang, Tao; Geng, Dongping; Niu, Chunjuan; Li, Ke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">685-699</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of novel cyclopropylamide analogs of combretastatin-A4 (CA-4) were designed and synthesized.  Most of them had significant in vitro antiproliferative activities.  Moreover, compd. I was also equally potent against paclitaxel resistant cancer cells.  Interestingly, the novel cyclopropylamide analogs had different binding mechanisms from CA-4.  Instead of inhibiting tubulin polymn., these CA-4 derivs. were able to stimulate tubulin polymn.  Flow cytometry revealed that compd. I arrested A549 cancer cells in the G2/M phase and resulted in cellular apoptosis.  Further immunofluorescence assays revealed that compd. I induced mitotic arrest in A549 cells through disrupting microtubule dynamics.  In addn., compd. I also effectively inhibited the tumor growth in the A549 xenograft model without causing significant loss of body wt.  Compd. I represents a novel class of microtubule-stabilizing agent and can be used as a promising lead for the development of new antitumor agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcQqkKQT1ImbVg90H21EOLACvtfcHk0lhx5XhZdJRcyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFaqtLw%253D&md5=63f76583efba1c8902844c97afa6da73</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm301864s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301864s%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DLv%26aufirst%3DZ.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DGeng%26aufirst%3DD.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DK.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520cyclopropylamide%2520analogues%2520of%2520combretastatin-A4%2520as%2520novel%2520microtubule-stabilizing%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D685%26epage%3D699%26doi%3D10.1021%2Fjm301864s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T8I" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1T8I','PDB','1T8I'); return false;">PDB: 1T8I</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SA0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SA0','PDB','1SA0'); return false;">PDB: 1SA0</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i89"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01626">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_44762"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01626?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01626</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Biological assays of compound <b>15j</b> against a panel of 30 antitumor targets and HPLC chromatograms of compounds <b>15j</b> and <b>15js</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01626/suppl_file/jm9b01626_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings of the target compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01626/suppl_file/jm9b01626_si_002.csv">CSV</a>)</p></li><li><p class="inline">Molecular docking of compound <b>15j</b> with Top1 (15j_1T8I.pdb) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01626/suppl_file/jm9b01626_si_003.pdb">PDB</a>)</p></li><li><p class="inline">Molecular docking of compound <b>15j</b> with tubulin (15J_1SA0.pdb) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01626/suppl_file/jm9b01626_si_004.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01626/suppl_file/jm9b01626_si_001.pdf">jm9b01626_si_001.pdf (339.92 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01626/suppl_file/jm9b01626_si_002.csv">jm9b01626_si_002.csv (2.85 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01626/suppl_file/jm9b01626_si_003.pdb">jm9b01626_si_003.pdb (2.13 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01626/suppl_file/jm9b01626_si_004.pdb">jm9b01626_si_004.pdb (900.33 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01626&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01626%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-2%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01626" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677aabee8c6c1955","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
